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i 
 
 
 
The liver is home to a number of tissue associated lymphocyte populations, of which 
many have been implicated in the pathogenesis of chronic liver diseases.  γδ T cells, 
particularly the Vδ2neg subset, are known to comprise a substantial proportion of tissue 
associated lymphocytes, although their immunobiology remains poorly understood.  
Here, the localisation, TCR diversity, immunophenotype and function of human 
intrahepatic γδ T cells was explored with an emphasis on highlighting any potential role in 
chronic liver disease and also to further understanding of tissue associated γδ T cells, 
using the liver as a model tissue.  Intrahepatic γδ T cells were predominantly localised in 
the sinusoids and did not increase in frequency with chronic inflammation.  Vδ2neg cells 
exhibited private TCR clonal focussing, with complex CDR3 regions suggestive of antigen-
driven expansions, concordant with a loss of naïve-like CD27hi cells present in the 
periphery.  Expanded clonotypes were phenotypically TEM- or TEMRA-like, with TEMRA-like 
clonotypes shared between liver and blood and resembling vasculature-associated virus 
specific CD8+ T cells while TEM clonotypes were identified only in the liver and resembled 
tissue-resident CD8+ T cells.  These findings suggest that disease has minimal impact on 
intrahepatic γδ T cells, while supporting an adaptive paradigm for these cells in the 
formation of tissue-associated subsets.    
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Introduction  
 
2 
1.1 The mammalian immune response 
 
The immune response has evolved to protect host organisms from attack by exogenous 
intracellular and extracellular pathogens, including bacteria, viruses and parasites, and 
also has a significant role in the homeostasis of host tissues through modification of the 
microenvironment, removal of dead or dying cells, and wound repair.  Two arms of the 
immune system have developed, one, the innate immune response, forming the first line 
of defence against invading pathogen and playing a major role in tissue homeostasis, the 
other, the adaptive immune response, responsible for removal of pathogens that escape 
the innate response and for the formation of immunological memory, enabling rapid and 
effective responses to any repeated insult. 
1.1.1 The innate immune response 
 
Many common pathogens share molecular elements that are not found in the host 
organism.  These are termed pathogen-associated molecular patterns (PAMPs), and 
include lipopolysaccharide (LPS) found in bacterial cell walls, and viral RNA, amongst 
many others (Medzhitov and Janeway, 2002).  Damage to cells from physical or chemical 
sources can also trigger the release of damage-associated molecular patterns (DAMPs) 
(Bianchi, 2007).  Through the evolution of immune cell surface receptors that recognise 
these elements (pattern recognition receptors, or PRRs), innate immune cells are capable 
of quickly identifying pathogens and instigating an immune response.   This response 
occurs either through direct means such as endocytosis or cytolysis, indirectly through 
the release of inflammatory cytokines and recruitment of other immune cells to the site 
of infection, or very often a mix of both (Brightbill et al., 1999, Svanborg et al., 1999).  
 
3 
Cells of the innate immune response also have a critical role as antigen presenting cells 
(APC), priming the adaptive immune response, as will be discussed below. 
Cells of myeloid origin are particularly important in innate immunity, with monocyte-
derived macrophages and dendritic cells (DC) playing key roles, but lymphoid cells also 
play a role, particularly natural killer (NK) cells (Yokoyama and Plougastel, 2003), NKT cells 
(Kronenberg and Gapin, 2002) and innate-like lymphocytes (ILC) (Hwang and McKenzie, 
2013). 
1.1.2 The adaptive immune response 
 
While PRR such as the Toll-like receptors (TLR) expressed by cells of the innate response 
are capable of detecting many pathogens based on generic molecular features (Takeda et 
al., 2003), cells of the adaptive immune response, namely T lymphocytes and B 
lymphocytes, have highly targeted antigen recognition capabilities.  This takes the form of 
the T cell receptor (TCR) or B cell receptor (BCR) respectively.  These receptors are 
generated by somatic rearrangement of the genes at the TCR/ BCR locus, orchestrated in 
part by enzymes encoded by the RAG1 and RAG2 genes (Shinkai et al., 1992).  This results 
in T cells and B cells being able to recognise a hugely diverse repertoire of potential 
antigens – potentially up to 1015 individual specificities (Davis and Bjorkman, 1988). 
As with PRR, activation of the T cell receptor by binding with its cognate antigen triggers 
the lymphocyte to either develop cytotoxic properties or to secrete cytokines specific to 
the cytokine milieu encountered by the cell during antigen recognition (Croft et al., 1994, 
Nakamura et al., 1997).  In B cells, recognition of cognate antigen through the BCR 
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triggers differentiation of the cell into a plasma cell, capable of secreting immunoglobulin 
(Ig) antibodies (Slifka et al., 1998).  
In addition, long-lasting immune protection can only be conferred by the creation of 
immune cells capable of rapidly expanding in response to challenge.  The formation of 
these memory cells is carried out by the adaptive immune response, through clonal 
expansion of lymphocytes that have been exposed to antigen via their TCR/ BCR (Kaech et 
al., 2002). 
1.1.3 Conventional T cells 
 
Conventional T cells express a TCR composed of a heterodimer of a disulphide linked α 
chain and β chain.  These chains consist of an extracellular immunoglobulin-like domain, a 
short cytoplasmic domain and a transmembrane domain that allows association with the 
CD3 tetramer complex, together forming the TCR complex (Clevers et al., 1988).  Antigen 
specificity is conferred by the highly variable membrane distal domains of the TCR chains, 
which share structural homology with Ig variable (IgV) domains.  Like IgV, these domains 
contain three complementarity determining regions (CDR), loops of the protein chain 
with highly varied amino acid sequence.  The three CDR of the α chain combine with 
those of the β chain to form the antigen binding site, and due to the unique combination 
of amino acids present, each binding site will have a unique conformation, polarity and 
hygroscopicity, being therefore highly selective for a particular antigen (Garboczi et al., 
1996). 
The TCR complex is unable to bind free antigen.  Instead, antigen in the form of short 
peptide sequences must be presented by another molecule on the surface of the target 
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cell, namely the major histocompatibility complex (MHC) (Germain, 1994).  In humans, 
there are nine genes encoding for the MHC, termed the human leucocyte antigen (HLA) 
complex.  Three of these genes, HLA-A, HLA-B and HLA-C, encode for MHC class I 
molecules, while the HLA-D family of six genes encode MHC class II.  Antigens derived 
from intracellular pathogens and processes are typically presented on MHC class I 
molecules, while those derived from extracellular pathogens are presented on MHC class 
II.  While MHC class I molecules are normally expressed on all nucleated cells, MHC class 
II molecules are normally expressed only by professional APC, such as macrophages and 
DC (Steimle et al., 1994).  Diversity of the HLA locus genes is very high due to an extensive 
number of polymorphisms, and as such the protein products of these genes constitute a 
marker of “self” in terms of cellular recognition.   
In addition to recognition and binding of the target cell MHC-peptide complex by the TCR, 
T lymphocytes require additional stimulation to gain effector function (Rudolph et al., 
2006).  CD8 is a co-stimulatory molecule expressed by a subset of T cells that recognises 
the invariant domain of MHC class I molecules and amplifies the intracellular signalling 
cascade triggered by MHC-peptide binding through the TCR (Gao et al., 1997).  T cells 
expressing CD8 that are activated in this way become cytotoxic T lymphocytes (CTL), 
capable of secreting perforin and granzyme and thereby killing the target cell, or inducing 
programmed cell death (Green et al., 2003).  In this way the source of intracellular 
antigen will be destroyed.  CD4 is another co-stimulatory molecule that recognises the 
invariable domain of MHC class II (Wang and Reinherz, 2002).  CD4+ T cells are generally 
termed T helper cells (TH) due to their influence on other immune cell subsets.  Due to 
the varied nature of extracellular pathogens, CD4+ T cells require an additional signal to 
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differentiate, in the form of cytokine stimulation (Mucida and Cheroutre, 2010).  Binding 
of MHC class II and CD4 co-stimulation in the presence of IL-12 will commit the T cell to 
the TH1 phenotype, expressing the pro-inflammatory IFN-γ and TNF-α, which helps 
activate CTL, NK and bactericidal macrophages (Berberich et al., 2003).  IL-4 in the 
microenvironment will result in adoption of a TH2 phenotype by the CD4
+ T cell, capable 
of stimulating B cell differentiation to generate a humoral response against parasites 
(Kaplan et al., 1998).  Antigen binding in the presence of IL-6 and IL-1β leads to a TH17 
phenotype, with expression of IL-17 and IL-22 leading to recruitment of 
polymorphonuclear cells capable of dealing with invading bacteria and fungi.  Finally, 
recognition of antigen in the presence of TGF-β leads to generation of a regulatory T cell 
phenotype (Treg), capable of expressing IL-10, TGF-β and T cell inhibitory molecules such 
as cytotoxic T lymphocyte antigen 4 (CTLA-4), thereby dampening an immune response 
and limiting immunopathology (Sakaguchi, 2005).  
1.1.4 Kinetics of the adaptive immune response 
 
Proteins inside the cell are continuously degraded by the proteasome complex in the 
cytosol and the resulting short peptides are transported into the endoplasmic reticulum 
(ER) via the transport-associated with antigen processing complex (TAP).  In the ER these 
peptides associate with the MHC class I subunits and the entire complex is assembled and 
transported to the cell surface.  In cells capable of expressing MHC class II, i.e. 
professional APCs, antigenic pathogens are phagocytosed, or extracellular proteins are 
endocytosed, degraded, and these vesicles are fused with ER derived vesicles containing 
nascent MHC class II molecules before being transported to the cell surface 
(Guermonprez et al., 2002).  Uptake of pathogen and antigen presentation is associated 
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with migration of APC, specifically DC, to the lymph nodes or spleen, where they can 
interact with naïve T lymphocytes, or the release of chemoattractants that recruit T cells 
to the site of infection (Allan et al., 2006).  In either case, passing naïve T cells with 
specificity for the presented MHC-peptide complex will bind with the target cell or APC, a 
process also requiring the interaction of signal 2 molecules such as CD28, expressed by T 
cells (Acuto and Michel, 2003), with CD80 or CD86, expressed by many APC (Greenwald 
et al., 2005).  This priming interaction will trigger T cell effector function development, as 
well as proliferation and migration to the site of infection (Kapsenberg, 2003).  A 
proportion of these cells will not follow these differentiation steps but will instead 
acquire a memory phenotype.  This generates a central pool of long-lived, antigen-
specific cells capable of rapid response to further challenge by previously encountered 
antigen.  While the innate immune response mediated by macrophages, neutrophils and 
NK cells is very rapid, the adaptive immune response requires a longer timeframe due to 
the need for migration, APC and T cell interaction and consequent expansion of effector 
cell populations.  However, it is becoming apparent that another branch of adaptive 
immunity may be capable of bridging the gap between the innate and adaptive response, 
a branch composed for the most part of unconventional T cells.  Unconventional T cells all 
express a TCR but are generally incapable of recognising MHC-peptide complex, instead 
binding with MHC-like molecules, including CD1 and MR1 (Treiner and Lantz, 2006).  
While several subsets of unconventional T cells exist, including natural killer T cells (NKT) 
and mucosal associated invariant T cells (MAIT), this thesis will focus on γδ T cells, and in 
particular their role in the liver. 
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1.2 Gamma delta T cells 
 
1.2.1 Defining the immunological niche of γδ T cells 
 
γδ T cells express a TCR composed of a γ chain and a δ chain, encoded by γ and δ genes 
that rearrange in the same way as Ig and αβ+ TCRs (Elliott et al., 1988).  Although these 
chains have far fewer corresponding variable (V) region gene segments than αβ T cells, 
with only 70 possible combinations of Vγ and Vδ segments compared with 2,500 for αβ 
TCRs, the variability of the γδ TCR is increased hugely by use of multiple reading frames 
for transcription and recombination of the Vδ segment with diversity (D) regions in the δ 
chain, resulting in up to 1018 individual specificities (Davis and Bjorkman, 1988).  In both 
mice and humans however, use of the Vδ segment is often restricted, and in mice in 
particular specific combinations of Vγ and Vδ regions are often observed, especially in 
tissue associated γδ T cell populations.  For example, in mice, the dermal epithelium is 
populated exclusively with γδ T cells expressing the Vγ5Vδ1 combination, while in 
humans the blood subset of γδ T cells expresses the Vγ9Vδ2 combination at a frequency 
of 90 – 99%.  In human epithelial tissue, γδ T cells primarily express Vδ1 or Vδ3, in 
combination with a variety of Vγ segments, and they may constitute up to 50% of the 
total CD3+ lymphocyte population (Guy-Grand et al., 2013).  This observed enrichment of 
γδ T cells in epithelial tissue suggests a role for these cells in innate-like protection 
against invading pathogen, especially since it is apparent that these cells do not migrate 
to the lymphoid tissue for priming in the same way that naïve αβ T cells do, and therefore 
will not be exposed to the large number of diverse antigens presented there by DC. 
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Although monoclonal proliferation of antigen specific γδ T cells has been documented in 
response to infectious agents such as listeria, salmonella and toxoplasmosis, as indeed 
has the formation of an effector memory population of virus specific Vδ2neg T cells 
following cytomegalovirus (CMV) infection in some patients (Pitard et al., 2008), in 
general previous studies of γδ T cells have suggested that they do not seem to form 
genuine memory cells as occurs in true adaptive immunity. 
As well as the TCR, γδ T cells express a variety of cell surface receptors common to cells of 
the innate lineage, including both activatory and inhibitory NK receptors, such natural 
killer group 2 member D (NKG2D), TLRs and the Fc receptor CD16.  This supports the 
notion of γδ T cells as predominantly innate-like, but several studies have in fact 
highlighted the importance of TCR engagement in the acquisition of functionality by 
these cells.  If this is the case, understanding the nature of the ligand recognised by the 
γδ TCR may be crucial in attempts to understand their function.  
1.2.2 γδ TCR ligands 
 
Ligand recognition by the γδ TCR is one of the chief mysteries pursued by researchers in 
the γδ T cell field.  A lack of diversity amongst V chain composition, especially in the 
tissue resident population of γδ T cells, suggests that foreign antigen may not be the 
primary target of these cells, and, together with evidence of NK receptor expression, 
suggests a role for γδ T cell in lymphoid stress surveillance, perhaps with self-stress 
molecules representing the primary group of γδ TCR ligand (Vantourout and Hayday, 
2013).  Nevertheless, the highly variable nature of the CDR3 region of the δ chain may 
suggest this is not the case, and efforts to determine the γδ TCR ligands have discovered 
several targets, both endogenous and exogenous in nature. 
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Several MHC-like molecules have been found to act as antigen for the γδ TCR.  These 
include, in mice, the non-peptide-binding MHC molecules H2-T10 and H2-T22 (Crowley et 
al., 2000), and in humans CD1c and CD1d (Adams, 2014).  Additionally, the MHC class I-
like (MIC) proteins MICA and MICB have been proposed to act as ligands for the γδ TCR 
(Coulthard et al., 2003).  This evidence is derived from functional studies rather than 
direct binding, and as such remains unproven, especially since these molecules are 
recognised ligands for NKG2D, also expressed by γδ T cells.  Indeed, direct binding and 
structural evidence has only been determined for T22 and CD1d, and that from small 
numbers of γδ TCR clones, so the physiological relevance remains unproven. 
An important aspect of these studies into MHC-like molecule binding by the γδ TCR is that 
peptide or lipid presentation by these molecules is generally not required as part of the 
binding process.  Since many antigen-presenting molecules are upregulated during 
cellular stress, it is possible that this recognition by γδ T cells is part of the lymphoid 
stress surveillance mechanism (Hayday, 2009). 
Phosphoantigens (P-Ag) are small non-peptidic phosphorylated moieties produced during 
isoprenoid biosynthesis by pathogenic prokaryotes and in higher eukaryotes.  They are 
therefore, potentially both endogenous and exogenous in nature.  They include 
hydroxymethyl-but‑2‑enylpyrophosphate (HMB-PP), which is not produced by 
vertebrates but is a strong agonist of the human Vγ9Vδ2+ TCR, suggesting a role as a 
PAMP in this setting (Eberl and Jomaa, 2003).  Isopentenyl pyrophosphate (IPP) is 
produced by both bacteria and in eukaryotes, where its production through altered 
metabolism in transformed cells has been linked with a role for the Vγ9Vδ2+ T cell subset 
in tumour immunosurveillance (Morita et al., 1999).  The sensitivity of these γδ T cells for 
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IPP is several logs lower than for HMB-PP, consistent with the possible role for IPP as an 
auto-antigen in examples of cell stress.  Evidence for direct binding of P-Ag to the γδ TCR 
is weak and it is likely that processing by an intermediate cell type such as monocytes or a 
presentation molecule is involved in the binding process.  The crystal structure of the 
Vγ9Vδ2+ TCR suggested all CDR loops are involved in antigen binding (Wang et al., 2010), 
suggestive of a much larger epitope than a simple P-Ag.  Recently, a candidate 
presentation molecule has been proposed, butyrophilin 3A1 (BTN3A), although the exact 
mode of recognition remains controversial (Harly et al., 2012).  BTN3A has been 
demonstrated to be upregulated on potential target cells such as epithelia following 
cytokine or hypoxia-mediated stress, as well as tumour tissue (Compte et al., 2004).  
Through knockdown and mutation studies, the intra-cellular B30.2 domain of BTN3A was 
demonstrated to be indispensable to P-Ag sensitivity (Harly et al, 2012); (Sandstrom et 
al., 2014), however, exactly how the P-Ag, which is often secreted by pathogen, is taken 
up by the lymphocyte to bind the intra-cellular B30.2 domain remains unresolved. 
Furthermore, the B7-family butyrophilin-like (BTNL) family of molecules has been 
associated with regulation of murine and human γδ T cells.  Homologous with the Skint1 
gene, which is critical to the thymic development of Vγ3+Vδ1+ in mice (Chodaczek et al., 
2012) and expressing intra-cellular B30.2 domains, the conserved BTNL family have been 
demonstrated to critically and selectively promote survival of Vγ5+ γδ T cells in murine 
small intestine (Btnl1) (Di Marco Barros et al, 2016).  This paradigm may extend to human 
epithelial tissue, where BTNL3 and -8 have been demonstrated to specifically activate 
Vγ4+ γδ T cells (Di Marco-Barros et al, 2016).  It is possible that BTNL molecules are co-
stimulatory in this scenario, rather than direct-TCR ligands (Nielsen et al., 2017). 
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The likelihood of the γδ TCR being employed in recognition of foreign antigen is 
supported by the work of Chien and colleagues who determined that that algal protein 
phycoerythrin was a ligand for murine and human γδ TCR, and that the CDR3 region was 
critical in determining binding specificity (Zeng et al., 2012).  Again, the physiological 
relevance of this particular antigen remains in question, but nevertheless as a proof of 
principle this work offers persuasive evidence.  As with MHC-like binding, antigen 
presentation in γδ TCR binding of phycoerythrin does not seem necessary, distinguishing 
this interaction from that of αβ T cells and their target antigen whilst simultaneously 
expanding the range of potential targets for lymphocytes in general.  In addition, early 
studies of human γδ T cells suggested that clonal expansion and formation of memory 
cells does not seem to occur, suggesting that even on the recognition of genuinely foreign 
peptide, γδ T cells behave with more innate-like kinetics than a conventional adaptive T 
cell response. 
 
1.2.3 Function of gamma delta T cells 
 
1.2.3.1 γδ T cell effector functions 
 
Activated γδ T cells in both mice and humans express a range of cytokines associated with 
conventional CTL responses, including IFN-γ and TNF-α, as well as cytotoxicity proteins 
granzyme, perforin, Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL).  In this 
way γδ T cells are clearly capable of functioning as cells of the late adaptive immune 
response (Salerno and Dieli, 1998).  However, γδ T cells can simultaneously also express a 
range of factors, particularly cytokines, chemokines and growth factors normally 
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associated with helper T cell subsets and the early phase of an adaptive immune 
response, including Th2 and Th17 cytokines.  Chemokines secreted by γδ T cells are 
involved with recruitment of macrophages, NK cells, B cells and T cells.  Studies have 
highlighted interaction between γδ T cells and both B cells and DC, and work by Moser’s 
group has demonstrated the capacity of human Vγ9Vδ2+ T cells to act as antigen 
presenting cells; phagocytosing opsonised target cells, subsequent expression of CCR7 
and migration to lymph nodes with concomitant expression of CD80 and CD86 (Brandes 
et al., 2005).  This suggests a vast array of potential functions for activated γδ T cells. 
1.2.3.2 Anti-pathogenic protection 
 
The direct, critical involvement of γδ T cells in combating infections has only been 
demonstrated in a limited number of mouse TCRδ knockout studies, for example, during 
lung-tropic Nocardia asteroides infection (Tam et al., 2012). However, many studies have 
demonstrated increased inflammation, morbidity and mortality with γδ T cell deplete 
mice, although the mode by which γδ T cells contribute to immunoprotection varies.  
While mortality is increased in TCRδ knockout mice infected with vaccinia virus, memory 
cell formation and successful immunity on secondary infection is not affected in these 
mice, suggesting they are functioning as innate-like cells and not contributing towards a 
successful adaptive response (Selin et al., 2001).  IL-17 production and consequent 
inflammation seems to be important in protecting mice against several bacterial 
pathogens including Klebsiella pneumonia (Matsuzaki and Umemura, 2007), while 
induction of CD8+ memory cells by γδ T cells has been highlighted in establishing 
immunological memory against West Nile virus (Wang et al., 2006).  As previously 
mentioned, Vδ2neg γδ T cells expand in an apparently antigen-specific manner following 
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CMV infection, particularly in immunosuppressed patients following transplantation or 
chemotherapy (Couzi et al., 2009).  This potential role of γδ T cells to behave like αβ T 
cells in response to certain pathogens in the absence of an αβ T cell response may reflect 
the fact that they are the first cells of the immune system to develop in neonates and 
have a clear role in neonatal protection (Gibbons et al., 2009). 
1.2.3.3 Lymphoid stress surveillance 
 
As has been mentioned, various potential antigens of the γδ TCR, as well as ligands for 
NKG2D expressed by γδ T cells, are upregulated in response to cellular stress, including 
infection and transformation.  This enables γδ T cells to quickly identify such infected or 
stressed cells, and instigate either a direct cytotoxic response or to stimulate an adaptive 
response.  Since the myeloid lineage DC are classically associated with this sort of 
immune surveillance, Hayday and colleagues coined the phrase “lymphoid stress 
surveillance” to distinguish the role of lymphocytic γδ T cells (Hayday, 2009).  The 
localisation of discrete γδ T cell populations to epithelial tissues supports this hypothesis, 
at least in murine studies.  Since these tissues are the first to be exposed to invading 
pathogen, having a local subset of immune cells capable of mounting a rapid, and 
perhaps antigen-specific, response would seem to make evolutionary sense.  In addition, 
these tissues exhibit a high rate of cellular turnover and consequentially are prone to 
DNA replication errors and transformation.  Several studies have demonstrated γδ T cell 
mediated killing of various cancer cell lines, and the importance of γδ T cells in preventing 
the formation of tumours in murine models of cutaneous and colon carcinogenesis 
(Girardi et al., 2001).  As such, there have been several clinical trials over the past few 
years that have attempted to utilise stimulated autologous Vγ9Vδ2+ T cells in adoptive 
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transfer as a means of treating various cancers in humans (reviewed by Fournie et al., 
2013).  
1.2.3.4 Immunoregulation and homeostasis 
 
A growing body of work has highlighted the contribution of γδ T cells to immune 
regulation, particularly in epithelial tissues.  In experiments in mice, γδ T cell depletion 
has been demonstrated to increase inflammation and IFN-γ levels in both lung (Liu et al., 
2013) and gut (Waters et al., 1999) epithelia following introduction of pathogen.  
However, this may be due to the lack of an effective early γδ T cell response in controlling 
the pathogen and subsequent prolonged activation of an αβ T cell-mediated response.  
Despite this, γδ T cells are known to interact with a number of immune and stromal cells 
in a potentially regulatory fashion, both in sterile and pathogenic inflammatory scenarios 
(Hayday and Tigelaar, 2003). 
Although the exact nature of the interactions between αβ T cells and γδ T cells is yet to 
be fully elucidated, there is some evidence that the two subtypes compete for pro-
proliferative factors such as DC-derived IL-15, and thereby γδ T cells could loosely be said 
to have a regulatory effect on αβ T cell function (Do and Min, 2009).   Generally, γδ T cells 
are capable of producing the immunosuppressive cytokines IL-10, TGF-β as well as 
expressing LAG3, FasL and TRAIL, all of which have been implicated in regulation of T cell 
activity through induction of anergy or apoptosis (Hayday and Tigelaar, 2003).  γδ T cells 
have also been linked with regulation of pro-inflammatory macrophages, contributing 
towards resolution of inflammatory processes.  During L. monocytogenes infection, γδ T 
cells have been demonstrated to induce cytolysis of pro-inflammatory macrophages 
(Tramonti et al., 2008).  Several studies have also highlighted the importance of 
 
16 
monocyte/ macrophage derived factors in the recruitment and stimulation of γδ T cells, 
so, as with most of the γδ T cell – immune cell interactions, there is a degree of 
reciprocity.  Mesenchymal stem cells (MSC) are important precursors to a variety of 
stromal cells, including osteoblasts, chondrocytes and myocytes.  Through expression of 
prostaglandin E2, MSC have been demonstrated to suppress the proliferation of γδ T cells 
in vitro (Martinet et al., 2009).  Although constrained to the Vγ5Vδ1 expressing murine 
dendritic epidermal T cells (DETC), some studies have also suggested a role for γδ T cells 
in regulation of neighbouring stroma, for example through the secretion of insulin-like 
growth factor 1 (IGF) and keratinocyte growth factor (KGF) (Toulon et al., 2009).  In 
addition, chemokine secretion by γδ T cells following trauma such as burn injury has been 
linked with recruitment of macrophages and promoting wound repair (Rani et al., 2014). 
1.3 Liver biology 
 
1.3.1  Liver physiology 
 
Certain subsets of γδ T cells have been found to localise to specific tissues in both mice 
and humans.  In humans, while the Vδ9 Vδ2+ subset are mainly found in the periphery, γδ 
T cells with the Vδ1 chain have been demonstrated to localise to epithelial tissues, with 
an enlarged δ1/δ2 ratio in gut, lung and dermis compared with that in blood (Groh et al., 
1989).  During the last 20 years, studies demonstrated a similar δ1/δ2 ratio and increased 
percentage of γδ T cells of the total T cell population in liver compared with the periphery 
(Kenna et al., 2004), suggesting the possibility of a similar role for these cells in the liver 
as in gut and other epithelial tissues.  However, the nature of that role remains unclear.  
To begin to understand the function of γδ T cells in the liver, it is important to have an 
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understanding of the unique physiology and functions of the liver organ, and its vital role 
in human immunity.   
1.3.1.1 Liver function 
 
The liver is the largest internal organ in humans and receives up to 30% of the total blood 
volume of the body every minute.  As well as receiving up to 20% of its blood from the 
main arterial supply, the liver is the first destination of venous blood from the gut.  This 
blood contains carbohydrates, proteins and lipids absorbed into the blood stream 
following digestion.  The liver is responsible for metabolising these nutrients, as well as 
clearing any toxins or pathogens that reach it from the gut.  Nutrient-rich blood drains 
from the gastrointestinal tract through the hepatic portal vein, where, in combination 
with arterial blood supplied by the hepatic arteries, it passes into the liver sinusoids, and 
then into contact with hepatocytes by passing through fenestrations of the liver 
sinusoidal endothelial cells (LSEC).  Hepatocytes are the majority cell type in the liver, 
accounting for ~80% of the cytosolic organ mass, and form the liver parenchyma.  These 
cells carry out a vast number of functions related to metabolism and catabolism of 
various nutrients, including synthesis of many proteins, including lipo- and glycoproteins, 
metabolism of carbohydrates - the liver being the primary site of gluconeogenesis in the 
body, and storage of fats, triglycerides, carbohydrates and iron.   Hepatocytes produce 
and secrete bile salts which emulsify lipids during digestion in the duodenum.  
Hepatocytes also have a major role in detoxification and removal of many exogenous 
ingested and endogenous compounds such as drugs, ammonia and steroids. 
In addition to nutrients, any pathogens or pathogen derived antigen such as LPS that 
evade the predominantly innate immune response in the gut also move to the liver, so 
 
18 
the immune system there has to be able to deal with these to prevent infection.  Despite 
this, the liver also has an important role in establishing immunotolerance to many 
antigens that may otherwise cause inflammation and damage to the sensitive liver 
parenchyma (Horst et al., 2016).  This necessary balance between removal of pathogens 
and induction of immune tolerance is exploited successfully by several hepatotrophic 
pathogens including Hepatitis B and C viruses (Knolle et al., 2015) and Plasmodium spp. 
sporozoites (Wunderlich et al., 2014).  Cells of the immune system resident in the liver 
are critical in both defense against pathogens and establishment of immunotolerance 
toward foreign antigen.   
 
1.3.1.2 Liver microanatomy 
 
Within the liver a vast meshwork of hexagonal lobules are formed, with the portal 
venules, arteries and interlobular bile ducts clustered at each corner of the hexagon, 
forming the “portal triad”, and a central vein that receives the draining blood supply 
(Figure 1.1).  The liver sinusoids have a very small diameter but form a huge endothelial 
bed, resulting in a five-fold drop in blood pressure between the portal arteries and these 
sinusoids, running between the portal tract and the central vein. This yields a blood flow 
of around half the speed of other capillary beds.  This allows prolonged contact between 
the hepatic blood and the specialised cells of the liver, cells including LSEC, hepatic 
stellate cells (HSC), liver-resident macrophages called Kupffer cells and intra-hepatic 
lymphocytes.  This long interaction is particularly important for the immune system cells, 
allowing time for pathogen or pathogen-derived antigen to be taken up by antigen- 
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Figure 1.1:  Microanatomy of the liver 
From: Adams et al. Nature Reviews Immunology 6, 244–251 (March 2006) | doi:10.1038/nri1784 
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presenting cells, as well as time for passing lymphocytes to be recruited from the blood 
supply into contact with the parenchymal cells.  
The first point of contact for blood leaving the portal tract and entering the liver sinusoids 
is the hepatic sinusoidal endothelial cells.  These cells effectively form a barrier between 
the blood and the hepatocytes, although this barrier is relatively permeable due to their 
sieve-like, fenestrated formation, and is indeed breached by the hepatocytes themselves 
on occasion via extensions of the hepatocyte membrane (Wisse et al., 1996).  Despite this 
porous structure, the fenestrations are in fact tightly regulated and only allow passage of 
specific macromolecules from the endothelial lumen into the underlying tissue.   
As such, the LSEC form an important gateway for anything attempting to reach the 
hepatocytes, and accordingly have a vital role in regulation of liver function (Knolle and 
Wohlleber, 2016).   
Lacking a contiguous basement membrane structure, the LSEC have a gap between them 
and the underlying parenchyma, the Space of Dissé.  This gap is occupied by a loose 
network of phenotypically astral cells that extend long dendritic processes around the 
sinusoids.  These are the hepatic stellate cells (HSC), normally involved in lipid and 
Vitamin A storage.  Under inflammatory conditions HSC go from a quiescent state to 
adopt a fibrinogenic phenotype, and are the major contributors towards fibrosis in 
chronically inflamed livers (Weiskirchen and Tacke, 2014). 
Also present in the sinusoids are liver-resident immune cells, including macrophages, 
termed Kupffer cells (KC), dendritic cells and lymphocytes.  Recent studies have 
suggested that KC may develop from liver-based haematopoitic cells, rather than from 
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monocytes derived from bone marrow stem cells (Perdiguero et al., 2015).  While their 
ontogeny remains unclear, KC have been demonstrated to adhere to LSEC and as such 
represent a unique population of macrophages that remain static, rather than crawling to 
search for pathogen (Jenne and Kubes, 2013).  Indeed, KC are the only subset of 
macrophages yet known that are capable of capturing bacteria under flow conditions, 
rather than static, using a unique combination of shear-stress activated receptors for the 
complement protein C3b (Gorgani et al., 2008).  Loss of KC has been demonstrated to 
contribute to bacteremia and host death in Listeria monocytogenes infection, highlighting 
their critical role in immune protection (Ebe et al., 1999).  KC also function as important 
APCs in the liver, as will be discussed later. 
Dendritic cells are present in the liver, clustering around the portal tract and central vein, 
and have been demonstrated to mature as they progress via the sinusoids from one to 
the other (Sato et al., 1998).  Activated DC can translocate across the LSEC membrane, 
enter the Space of Dissé and thereby drain via the lymphatic system to lymph nodes to 
orchestrate an immune response.  Lymphocytes, including natural killer cells, NKT, CD8+ T 
cells and γδ T cells, are found in the portal tracts and dotted throughout the liver 
parenchyma.  Relative numbers of all of these cell types are increased over those found in 
the periphery, with the liver exhibiting the highest density of NK and NKT cells anywhere 
in the body.  The role of these cells will be examined in the following section. 
1.3.2 Liver immunology  
 
Blood from the gut typically bypasses the usual lymphatic circulation, particularly if the 
gut epithelium is damaged or dysfunctional, avoiding contact with tissues normally 
responsible for immune surveillance – lymph nodes and the spleen. Accordingly, the liver 
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likely represents the first line of defense against blood-borne pathogens, regardless of 
whether these enter via the gut or elsewhere.  Depletion of liver-resident immune cells 
leads to increased pathogen burden and animal death, whereas in contrast, removal of 
the spleen does not, indicating the crucial role this organ has in immunosurveillance.  
How the liver performs this function has been extensively studied, but there are many 
questions remaining. 
1.3.2.1 The innate immune response in the liver 
 
Three immune cells subtypes that play key roles in the innate immune response are 
present in high densities in the liver; KC, NK and NKT.  KC can directly phagocytose 
invading pathogen that has been targeted by complement or antibody, and express PRRs 
such as mannose receptors and TLRs which enable these cells to identify exogenous and 
endogenous antigen and instigate cell activation and phagocytosis (Bilzer et al., 2006).  
Upon activation, KC secrete CXCL3, IL-12 and IL-18, inducing activation and expansion of 
nearby NK and NKT cells, which in turn can produce high levels of the anti-viral IFNγ.  
Also, CXCL2, TNF-α, IL-6 and IL-1β secreted by KC have been demonstrated to recruit and 
activate neutrophils to the liver sinusoids, where they secrete pro-inflammatory 
cytokines inducing influx and activation of T cells, as well as directly phagocytose KC-
bound bacteria (Gregory et al., 1996).    
NK cells compose around one third of all the intra-hepatic lymphocytes, more than three 
times the ratio found in blood, likely reflecting the importance of an efficient innate 
response in the liver.  As well as the normal NK functions described earlier, liver NK cells 
can modulate MHC expression by hepatocytes and HSC, thereby forming an additional 
layer of tuning to the immune response (Doherty and O'Farrelly, 2000).  IFNγ secreted by 
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activated NK cells causes hepatocytes and LSEC to produce CXCL9, recruiting T cells to the 
site of inflammation.  The importance of the liver derived NK population was highlighted 
in a study that demonstrated that resolution of acute HCV infection is mediated at least 
in part by particular KIR haplotypes (Khakoo et al, 2004).  In addition, recent work with 
mouse models and human tissue has determined there to be a liver-resident memory NK 
population, although the ontogeny and mechanism of this memory phenotype remains to 
be fully elucidated (Melsen et al., 2016). 
CD1d is expressed by KC, hepatocytes and DC in the liver, and accordingly CD1d-restricted 
NKT cells have an important role in mediating the innate response to non-peptidic 
antigen in the liver (Yanagisawa et al., 2013).  As well as having cytotoxic function via 
perforin and granzyme and being key modulators of the immune response via fast release 
of either Th1 or Th2 cytokines, NKT cells are the only liver resident immune cell that has 
been demonstrated as actively crawling to find pathogen, independent of the direction of 
blood flow in the sinusoids (Geissmann et al., 2005). 
Together, the actions of these cells result in a typically fast response to the presence of 
sinusoidal pathogen, resulting in rapid elimination of the pathogen. 
1.3.2.2 Antigen presentation and the induction of immune tolerance in the 
liver  
 
Induction of an effective adaptive immune response requires activation of primed T cells 
via binding of their TCR to cognate MHC-bound antigen, as well as the presence of certain 
pro-inflammatory soluble factors in the immune microenvironment.  T cells are usually 
primed by interacting with dendritic cells loaded with antigenic peptide that have drained 
to the lymph node, where they interact with naïve T cells.  However, as well as DC, the 
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liver contains a number of additional cell subsets that express all the surface molecules 
required to present antigen to naive T cells and instigate an adaptive immune response, 
including MHC Class I and II, as well as costimulatory molecules CD80 and CD86, without 
the initial priming in the lymph node (Jenne and Kubes, 2013). 
LSEC express a wide variety of PRR, including TLRs and mannose receptors, which enable 
them to endocytose not only pathogenically-derived antigen but also cellular debris 
containing intracellular antigen released by a dying cell.  They can then process and 
present these antigens on their MHC Class I and, unusually, Class II molecules in a process 
called cross-presentation.  LSEC are particularly effective cross-presenting cells, and have 
been demonstrated to directly instigate T cell responses (Limmer et al., 2000).  However, 
as part of the MHC:TCR interaction, the costimulatory molecule PD-L1 is upregulated in 
the LSEC, which induces the expansion of non-responsive T cells following TCR 
engagement via interaction with the PD-L1 receptor, PD-1 (Carambia et al., 2013).  This 
results in a large population of antigen-nonresponsive T cells and contributes toward 
immune tolerance in the liver. 
KC also express antigen presentation molecules but in normal resting state have poor APC 
function.  Continual exposure to low levels of exogenous antigen such as LPS reduces the 
ability of KC to stimulate a T cell response, as also occurs in LSEC; an important 
mechanism in preventing continuous damaging inflammation in response to commonly 
encountered gut derived antigen (Knolle et al., 1999).  Both KC and LSEC produce anti-
inflammatory IL-10 and TGFβ in these circumstances, which further dampens any T cell 
mediated response through loss of effector functions following priming with IL-10 and 
change of chemokine receptor expression in DC that reduces their migration to lymph 
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nodes (Knolle et al., 1995).  In pro-inflammatory conditions however, KC have been 
demonstrated to act as strong APC and trigger normal T cell activation and maturation. 
Hepatocytes express MHC Class I and limited Class II, as well as CD80 and CD86, and 
therefore although they cannot cross-present they may be able to induce direct T cell 
activation.  They have been demonstrated to express PRR such as TLRs, and therefore 
may be capable of taking up pathogenic antigen from their surroundings (Chen et al., 
2005).  Similarly, HSC also express the cellular machinery required to activate T cells, 
although no mechanism for antigen uptake has been described in HSC, suggesting their 
role as APC in the liver may be limited (Winau et al., 2007). 
Therefore, despite the abundance of potential APC in the liver, it seems likely that 
antigen presentation in these cells has evolved in such a way as to in fact induce 
tolerance towards regularly encountered antigen that may otherwise cause a damaging 
inflammatory response, particularly under normal basal conditions.  However, robust 
adaptive immune responses can and do occur in the liver; they simply require the correct 
inflammatory signals. 
1.3.3 Immune mediated liver pathology 
 
Chronic liver inflammation, resulting in fibrosis and potentially leading to cirrhosis and 
hepatocellular carcinoma, occurs in a number of clinically relevant situations.  Some 
hepatotrophic pathogens, primarily the hepatitis B and C viruses, have evolved 
mechanisms that prevent their rapid elimination by the liver immune system and instead 
perpetuate in the hepatocytes, inviting a low level continuous immune response that can 
lead to fibrosis and ensuing pathogenesis (Horner and Gale, 2013).  Damage to 
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hepatocytes caused by long term exposure to certain toxins, primarily alcohol, can induce 
a similar prolonged immune response, again leading to fibrosis, as can metabolic 
disorders such those attributed to non-alcoholic fatty liver disease (Wang et al., 2012).  
Finally, several auto-immune disorders in liver tissues have been described, and although 
each has a different aetiology, the outcome, chronic liver inflammation, fibrosis and liver 
dysfunction, is always associated with an unchecked or unwarranted immune response.  
1.3.3.1 The immunology of liver fibrosis 
 
Induction of type-I collagen-derived fibrosis is part of the normal wound repair response 
to tissue damage in the liver and contributes to the protection of hepatocytes from 
toxins.  However, excessive fibrosis and the resulting scar tissue caused by prolonged 
tissue injury leads to liver dysfunction, portal hypertension and ultimately liver failure 
(Parsons et al., 2007).  
While there are several known causes of fibrosis, including tumours and foreign objects in 
tissue, it is important to note that all of them are associated with the instigation of an 
immune response.   Without this immune response, fibrosis does not occur.  In the 
context of the liver, the two main causative factors are tissue damage through exposure 
to toxins and pathogenically/ autoimmune mediated inflammation.  
As part of the normal immune response to hepatocyte injury, whether it be toxin-
induced, metabolically induced or pathogenically induced, a number of pro-inflammatory 
cytokines and growth factors are secreted by both the damaged cells and cells of the 
immune system that are recruited to the site of injury.  These include TGFβ, platelet 
derived growth factor (PDGF), IL-13 and connective tissue growth factor (CTGF), and are 
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thought to contribute towards the differentiation of liver mesenchymal cells, namely HSC 
and portal fibroblasts, into myofibroblasts (Li et al., 2008).  TGFβ induces the 
upregulation of type-1 collagen and α-smooth muscle actin (α-SMA) in these cells, while 
PDGF induces their expansion (Xu et al., 2016).  These activated cells then secrete the 
extra-cellular matrix (ECM) proteins that form the basis of the scar tissue and also pro-
inflammatory cytokines that further promote HSC differentiation in an autocrine 
feedback loop and chemokines that recruit immune cells to maintain HSC differentiation 
(Marra and Tacke, 2014). 
Macrophages are key mediators of fibrosis.  Following typical acute tissue injury, 
macrophages will break down ECM deposited by activated myofibroblasts, once the 
source of the injury has been removed.  They do this through the action of a variety of 
matrix metalloproteinases (MMPs) (Duarte et al., 2015), which are inhibited by 
myofibroblast-derived tissue inhibitors of metalloproteinases (TIMPs) (Iredale et al., 
1992).  However, during inflammation macrophages have been observed to be pro-
fibrotic, secreting TGFβ and PDGF to maintain the myofibroblast population.  
Additionally, recent studies have suggested that these pro-fibrotic macrophages are likely 
circulating monocyte-derived rather than KC, and that KC numbers actually decline during 
induction of fibrosis (Liaskou et al., 2013). 
Other immune cells have also been demonstrated to have both pro- and anti-fibrotic 
activity.  Th1 cells have exhibited anti-fibrotic activity, likely through the action of IFNγ, 
which modulates the balance between MMP and TIMP enzymes.  Th2 and Th17 have 
been described as having pro-fibrotic properties.  NK cells and γδ T cells have been shown 
to have potential anti-fibrotic effects via the induction of apoptosis in myofibroblasts 
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(Hammerich et al., 2013, Radaeva et al., 2006).  Despite an increasing body of work in the 
field, in remains unclear precisely what role these subsets are having in the fibrosis 
scenario, and it is likely that the response will vary depending on disease aetiology and 
perhaps even on a case by case basis. 
Fibrosis is generally a reversible process, with breakdown of excessive ECM carried out by 
macrophages and other cells expressing MMPs (Pellicoro et al., 2014).  However, during 
chronic inflammation, the scar tissue often undergoes pathological changes that render it 
less susceptible to breakdown.  Extensively cross-linked mature scar tissue is more 
resistant to protease action, and large deposits are inaccessible to MMPs and the 
macrophages that produce them. 
As well as induction of ECM deposition by activated HSC, liver damage caused by chronic 
inflammation also causes hepatocytes to undergo proliferation in an attempt to 
regenerate lost tissue.  In severely damaged livers, stem-like liver progenitor cells, located 
in the biliary tree, proliferate, generating the hepatic nodules indicative of liver cirrhosis 
(Shang et al., 2016).  Although the exact molecular mechanisms remain to be elucidated, 
it is apparent that the rapid proliferation of these cells against a background of high 
inflammation would potentially generate the DNA damage and ensuing genetic 
mutations that could lead to the development of neoplastic cells and the onset of HCC 
(Affo et al., 2017). 
1.3.3.2 The immunology of hepatitis viruses 
 
Hepatitis B, a hepadnavirus, and Hepatitis C, a flavivirus, are hepatotrophic, non-
cytopathic blood-borne viruses with multiple genotypes that lead to acute and chronic 
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infections.  While hepatitis B virus (HBV) is a self-limiting infection that resolves in 90% of 
cases, the downstream effects of chronic hepatitis B infection, namely liver cirrhosis and 
HCC, still account for one million deaths per year, with over 350 million people infected 
with the virus (Nannini and Sokal, 2017).  Hepatitis C virus (HCV) chronically infects 
around 200 million worldwide and acute infection leads to chronic infection in up to 90% 
of cases, and the same outcomes as HBV are likely for those untreated (Ahmed et al., 
2017).  Although a vaccine and a non-curative therapy are available for HBV, and curative 
therapy is now available for HCV, the costs and logistics involved with these mean many 
millions of people will remain infected with these viruses for decades to come. 
Both HBV and HCV infect hepatocytes, and the immune system has been implicated both 
in the clearance of virus in acute infections and disease progression in chronic infection.  
Viral clearance in acute infections is associated with a strong CD4 and CD8 T cell 
response, and neutralising antibodies are an important part of HBV immunity.  However, 
if the CD4/ CD8 anti-viral response is not strong or widespread enough to control the 
infection, the natural induction of tolerance to prolonged antigen observed in the liver 
occurs, and virus-specific T cells become phenotypically and functionally exhausted and 
are then eliminated (Rosen, 2013).  Mutation of the viral epitopes recognised by these T 
cells is the final stage in immune escape, so that in chronic HBV and HCV infection, virus-
specific T cells play little to no role in either controlling the infection or development of 
fibrosis.  So, rather than antigen-specific T cells playing a role in disease progression, it is 
likely that non-specific immune cells, including T cells, NK cells and macrophages, which 
are recruited to the site of infection by pro-inflammatory signals, mediate the onset of 
fibrosis (Golden-Mason and Rosen, 2013).  On the other hand, cytolytically active but non 
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anti-viral NK cells have also been attributed with the regulation of fibrosis via cytolysis of 
activated HSC (Radaeva et al., 2006).  
1.3.3.3 Autoimmune liver diseases 
 
There are three common liver diseases that have a basis in autoimmune disorders, each 
potentially inducing fibrosis, cirrhosis and cancer.  Primary sclerosing cholangitis (PSC) is a 
disease of unknown aetiology affecting over 1 in 100,000 people in northern Europe and 
currently with no known cure, other than liver transplant, which is not always effective 
and often not possible since late stage PSC often develops into tumourigenesis.  It is 
mediated by gut-derived lymphocytes erroneously targeting cells of the hepatobiliary 
tree, specifically cholangiocytes, epithelial cells lining the bile ducts.  Chronic 
inflammation, bile duct destruction leading to cholestasis and fibrosis of the portal 
regions lead to cirrhosis (Karlsen et al., 2017).   
60-80% of patients with PSC also present with inflammatory bowel diseases (IBD), usually 
a form of ulcerative colitis, an immunological disorder that has genetic underpinnings and 
involves targeting of the commensal gut microbiota by the host immune system.  The 
exact mechanism of the link between IBD and PSC is not fully understood, although there 
are genetic factors common to both (Eksteen, 2016).  Theories include the translocation 
of gut microbiota across an inflamed gut epithelium and subsequent activation of an 
immune response in the liver.  In addition, inflammation in the liver has been 
demonstrated to increase expression of usually gut-specific adhesion molecules such as 
mucosal addressin cellular adhesion molecule 1 (MAdCAM1) and vascular adhesion 
protein 1 (VAP-1), resulting in the recruitment of gut-primed T cells that contribute to 
pathogenesis in the liver (Grant et al., 2001, Trivedi et al., 2017).  Once inflammation of 
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the bile duct area has begun, destruction of the bile resistant epithelia may lead to 
further damage to hepatocytes by toxic bile, generating further inflammation. 
Autoimmune hepatitis (AIH) affects up to 3 in 100,000 people and usually presents in 
young people, particularly women.  It is associated with the production of liver 
autoantibodies, specifically anti-nuclear antibodies and anti-α-SMA antibodies, which 
defines Type I AIH, and anti-liver kidney microsomal type 1 antibody, which defines Type 
II AIH (Liberal et al., 2016).  Like PSC, AIH has an unknown aetiology, but is also linked 
with genetic factors, with a high frequency of cases associated with possession of certain 
alleles of the HLA genes, which encode the human MHC molecules and are therefore 
involved with TCR recognition.  A number of postulated triggers exist, including infection 
with hepatitis C, which has regions that share a high amino acid homology with the target 
of the auto-antibodies associated with AIH (Himoto and Masaki, 2012).  Generation of 
antibodies to such an infection may then generate an antibody response to self-antigens, 
in a case of molecular mimicry.  
There is also a possible role for impaired Treg function in AIH, as well as impaired self-
regulation by autoreactive T cells through the loss of expression of usual inhibitory co-
receptors such as PD-L1 and CTLA-4 (Herkel, 2015).  The mechanisms involved in the 
development of these pathways and their contribution to AIH pathogenesis remain 
unclear.  
The third auto-immunity linked liver disorder is primary biliary cholangitis (PBC), which is 
classically linked with patient development of autoantibodies against mitochondrial 
enzymes, particularly the E2 domain of the pyruvate dehydrogenase complex (PDC-E2) 
(Gershwin et al., 2000).  Bile duct epithelia exhibit intact PDC-E2, and mouse models have 
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demonstrated a loss of tolerance to this autoantigen in the development of PBC.  
Autoreactive CD4+ and particularly CD8+ T cells then mediate destruction of the small bile 
ducts and on occasion instigate portal fibrosis and chronic liver damage (Liaskou et al., 
2014).  The vast majority of PBC cases are female, and up to 40 people per 100,000 are 
affected depending on geographical location.  A reduction in the frequency of circulating 
Tregs has been observed in PBC patients (Lan et al., 2006). 
 
1.3.3.4 Fatty liver diseases 
 
There are two forms of fatty liver disease, alcoholic liver disease (ALD) and non-alcoholic 
fatty liver disease (NAFLD) which can develop into the more severe non-alcoholic 
steatohepatitis (NASH).  The pathogenesis of both diseases can involve the immune 
system, and both can lead to liver cirrhosis and HCC.  
ALD is one of the leading causes of morbidity and mortality worldwide, and stems from 
excessive consumption of alcohol.  Alcohol is directly toxic to hepatocytes, and also 
potentiates other liver diseases such as NAFLD and chronic HCV infection.  Steatosis, that 
is, abnormal retention of fat within hepatocytes, occurs in the liver of 90% of heavy 
drinkers, and although reversible through abstinence, this leads to fibrosis in 20 – 40% of 
patients that continue to drink, with ensuing cirrhosis and risk of HCC development.  As 
well as being a direct toxin to hepatocytes, and inducing a large pro-inflammatory 
neutrophilic infiltration in response to injured and dying cells, alcohol and its derivatives 
activate HSC to produce collagen, inhibits anti-fibrotic NK function and increases gut 
permeability to exogenous toxins such as LPS, thereby inducing release of pro-
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inflammatory cytokines and the development of chronic steatohepatitis (Wang et al., 
2012). 
NAFLD affects around one third of the Western world, making it the most common liver 
disease in the world.  The more severe NASH, associated with chronic inflammation, 
affects 10 – 20% of patients with NAFLD.  NAFLD is associated with obesity, which can 
lead to disruption of normal lipid metabolism and insulin resistance, increased free fatty 
acids and gut permeability, both of which trigger inflammation via production of various 
PAMPs and DAMPs (Benedict and Zhang, 2017). 
1.4 Gamma delta T cells in the liver 
 
1.4.1 Recruitment of γδ T cells to the liver 
 
An important question in γδ T cell biology is how these cells are recruited to specific parts 
of the body, particularly in tissues where the TCR repertoire is altered from that of the 
circulating blood, such as in skin, gut and liver.  Other than preferential survival or 
proliferation, it is only through recruitment or retention via chemokine and integrin axes 
that these altered repertoires can be established.  Data on γδ T cell recruitment to the 
liver is very limited, but several studies have been conducted focussing on other tissues 
and in pathological scenarios such as autoimmunity and cancer, which may help build a 
foundation for further research in the context of the liver.   
CCR9, CCL25 and α4β7 are gut-tropic molecules and recruit murine γδ T cells to the gut. 
These cells leave the gut but rapidly recirculate, creating a stable yet dynamic population 
(Guy-Grand et al., 2013).  This supports the suggestion that the intra-hepatic lymphocyte 
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population is shaped by the dynamics of the entry and exit processes, rather than 
proliferation in situ, as proposed by Klugewitz (Klugewitz et al., 2004).  In human IBD 
patients, including UC and Crohn’s disease, circulating γδ T cells expressed higher levels 
of gut-homing CCR9 than healthy controls (Mann, McCarthy et al. 2012).  In a murine 
model  of allergic reaction, CCL25 induced specific migration of IL-17+ γδ T cells to the site 
of inflammation, mediated by α4β7 integrin and the CCR6 chemokine receptor. In mice, 
these are expressed by IL-17+ as opposed to IFNγ producing cells (Costa et al., 2012). 
In a mouse melanoma model, CCR2/ CCL2 mediated accumulation of γδ T cells at the site 
of the tumour.  These cells also were mainly Vδ1+, which in humans express CCR2 (Lanca 
et al., 2013).  CCL2 expression is dysregulated in many human tumours, including HCC.  In 
addition, Vδ1+ cells have been shown to accumulate in squamous cell carcinoma in vitro 
and oesophageal tumour tissue ex vivo based on expression of CD11a, CD49d and other 
integrins (Thomas et al., 2001). 
Th17 CD4+ T cells are recruited to the liver via CXCR3 and CCR6 (Oo et al., 2010), 
suggesting that expression of these molecules may be important in recruitment of 
lymphocytes to the liver.  In an acute liver injury mouse model, γδ T cells accumulated in 
the liver via CXCR3/ CXCL9 axis and initiated acute liver toxicity via CD8 T cell recruitment 
and activation, perhaps by APC function (Ajuebor et al., 2008).  In a mouse model of 
chronic liver injury, CCL20 recruited IL-17- and IL-22-producing CCR6+ γδ T cells, which 
induced apoptosis of HSC independently of the action of IL-17, suggesting a possible 
protective role for γδ T cells against fibrosis (Hammerich et al., 2013).  In the same study, 
sections of human chronic liver disease patients were analysed by immunohistochemistry 
and displayed CCL20 and CCR6 expression.  In humans, the CXCR6/ CXCL16 axis is 
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responsible for recruiting NKT to the livers of chronic liver disease patients, leading to 
enhanced fibrosis and liver injury (Wehr et al., 2013).  Whether this has a role in γδ T cell 
recruitment is not known. 
In mice, evidence suggests that γδ T cells receive functional and locational instruction in 
the thymus, depending of the degree of engagement of the TCR received there, and 
potentially the ligand they are exposed to (Haas et al., 2012).  Accordingly, γδ T cell 
subsets will be recruited to different locations in the murine body based on a chemokine 
receptor repertoire that is linked to function and possibly TCR specificity.  
While data are limited, humans do not seem to share an equivalent method of thymic 
selection and differentiation of γδ T cells (Ribot et al., 2014), so data obtained from 
mouse models, especially when concerning chemokine receptor expression and 
postcoding to specific tissues, has to be treated with care when being applied to humans.  
This is also relevant for functional differentiation, discussed in the next section.  
1.4.2 The function of γδ T cells in the liver 
 
In chronic HCV patients, increased γδ T cell infiltration was observed in infected livers 
compared with blood (Nuti et al., 1998).  Vδ1+ γδ T cells increased in the liver of HCV 
patients compared with blood, up to 8.7% of the CD3+ lymphocyte population (Agrati et 
al., 2001).  Mitogenic stimulation of these cells ex vivo induced a Th1 cytokine expression 
profile.  Care must be taken when interpreting the results of such studies however, since 
normal healthy liver is not easily accessible as a control, and very few studies have 
examined the γδ T cell burden in a truly healthy liver.  In tissue taken from healthy donor 
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livers, 15% (6.8 – 34%) of liver-infiltrating CD3+ lymphocytes express the γδ TCR, 
compared with 0.9 – 2.7% in PBMCs (Norris et al., 1998).   
The ratio of γδ T cells to CD3+ lymphocytes may not be the best marker of γδ T cell 
burden in the liver, since many chronic liver diseases are associated with a large 
lymphocytic infiltration to the portal areas, and unless γδ T cells are recruited at the same 
frequency or greater than αβ T cells, it is likely that the proportion of γδ T cells: CD3+ 
lymphocytes will drop during chronic inflammation, even if the absolute number of 
infiltrating cells increases.  In an IHC-based study, Kasper et al observed that the number 
of infiltrating γδ T cells in patients with HCV infection of varying aetiologies did not 
change, and was led to conclude that it was increasing numbers of αβ T cells that were 
responsible for increased inflammation (Kasper et al., 2009).   There is no doubt however, 
that liver does contain a greater proportion of γδ T cells than the periphery, in both 
healthy and diseased livers, and even if they are not directly involved with necro-
inflammatory processes in chronic disease, they may have a supporting or perhaps even 
anti-inflammatory role.   
A growing body of evidence suggests that γδ T cells are likely to contribute to disease 
progression in acute liver injury, although this work is mainly restricted to mouse models 
where Th17-like γδ T cells are a more clearly identified subset than in humans.  A Poly I:C 
RNA virus mimetic induced IL-17 production by hepatic γδ T cells in a mouse model of 
acute liver injury, and in combination with macrophage IL-23 production this led to 
increased liver damage (He et al., 2013).  In an adenovirus-mediated acute liver injury 
model, γδ T cell-derived IL-17 production increased liver injury and recruitment of CD8+ 
Th1 cells (Hou et al., 2013).  As well as IL-17 as a γδ T cell derived mediator of liver 
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damage, Lu noted an increase in the number of γδ T cells and subsequent TNF-α 
production led to hepatocyte destruction in hepatitis virus strain 3-induced hepatitis in 
mice (Lu et al., 2012). 
In a study by Ren’s group, γδ T cell frequencies in peripheral blood were lower in patients 
with chronic HBV infection, although these cells exhibited a high cytotoxicity and TNF-α 
and IL-17 production.  This was mainly attributed to the acute-on-chronic HBV patients, 
and suggests there may be a role for γδ T cells with a pro-inflammatory phenotype in 
acute liver disease (Chen et al., 2012).  The same group had previously noted a decrease 
in the proportion of Vδ2 γδ T cells in the blood of chronic HBV patients, and reduced 
cytotoxicity and IFNγ production by these cells (Chen et al., 2008).   
In chronic HCV infection, peripheral Vδ9Vδ2 cells decrease in frequency compared with 
the blood of healthy donors (Par et al., 2002), and also appear to lose their cytotoxic 
responsivity to phosphoantigen stimulation, although it is rescued by Type 1 interferon 
treatment (Cimini et al., 2012).  γδ T cells expanded from HCV- and HBV-infected liver 
biopsies had high cytotoxicity and IFNγ production but failed to recognise any HCV 
antigen (Tseng et al., 2001).  However, Vδ9Vδ2+ T cells can inhibit subgenomic HCV 
replication in vitro, via IFNγ production (Agrati et al., 2006).  Expression of NK activating 
receptors, including CD226, enables Vδ9Vδ2+ cells to kill HCC cell lines in vitro (Toutirais 
et al., 2009).  The potential protective role of the Vδ2 subset in the liver was explored by 
Wu et al, who found that Vδ2 T cell frequencies in both peripheral blood and liver tissue 
decreased in immune-activated HBV-infected patients.  The authors suggest that these 
cells regulated Th17 CD4+ cells, through cell: cell contact and that with fewer Vδ2+ cells 
liver damage was increased (Wu et al., 2013). 
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Gamma delta T cells are enriched in the normal liver compared with matched blood from 
the same donors (6.6% of total CD3+ compared with 2%) and these cells can be induced 
to kill tumour cell lines and release IFNγ.  Of these cells, 21.2% were found to contain the 
Vδ3 chain (Kenna et al., 2004).  In HCC, γδ T cells lose their anti-tumour effect in the 
immunosuppressive microenvironment of the tumour itself.  They exhibit decreased 
infiltration of the tumour compared with the peri-tumoural tissue, with decreased 
cytotoxicity and IFNγ production.  Tumour-infiltrating Tregs secreting TGFβ and IL-10 
were attributed to this downregulation of effector function of γδ T cells (Yi et al., 2013).  
However, this process is likely reversible, since in a study by Mao et al, γδ T cells isolated 
from the peripheral blood of gastric cancer patients that were then cultured in vitro with 
syngeneic tumour cells were capable of killing tumour cell lines in vitro, inducing a 
CD4+/CD8+ T cell expansion, perhaps via APC function, and abrogating Treg-mediated 
immunosuppression (Mao et al., 2014).  Additionally, γδ T cells with the Vδ1 chain 
exhibited anti-metastatic properties in a mouse xenograft model of colon carcinoma 
(Devaud et al., 2013).  A recent study by Huang’s group has observed that IL-17 producing 
γδ T cells contribute to myeloid-derived suppressor cell accumulation in human colorectal 
cancer tissue samples, leading to immunosuppression and aiding tumour progression 
(Wu et al., 2014).  
Gamma delta T cells have been implicated in macrophage regulation.  Murine Vδ1+ γδ T 
cells kill macrophages as part of the resolution of immune response to various pathogens 
(Egan et al., 2005).   In an in vitro study of γδ T cells interaction with liver-tropic L. 
monocytogenes-activated macrophages, Vδ2+ and Vδ4+ γδ T cells increased cytokine 
production by these macrophages and were in turn induced to express IL-10 by the 
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activated macrophages, thereby controlling the infection and the immune response to it 
and preventing liver damage (Tramonti et al., 2006).  In mice, IL-17A production by γδ T 
cells plays a role in the innate immune response against L. monocytogenes in the liver 
(Hamada et al., 2008). 
Regulation of γδ T cells in a liver-specific context has also been linked to Vα14 invariant 
NKT cells, which were activated by TLR-3 ligand expression in the livers of mice injected 
with the hepatotropic poly I:C virus.  Suppression of γδ T cell accumulation and activation 
was mediated by induction of apoptosis in the γδ T cells by the iNKT cells (Gardner et al., 
2009). 
Although only one murine study to date has directly linked γδ T cells and liver fibrosis 
(Hammerich et al., 2013), where they appear to be protective, γδ T cells also appear to 
have a protective role in a murine model of lung fibrosis, via the Th17 cytokine IL-22, 
although the mechanism remains unclear (Simonian et al., 2010).  In a second, bleomycin 
instigated model of pulmonary fibrosis, γδ T cells exhibited an anti-fibrotic effect via 
CXCL10 production (Pociask et al., 2011).  The potential for an anti-fibrotic effect of 
human intrahepatic γδ T cells is clearly worth investigating for a potential therapeutic 
benefit. 
1.4.3 The potential role of the γδ TCR and antigen specificity in the liver 
 
Although the existing evidence suggests liver-derived γδ T cells are likely to have a 
predominantly innate-like phenotype and function, the potential role of the γδ TCR in 
liver homeostasis and pathology should not be discounted.  As described in section 1.3.2, 
there are few known ligands for the γδ TCR.  In the liver, where an elevated ratio of Vδ2- 
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γδ TCRs is typically found, it may be possible to draw comparisons with findings from the 
gut.  The MHC-like CD1 lipid-presentation family of molecules has been associated with 
recognition by γδ T cells, including the Group 1 CD1c (Spada et al., 2000) and the 
normally NKT associated CD1d.  Although CD1d is only expressed at low levels in healthy 
human liver (Canchis et al., 1993), studies have demonstrated an increased expression of 
CD1d in chronic HCV infection and PBC (Durante-Mangoni et al., 2004).  Gamma delta T 
cells are able to bind CD1d loaded with endogenous lipids such as cardiolipin (Dieude et 
al., 2011) and sulfatide (Luoma et al., 2013) in both mice and humans, in particular those 
possessing the Vδ1 and Vδ3 (Mangan et al., 2013) chains, which are the dominant 
subsets in liver tissue.  This occurs via the TCR, demonstrating an MHC-like restriction, 
antigen specific binding by γδ TCRs (Bai et al., 2012).  The crystal structure of a Vδ1 TCR in 
complex with CD1d has recently been published, verifying previous functional data 
(Uldrich et al., 2013).  Since these studies have been performed on expanded populations 
of gamma delta T cells, it is unclear whether these interactions are physiologically 
relevant, however HCV has been demonstrated to induce an expansion of CD1d reactive 
NKT cells, perhaps as part of the innate defense against acute infection in both mice (Liu 
and Huber, 2011) and humans (Yanagisawa et al., 2013).   In addition, HBV produces 
modified self-lipids that are presented on CD1d molecules and activate NKT cells (Zeissig 
et al., 2012).  It is possible that the liver may use endogenous or exogenous lipids as an 
indicator of cellular stress, particularly since the liver is the major site of lipid processing 
and metabolism in the body, and that gamma delta T cells may be involved in recognition 
of this.  If this is the case, determining the relevance of gamma delta T cell mediated 
recognition of CD1d lipid presentation when compared with NKT cells will be important.  
It is possible that the two cell types may have overlapping functions, with NKT cells 
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primarily associated with innate immune response, or it may be that a γδ T cell mediated 
interaction has additional properties, perhaps associated with immune regulation and 
tissue homeostasis.  In a study conducted on tissue biopsied from gut epithelium, isolated 
CD1d reactive gamma delta T cell clones expressed both Th1 and immunoregulatory TGFβ 
and IL-10, when compared with αβ T cells isolated from the same tissue (Russano et al., 
2007).  The possible identity of liver-specific and even disease-γδspecific lipid antigens for 
gamma delta T cells would also be worth investigating in any attempt to utilise this 
potential pathway for immunotherapy. 
Other known γδ TCR ligands that may have a role in the liver include phosphoantigens 
presented by butyrophilin, a molecule upregulated in HCC (Matos et al., 2009), and which 
may have a role in other forms of liver disease as a marker of cell stress or infection.  
Also, EPCR has been demonstrated to be expressed by HSC when activated to become 
myofibroblasts (Gillibert-Duplantier et al., 2010), suggesting a possible anti-fibrotic role 
for gamma delta T cells capable of recognising EPCR (Willcox et al., 2012).   
1.5 Thesis aims 
 
The liver is a key immunological organ that plays a vital role in tolerisation of the immune 
response toward gut derived non-harmful antigen whilst simultaneously acting as a 
firewall against pathogen-associated antigen.  Dysregulation of the immune homeostasis 
via potentially numerous chronic insults can result in chronic inflammation, fibrosis and 
ultimately cirrhosis and development of cancer.   
Gamma delta T cells are important effector cells capable of recognition and elimination of 
typically dysregulated-self targets, thereby playing a significant role in lymphoid stress 
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surveillance.  While our knowledge of the phosphoantigen-reactive Vδ2+ subset is 
reasonably well developed, Vδ2neg gamma delta T cells are less well studied.  Despite 
previous studies highlighting a tissue tropism for Vδ2neg gamma delta T cells, the nature 
of these cells and their role in immunosurveillance in human tissues is relatively poorly 
understood.   
In this study, the primary aim was to characterise the human gamma delta T cell 
population in human liver, through localisation, immuno-phenotyping and TCR 
sequencing studies.  Particular emphasis would be placed on comparing healthy liver with 
diseased tissue.  Additionally, this study afforded the opportunity to address fundamental 
questions regarding gamma delta T cell biology, such as their role in adaptive or innate-
like processes, and the role of the TCR in their function. 
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Materials and Methods 
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2.1 Tissue handling and cell isolation 
2.1.1 Lymphocyte isolation from blood 
 
Peripheral blood was collected in EDTA with informed consent from otherwise healthy 
haemochromatosis patients (ethical approval: Use of venesected blood from patients 
with haemochromatosis to isolate and culture immune cells, REC reference 
04/Q2708/41) as well as patients with autoimmune hepatitis and alcoholic liver disease 
(ethical approval via the University of Birmingham Human Biomaterials Resource Centre 
(NRES Committee North West – Haydock; Ref 15/NW/0079)).  In the case of matched 
blood and liver samples, venous blood was obtained from patients undergoing liver 
transplantation before the induction of anaesthesia.  Subsequently explanted diseased 
liver was obtained from the same patients to allow the isolation of matched blood and 
liver-derived cells (ethical approval: Cellular trafficking and immune response in the 
human liver, REC reference 06/Q2708/11).  Venous blood was also obtained from 
consenting healthy donors (protocol approved by the NRES Committee West Midlands 
ethical board; REC reference 14/WM/1254) in heparin.  Umbilical cord blood units were 
obtained from the Anthony Nolan Cell Therapy Centre Nottingham (ANCTC) under 
generic tissue bank ethics held by ANCTC and extended to the researchers under a 
material transfer agreement (MTA). 
Peripheral blood mononuclear cells were then isolated from whole blood by layering on 
top of Lympholyte-H Cell Separation Media (Cedarlane, Burlington, Canada) before 
centrifugation at 800g for 25 minutes at room temperature allowing separation based on 
gradient density.  PBMCs were aspirated from the cloudy partition layer and washed 
twice with sterile phosphate buffered saline (PBS) before counting using an improved 
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Neubauer haemocytometer with dead cells excluded using Trypan-blue (Sigma-Aldrich, 
Gillingham , UK) and further experimental procedure. 
2.1.2 Lymphocyte isolation from human liver 
 
Diseased liver tissue was taken with informed consent from patients undergoing liver 
transplant at Queen Elizabeth Hospital, Birmingham UK.  Chronically inflamed livers from 
the following patient groups were studied: alcoholic liver cirrhosis (ALD), non-alcoholic 
steatohepatitis (NASH), primary sclerosing cholangitis (PSC), primary biliary cholangitis 
(PBC), auto-immune hepatitis (AIH), chronic hepatitis C virus infection (HCV) and chronic 
hepatitis B virus infection (HBV).  Additionally, livers explanted for non-inflammatory 
chronic conditions including polycystic liver disease and α-1 antitrypsin deficiency were 
also studied in some cases, where a comparison between inflamed and non-inflamed 
liver tissue was required.  Non-diseased liver tissue was obtained from surplus tissue 
from cadaveric registered organ donors or from uninvolved liver tissue removed at the 
time of resection for colorectal hepatic metastases.  All samples were collected with 
informed patient consent and local research ethics committee approval (local research 
ethics committee approval 04/Q2708/41 and REC 2003/242). 
Explanted livers were cut into slices by a qualified pathologist at Queen Elizabeth Hospital 
and then transported to the Centre for Liver Research for further processing.  Under 
sterile conditions, liver slices weighing approximately 50 – 150 g were diced into 3 - 5 mm 
cubes using scalpels and then washed at least 5 times in PBS to remove any blood 
associated lymphocytes and erythrocytes.  Once washed, tissue was then transferred to 
Stomacher 400 Circulator bags (Seward, Worthing, UK) in approximately 150 ml chilled 
RPMI-1640 lymphocyte medium (Sigma-Aldrich) and then stomached for 5 – 7 minutes, 
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depending on severity of fibrosis, at 230 rpm in a Stomacher 400 machine (Seward, 
Worthing).  Mechanical homogenisation in this manner prevented loss of surface markers 
by enzymatic cleavage as well as being quicker and cheaper than enzymatic digestion.  In 
cases where very small amounts of tissue were obtained (typically less than 20 g), 
mechanical digestion was performed using GentleMACS dissociation C tubes (Miltenyi 
Biotech, Bergisch Gladbach, Germany) in a GentleMACS dissociator, running the mouse 
spleen standard protocol. 
Following homogenisation, liver tissue was filtered through a fine (63 micron) nytal mesh 
(John Stanniar and Co, Manchester, UK) and washed with twice the initial volume of 
chilled PBS.  Large cellular debris was then removed by centrifugation at 55 g for 5 
minutes.  Supernatants were then re-centrifuged at 2,000 rpm at 4oC , the supernatant 
discarded and the cell pellet washed at 4oC with PBS a further 3 – 5 times depending on 
the extent of steatosis present in the liver tissue.  Finally, washed cell pellets were re-
suspended in PBS, layered on Lympholyte-H cell separation medium and centrifuged at 
800 g for 25 minutes at room temperature.  Liver derived lymphocytes (LDL) were 
aspirated from the partition band and washed twice with cold PBS before counting using 
an improved Neubauer haemocytometer with dead cells excluded using Trypan-blue 
(Sigma-Aldrich). 
2.1.3 HSEC isolation and culture 
 
Primary human hepatic sinusoidal endothelium cells (HSEC) were isolated from explanted 
liver disease tissue or from normal donor liver surplus to transplant requirements.  Slices 
of liver tissue (20 – 50 g) were diced into 5 mm cubes using scalpels, washed with cold 
PBS as before and then incubated with collagenase type 1A (Sigma, St. Louis, USA) at 37oC 
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for 20 minutes in a shaker incubator.  Following digestion the tissue was layered on top of 
a 33%/ 77% Percoll: 1M NaCl solution gradient and centrifuged at 500 g for 30 minutes.  
The interface layer was aspirated and cells washed in cold PBS three times before 
cholangiocytes were labelled using a cholangiocyte specific mAb for HEA125 (Progen, 
Heidelberg, Germany) at 4oC for 20 minutes.  Following incubation, cholangiocytes were 
removed from the cell suspension by incubation with anti-mouse IgG1-coated Dynabeads 
(Invitrogen, Carlsbad, USA) and subsequent magnetic separation.  25 μL pre-washed and 
re-suspended Dynabeads were added to 1 mL of labelled cells in a polypropylene FACS 
tube and incubated for 20 minutes at 4oC before inserting the tube into a magnet for 2 
minutes to allow labelled cells to adhere to the tube walls. With the tube still in the 
magnet, the supernatant containing non-labelled cells was then removed.   
HSEC were then isolated from the resultant cell suspension by labelling using Dynabead-
conjugated anti-CD31 antibody (10 μg/mL; Invitrogen) and subsequent magnetic 
separation.  The protocol was identical to that for cholangiocyte removal except after 
magnetic incubation the supernatant was discarded and the adherent cells washed three 
times with PBS with an additional incubation in the magnet at each step, discarding non-
adherent cells each time to ensure cell purity. 
Isolated CD31+ HSEC were cultured in complete endothelial media (Gibco, Invitrogen, 
United Kingdom) supplemented with penicillin, streptomycin (100 µg/ml) and glutamine 
(2 mM, Gibco, CA, USA), heat-inactivated human AB serum (10% v/v, HD Supplies, 
Buckingham, UK),  hepatocyte growth factor (10 ng/ml Peprotech, Rocky Hill, NJ, USA) 
and vascular endothelial growth factor (10 ng/ml Peprotech), referred to hereafter as 
HSEC media.  Endothelial cells were grown in 25 cm2 tissue culture flasks coated with rat 
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tail collagen with regular medium exchanges until they became a confluent monolayer, 
then expanded in 75 cm2 tissue culture flasks coated with rat tail collagen. 
2.2 Cell based assays 
 
2.2.1 Flow cytometry – surface marker staining of blood- and liver-derived T 
cells 
 
Phenotyping of freshly isolated intrahepatic and peripheral blood derived T cell 
populations, including but not limited to pan-gamma delta T cells, Vδ1+, Vδ2+ and CD8+ 
cells was performed using flow cytometry.  In all protocols used in this study, dead cells 
were labelled using e506 viability dye (eBioscience, Hatfield, UK) prior to staining with 
antibodies.  This was performed at a dilution of 1:500 in 2% foetal bovine serum (FBS) 
(Sigma) diluted in PBS and incubated at 4oC for 20 minutes before washing twice with 
cold PBS to remove unbound dye.  Using this method, autofluorescent cells could also be 
excluded from the analysis by gating out all cells positive for e506.  For cell surface 
antigen expression analysis, cells were then incubated for 30 minutes at 4oC with 
antibodies against CD3, CD8, pan-γδ TCR, Vδ2 TCR,  and depending on the experiment 
Vδ1 TCR and/ or αβ TCR, as well as the antigen(s) of interest in 2% foetal bovine serum 
(FBS) diluted in PBS.  In some experiments, after washing with 2% FBS, cells were 
analysed immediately by flow cytometry or else they were fixed for 10 minutes with 3% 
formaldehyde solution at room temperature (Sigma Aldrich), washed again and analysed 
later.   
The following mouse anti-human antibodies were used for multi-colour flow cytometry: 
TCR αβ PE (IP26; 1:50), TCR γδ PEcy7 (B1; 1:100), CD3 BV421 (UCHT-1, 1:100), CD8 BV650 
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(SK1; 1:200), CD69 BV605 (FN50; 1:100), CD25 BV421 (2A3; 1:100), CD27 PE/ Dazzle 594 
(M-T271; 1:200), CD45RA PeCy7 (HI100; 1:200), CCR7 (G043H7; 1:100), CD62L (DREG-56; 
1:100), CD28 (28.2; 1:80), CD16 (3G8; 1:100), CD54 (HA58; 1:100), CXCR3 PE (G025H7), 
CD103 PE (BerACT8) and TCR Vδ2 PE (B6; 1:100); all BioLegend, San Diego, USA.  Mouse 
anti-human CXCR3 PE (FAB160P, FAB160F; 1:20), CXCR6 PE (56811/FAB699P; 1:20), CD18 
PE (2127011; 1:20) and CCR7 FITC (150503; 1:20) all from R&D Systems.  Mouse anti-
human CX3CR1-PE (2A9-1; 1:20), CD11a FITC (HI111; 1:10), CD49d PE (9F10; 1:50), CD29 
FITC (TS2/16; 1:20), 7 integrin FITC (FIB504; 1:20) from Immunotools, Friesoythe, 
Germany.  Mouse anti-human TCR γδ PeCy7 (IMMU510; 1:200), TCR Vγ9 PeCy5 
(IMMU360; 1:400) and CD127 (IM1980U; 1:20); Beckman Coulter, Brea, CA, USA.  TCR 
Vδ1 FITC (REA173; 1:100) and TCR Vδ2 APC (123R3; 1:200); Miltenyi Biotec. 
Single-fluorophore labelled anti-mouse IgG /negative control (FBS) compensation 
particles (BD Biosciences) were used for compensation.  All data was collected using 
either a nine colour, 3-laser CyAn ADP flow cytometer (Beckman Coulter) an LSR II 4-laser 
flow cytometer (Beckton Dickinson Biosciences, Franklin Lakes, NJ, USA) or an LSR 
Fortessa X20 4-laser flow cytometer (Becton Dickinson) and data analysed with FlowJo v. 
10.1 (TreeStar, Ashland, OR, USA), Summit 4.3 software (Dako Cytomation) or BD 
FACSDiva (Becton Dickinson). 
2.2.2 Intracellular staining of blood- and liver-derived T cells 
 
Freshly isolated liver infiltrating lymphocytes and/ or peripheral blood from different 
explanted diseased livers were used. For intracellular staining, cells were stimulated with 
100ng/ml of PMA and 1 µg/ml of ionomycin for 4 hours and incubated with 4µg/ml of 
Brefeldin A for the last 3 hours of stimulation. For intracellular staining of IL17, IL-22 IFN- 
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and RORc liver infiltrating lymphocytes were fixed and permeabilized with staining buffer 
(eBioscience) according to the manufacturer’s protocol. 1x106 cells stained with an anti-
mouse-IL17 mAb, IL-22mAb directly conjugated to PE and APC and IFN- mAb conjugated 
to FITC, or RORt conjugated to PE (eBioscience). 
To analyse expression of intracellular transcription factors and cytotoxicity factors, cells 
were stained for surface markers TCR γδ, TCR Vδ2 and TCR Vδ1 then fixed overnight in IC 
Fixation buffer (eBioscience), permeabilised and stained using the Foxp3/Transcription 
factor staining set (eBioscience) with antibodies directed against CD3, CD8 and the 
transcription factors Tbet PE, Hobit APC,  and EOMES APC and Granzyme A FITC (CBO9; 
1:100), Granzyme B APC (GB11; 1:100) and Perforin BV421 (B-D48; 1:80); all BioLegend.  
For intracellular cytokine staining, antibodies used were IFN- BV421 (340449; 1:200), 
TNF-α PE (554512; 1:200); BD Pharmingen, IFN- eFluor450 (4S.B3; 1:100), TNF-α FITC 
(Mab11; 1:50), eBioscience. 
2.2.3 Magnetic cell sorting of blood- and liver-derived T cells 
 
In certain experiments, purified populations of T cells were obtained from blood and/ or 
liver derived lymphocytes using magnetic sorting. This was achieved primarily using a 
positive sorting method using CD3 specific antibodies, as the negative sorting kits 
available all used CD56 and CD16 specific antibodies to deplete NK cells and monocytes, 
however, gamma delta T cells express both of these surface markers at variable levels 
and would therefore be removed from the final population.  Liver or peripheral blood 
derived lymphocytes were incubated with biotinylated mouse anti-human CD3 antibody 
(eBioscience) in 5 mL FACS tubes at room temperature for 10 minutes, before washing in 
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2% FCS in cold PBS + 10 mM EDTA and incubation with streptavidin coated MagniSort™ 
Positive Selection Beads (eBioscience) for a further 10 minutes at room temperature. 
Labelled cells were then inserted into EasySep separation magnets (Stemcell Technology, 
Vancouver, Canada) and incubated at room temperature for 5 minutes, after which the 
supernatant was discarded, the tube removed from the magnet and magnetised cells 
washed in 2% FCS.  This process was repeated twice to ensure good purity of CD3+ cells in 
the final population – typically greater than 98% of cells were CD3+. 
2.2.4 Static lymphocyte adhesion assay  
 
36 hours prior to the assay being performed, T25 cell culture flasks (Corning, New York 
City, USA) were coated with rat-tail collagen (Sigma-Aldrich) and allowed to dry in sterile 
conditions.  ~1x106 trypsinized primary human HSEC cells per flask were then added in 
HSEC medium and allowed to form a confluent monolayer at 370C, 5% CO2 overnight, 
with cell free medium used as a control in one flask per experiment.  Six hours prior to 
the assay the HSEC were either stimulated with addition of TNF-α (10 ng/ml) and IFN- 
(10 ng/ml) (Peprotech) to the medium or left untreated.  Typically 1x106 PBMC-derived 
lymphocytes were then either magnetically sorted to isolate CD3+ T cells or added in bulk 
and, following thorough aspiration of the HSEC medium and two washes with sterile PBS 
to remove trace cytokines and non-adherent cells, were re-suspended in RPMI-1640 
supplemented with 10% (vol/vol) heat-inactivated FCS (all Invitrogen), 
benzylpenicillin/streptomycin (100 IU/ml), and glutamine (2 mM) (all from Sigma Aldrich) 
and added on top of the HSEC monolayer in a total typical volume of 5 mL.  The culture 
flasks were then incubated for 15 minutes at 370C, 5% CO2 to allow adhesion of 
lymphocytes to the HSEC monolayer, before the non-adherent cells were harvested, the 
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cells washed with PBS and dead cells stained using the e506 viability dye (eBiosciences) at 
4C for 30 minutes.  Surface staining of γδ TCR antigens was then performed on the non-
adherent cells as described earlier and gamma delta T cell populations quantified by flow 
cytometry.   Data are expressed as the change in γδ TCR+ cells as a proportion of CD3+ T 
cells in the adherent cell population, calculated as the inverse of the non-adherent 
population measured by flow cytometry. 
2.2.5 Lymphocyte-endothelium transmigration assay 
 
36 hours prior to the assay being performed, 5 μm pore polycarbonate membrane 
Transwell inserts (Corning, New York City, USA) were coated with rat-tail collagen (Sigma-
Aldrich) and allowed to dry in sterile conditions.  ~100,000 trypsinized HSEC cells per well 
were then added on top of the Transwell insert in HSEC medium and allowed to form a 
confluent monolayer at 37 0C, 5 % CO2 overnight.  Six hours prior to the assay the HSEC 
were either stimulated with addition of TNF-α (10 ng/ml) and IFN- (10 ng/ml) 
(Peprotech) to the medium or left untreated.  Typically 250,000 PBMC-derived 
lymphocytes were then either magnetically sorted to isolate CD3+ T cells or added in bulk 
and, following thorough aspiration of the HSEC medium and two washes with sterile PBS 
to remove trace cytokines and non-adherent cells, were re-suspended in RPMI-1640 
supplemented with 10% (vol/vol) heat-inactivated FCS (all Invitrogen), 
benzylpenicillin/streptomycin (100 IU/ml), and glutamine (2 mM) (all from Sigma Aldrich) 
and added on top of the HSEC monolayer with cell-free medium added to the lower 
chamber to prevent drying out.  Transwell chambers were then incubated for 48 hours at 
370C, 5% CO2 to allow transmigration of lymphocytes across the HSEC monolayer, before 
the entire contents of both upper and lower chambers was harvested, the cells were 
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washed with PBS and dead cells stained using the e506 viability dye (eBiosciences) at 4C 
for 30 minutes.  Surface staining of γδ TCR antigens was then performed as described 
earlier and gamma delta T cell populations quantified by flow cytometry.  Data are 
expressed as the fold change in γδ TCR+ cells as a proportion of CD3+ T cells in both upper 
and lower chambers following incubation. 
2.2.6 Fluorescence activated cell sorting (FACS) 
 
For cell sorting, Vδ1+ and Vδ2+ populations were labelled with anti-CD3 (UCHT1; 1:100), 
TCR αβ (IP26; 1:50), TCR Vδ1 (TS8.2 or REA173; 1:100) or TCR Vδ2 (123R3; 1:100) and 
where indicated CD27 (M-T271; 1:200) and CD45RA (HI100; 1:200).  Alternatively, Vδ2neg 
T cell populations were sorted by labelling with anti-CD3 (UCHT1; 1:100), TCR αβ (IP26; 
1:50), TCR γδ (IMMU510; 1:200), TCR Vδ2 (123R3; 1:100).  Cells were filtered using a 25 
micron mesh to remove aggregates and resuspended in 2% FCS in cold PBS + 10 mM 
EDTA before sorting using a MoFlo Astrios Flow Cytometer Cell Sorter (Beckman Coulter) 
or a FACSAria II (Becton Dickinson). 
2.2.7 T cell activation assay 
 
Magnetically-sorted CD3+ T cells (section 2.2.3) were seeded in 24-well plates (Corning) in 
RPMI-1640 supplemented with 10% (vol/vol) heat-inactivated FCS, 
benzylpenicillin/streptomycin (100 IU/ml), and glutamine (2 mM) and incubated for 72 
hours either untouched, with washed Human T-Activator CD3/CD28 Dynabeads™ (Gibco) 
at a ratio of 1:1, or with recombinant cytokines IL-7 (25 ng/ mL), IL-12 (5 ng / mL), IL-18 (5 
ng/ mL) (all Peprotech) and IL-15 (25 ng/ mL, Miltenyi).  Gamma delta T cell subsets, CD8 
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T cells and activation markers CD69, CD54 and/ or CD25 were then determined by flow 
cytometry (2.2.1). 
2.2.8 In vitro activation of intrahepatic T cells by E. coli  
 
Liver-derived mononuclear cells were seeded in 12-well plates in RPMI-1640 
supplemented with 10% (vol/vol) heat-inactivated FCS, benzylpenicillin/streptomycin 
(100 IU/ml), and glutamine (2 mM) and incubated for 72 hours either untouched, with 
paraformaldehyde-fixed Escherichia coli (E. coli) (DH5α, Invitrogen) at 1000 bacteria per 
cell respectively or with E. coli and blocking antibodies against IL-12p40/70 (5 μg/ml, 
C8.6, eBioscience) and IL-18 (5 μg/ml, 125-2H, MBL International, USA).  Cell subsets were 
subsequently identified and activation assessed by flow cytometry labelling with IFNγ, as 
described previously. 
2.3 Cell localisation studies 
2.3.1 Immunohistochemistry 
 
Localization of gamma delta T cells in human inflammatory liver sections was performed 
using immunohistochemistry staining on formalin fixed paraffin embedded (FFPE) cubes 
of liver tissue.  Liver slices were cut and immediately fixed in 10% neutral buffered 
formalin for 24 – 48 hours prior to rinsing, dehydration and embedding in paraffin and 
subsequently sectioned into 5 μm thick sections and mounted on poly-L-lysine coated 
glass slides.  Sections were then de-paraffinised in multiple washes of xylene and then re-
hydrated in a series of decreasing strength ethanol baths. 
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Endogenous peroxidase activity was quenched by incubation in 0.3% hydrogen peroxide 
(Sigma Aldrich) in methanol for 20 minutes.  Antigen retrieval was then conducted by 
boiling the sections while immersed in 1% EDTA solution for 15 minutes in a microwave.  
After washing using 0.1% Tween in PBS, non-specific antibody binding was blocked using 
casein (1 in 10 in PBS) (Vector Laboratories, Burlingame, CA) for 20 minutes.  This was 
followed, after washing, by incubation for 1 hour in primary antibody (goat polyclonal – 
anti-human pan-VγVδ (50 μg/ mL, A-20, Santa Cruz Biotechnology, Santa Cruz, USA) or 
rabbit polyclonal – anti-human CD3 (2 μg/ mL, ab5690, Abcam, Cambridge, UK) or 
relevant IgG1 isotype control) diluted in PBS.  After washing, sections were covered with 
Impress HRP-linked anti-goat or anti-rabbit secondary antibody (Vector Labs 
Laboratories) and incubated for 30 minutes at room temperature.  Following washing, 
sections were developed using ImmPACTTM DAB reagent (Vector Laboratories) diluted as 
per the manufacturer’s instructions.  After desired level of staining was achieved, 
typically 2 - 5 minutes, excess DAB was removed by rinsing with distilled water.  Finally, 
sections were counterstained with filtered Mayer’s haematoxylin solution (Leica 
Biosystems) for 2 minutes or until desired level of staining was achieved.  This was 
developed by incubation in cold water for 2.5 minutes followed by hot water for 2.5 
minutes.  Once dry, slides were mounted using DPX (Cellpath, Newtown Powys, UK) and 
imaged on a Zeiss Axioskop 40 Microscope with a x20 or x40 objective lens. Regions of 
parenchymal and portal tract tissue were identified and numbers of CD3+ or γδ-TCR+ cells 
were counted per region identified, with 5 high power fields scored for each section. 
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2.3.2 In situ hybridisation (ISH) 
 
Localisation of chain-specific gamma delta TCR+ cells was performed in this study using 
two protocols, either the ViewRNA™ ISH Tissue 2-Plex Assay developed by Affymetrix and 
performed manually, or the RNAscope® 2.5 LS Duplex Assay (ACD) .  Although 2-Plex 
staining was not always performed, the protocol followed the manufacturer’s 
instructions up to the point of the second colour being developed in the case of 1-Plex 
staining.  For both protocols, liver slices were cut and immediately fixed in formalin for 24 
– 48 hours prior to embedding in paraffin and subsequently sectioned into 5 μm thick 
sections and mounted on poly-L-lysine coated glass slides, and immediately prior to the 
assay these slides were baked at 60 oC for 1 hour to immobilise the sections.   
2.3.2.1 Visualisation of γδ T cell subsets using manual ViewRNATM ISH 
 
Baked slides were then deparrafinised using three 5 minute xylene incubations, replacing 
the xylene with fresh each time, and dehydrated using two 5-minute incubations in 100% 
ethanol, before being allowed to air dry until completely dry in a fume hood.  Slides were 
then heated in a beaker containing Pretreatment Solution (Affymetrix) placed in a water 
bath at 90 – 95 oC for 15 minutes, and then washed three times in ddH2O.  Slides were 
then incubated for 30 minutes in a humidified hybridisation chamber pre-warmed to 40 
oC with protease solution diluted 1:100 in PBS (Affymetrix), and then washed three times 
in PBS before being fixed in 10% neutral buffered formalin for 10 minutes at room 
temperature.  Following 2 washes in PBS, slides were then incubated in the hybridisation 
chamber for 2 hours at 40 oC with the thawed target probeset diluted in Probe Set 
Diluent QT (Affymetrix).  Target probes were used as follows: 
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• a 20 ZZ probe targeting CD3E 
• a 20 ZZ probe targeting TRDC 
• a 7 ZZ probe targeting 2-564 of gi|99345462:619422-619991 (TRDV1) 
• a 7 ZZ probe targeting 4-481 of gi|99345462:946632-947128 (TRDV2) 
• a 8 ZZ probe targeting 2-470 of gi|28436398:56456-56931 (TRGV9) 
Slides were then washed 3 times in Wash Buffer (Affymetrix) before a 25 minute 
incubation in the hybridisation chamber at 40oC with pre-warmed PreAmplifier Mix QT 
(Affymetrix), a further three washes in Wash Buffer and then a 15 minute incubation in 
the hybridisation chamber with Amplifier Mix QT (Affymetrix).  Following 3 washes in 
Wash Buffer and depending on the probe set being used (Type 1 or Type 6), slide were 
then incubated with Label Probe 6-AP or Label Probe 1-AP at 1:1000 in prewarmed Label 
Probe Diluent QF (Affymetrix) in the hybridisation chamber for 15 minutes.  For 2-Plex 
assays, Label-6 probe sets were visualised using Fast Blue – following 3 washes with Wash 
Buffer, slides were incubated with Fast Blue substrate (Affymetrix) in the dark for 30 
minutes in the hybridisation chamber.  After washing, the fast blue reaction was 
quenched using AP Stop QT (Affymetrix) in a further 30 minute incubation in the dark in 
the hybridisation chamber.  For the second probeset, typically Type-1, and for 1-Plex 
assays, positive hybridisation was visualised using FastRed Substrate (Affymetrix).  After 3 
washes with Wash Buffer, sections were incubated for 5 minutes at room temperature 
with AP Enhancer Solution (Affymetrix) with Fast Red Substrate (one fast red tablet 
dissolved in 5 mL naphthol buffer) added immediately afterwards and incubated for a 
further 30 minutes at 40 oC in the hybridisation chamber.  Slides were then washed in PBS 
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and counter-stained using Mayer’s haematoxylin solution as described before and 
mounted using ProLong Gold (Invitrogen).  Imaging was performed on a Zeiss Axioskop 40 
Microscope with a x20 or x40 objective lens. 
2.3.2.2 Visualisation of γδ T cell subsets using automated RNAscopeTM ISH 
 
Although manufactured by a different company, the technology and protocol used in the 
RNAscope assay is very similar in most respects to that of the ViewRNA assay, with 
pretreatment, wash, probe incubation and signal amplification steps occurring in the 
same format.  However, this protocol had been optimised by the manufacturers to be 
used in conjunction with the BOND RX Research Advanced Staining System (Leica 
Biosystems), using proprietary BOND dewaxing, wash, and antigen retrieval buffers 
(Leica) and amplification buffers manufactured by ACD.  Minor modification of the 
staining protocol supplied by ACD was required but otherwise sample preparation, 
counterstaining and mounting was performed as for the ViewRNA assay. 
2.4 Sequencing studies 
2.4.1 γδ TCR sequencing 
 
For next-generation sequencing studies, peripheral blood or liver derived lymphocytes 
were labelled with antibodies and FACS sorted according to the protocol detailed in 
section 2.2.6.  Sorted Vδ2+, Vδ1+ or Vδ2neg cells were collected in numbers from 8,000 to 
50,000 directly in RNAlater (Sigma Aldrich), vortexed and frozen at -80oC for subsequent 
RNA extraction.  This was performed using the RNeasy Mini extraction kit made by 
Qiagen (Hilden, Germany).   Following centrifugation, the cell pellet was lysed and 
homogenised using Buffer RLT + 1% β-mercaptoethanol followed by thorough vortexing.  
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1:1 volume of 70% ethanol was then added before transferring the mixed lysate to an 
RNeasy spin column and centrifuged at 12,000 rpm for 15 seconds.  To remove genomic 
DNA, 350 µl Buffer RW1 was added to the column and centrifuged at 12,000 rpm for 15 
seconds before 80 µl of DNase I incubation mix was added to the column and incubated 
at room temperature for 15 minutes.  To remove ethanol, the column was then washed 
again with RW1 before 500 µl Buffer RPE was added to the column and centrifuged at 
12,000 rpm for 15 seconds and then again for 2 minutes with fresh Buffer RPE.  To elute 
RNA, the column was transferred to a new collection tube and 30 µl RNase-free water 
added directly to the spin column membrane before centrifugation at 12,000 rpm for 1 
minute.  This was then repeated to ensure high RNA yield.  RNA concentration was then 
determined using a NanoDropTM 3300 spectrophotometer (ThermoFisher, Waltham, MA, 
USA) and stored at -80 oC. 
For high throughput deep sequencing of TCRs, amplicon rescued multiplex (ARM)-PCR 
and NGS methods were employed to analyse all sorted gamma delta T cell populations 
(iRepertoire Inc. Huntsville, USA).  Following initial first-round RT-PCR using high 
concentrations of gene-specific primers, universal primers were used for the exponential 
phase of amplification (Patent: WO2009137255A2), allowing deep, quantitative and non-
biased amplification of TCR γ and TCR δ sequences.  All cDNA synthesis, amplification, 
NGS library preparation and sequencing were performed by iRepertoire.  V, D and J gene 
usage and CDR3 sequences were identified and assigned and tree maps generated using 
iRweb tools (iRepertoire). For more detailed analysis and error correction, data sets were 
then processed using the MiXCR software package. Diversity metrics, clonotype overlap 
and gene usage were plotted in R, by VDJTools. 
 
60 
2.4.2 Single cell PCR γδ TCR sequencing 
 
For exploration of the intrahepatic gamma delta TCR repertoire, single cell PCR was used.  
Individual Vδ1+ or Vδ3+ cells were sorted using a FACSAria II cell sorter (Becton Dickinson) 
(2.x.x) into a RNAse-free 96-well PCR plate (Axygen) containing 2 μL SuperScriptTM VILO 
reaction mixture containing 0.21 μL 1% Triton-X, 0.4 μL 5x VILO reaction mix, 0.2 μL 
SuperScript RT enzyme and 1.2 μL molecular grade water (Sigma) to lyse the cells and 
catalyse subsequent cDNA synthesis.  Two wells per plate were left empty and two wells 
per plate filled with 50 cells as negative and positive controls respectively.  Following 
brief centrifugation to ensure the cell was at the bottom of each well, the plate was 
incubated in a 2720 thermal cycler (Applied Biosystems) at 25°C for 10 minutes and then 
at 42°C for 120 minutes. The reaction was terminated at 85°C for 5 minutes before 
cooling to 4oC and subsequent storage at -20oC. 
TCRγ and TCRδ cDNAs were then amplified in a nested 2-round PCR procedure.  Firstly, 
0.5 μL  of “external” primers for TRDV1/3, TRDC, TRGV9 and TRGV1-8 (see Table 2.1) at 
0.5 μM were included with 12.5 μL GoTaq mastermix (Promega, Madison, USA), 2 μL 
template cDNA and 9.5 μL molecular grade water (Sigma) and annealed at 50 oC over 35 
cycles.  Then, 2 μL of the PCR product from this first round was used as a template for a 
second PCR round using GoTaq mastermix and 0.5 μM of the “internal” primers of 
corresponding genes included in the first round, using the same PCR protocol.  All primers 
were generously donated by Adam Uldrich, University of Melbourne. 
To ensure effective amplification, 10 μL of second round PCR product was then run on a 
1.2% agarose gel.  Samples were diluted in 1X loading dye (40% sucrose, 0.5% 
bromophenol blue) and loaded into an agarose gel (1% agarose (Sigma)) in TBE Buffer 
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(89mM Tris base, 89mM Boric acid and 2mM EDTA) with the addition of ethidium 
bromide for visualization by ultraviolet light. Samples were separated by size by the 
application of 80V across the gel until the desired separation was achieved. The 1kb plus 
ladder (Life Technologies) was used for fragment size determination.  Samples with 
correctly visualised bands on the gel were then purified using ExoSAP-IT (ThermoFisher) 
to remove excess primers and nucleic acids.  5 μL of PCR product was added to a fresh 96- 
well plate together with 1 μL ExoSAP-IT and the mixture incubated at 37oC for 15 minutes 
and then 85oC for a further 15 minutes to inactivate the ExoSAP-IT enzyme. 
Finally, the PCR products were prepared for Sanger sequencing by cycle sequencing with 
BigDye Terminator 3.1 (Applied Biosystems) using 1 μL of the 0.5 μM “internal” reverse 
primers , 1 μL Big Dye (Applied Biosystems), 1 μL DMSO, 5 μL Dilution Buffer (Applied 
Biosystems), 6 μL molecular grade water and 6 μL PCR product template.  The mixture 
was then incubated in a thermal cycler at 95oC for 5 minutes, followed by 35 cycles of 
96oC for 10 sec for denaturation, 50oC for 5 sec for annealing, and 60oC for 4 minutes for 
extension, with a final hold temperature of 4oC.  Reaction mixtures were then purified for 
capillary electrophoresis using BigDye Xterminator; 45 μL SAM solution and 10 μL BigDye 
XTerminator bead solution were mixed with the reaction mixture, vortexed and 
centrifuged at 1,000 g for 2 minutes prior to storage at 4oC.  Capillary electrophoresis was 
performed using an ABI 3730 capillary sequencer (Applied Biosystems) at the Functional 
Genomics Facility, University of Birmingham. 
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Round 1 
   number name sequence n 
101 
short Vδ1 Forward CAAGCCCAGTCATCAGTATCC 21 
101 Vδ1 Forward ACTCAAGCCCAGTCATCAGTATCC 24 
102 Cδ Reverse  GCAGGATCAAACTCTGTTATCTTC 24 
103 Vγ1-5 Forward GTCATCTGCTGAAATCACYTGYG 23 
104 Vγ8 Forward AATGCCGTCTACACCCACTG 20 
105 Vγ9 Forward AGAGAGACCTGGTGAAGTCATACA 24 
106 Vγ10 Forward GAGCACCTGATCTATATTGTCTCAAC 26 
107 Vγ11 Forward GCATCCATCCAAGGCTTTAG 20 
108 Cγ Reverse CTGACGATACATCTGTGTTCTTTG 24 
 Round 
2A 
   number name sequence n 
206 Vδ1 Forward CAACTTCCCAGCAAAGAGATG 21 
201 Cδ Reverse TCCTTCACCAGACAAGCGAC 20 
 Round 
2B 
   number name sequence n 
103 Vγ1-5 Forward GTCATCTGCTGAAATCACYTGYG 23 
104 Vγ8 Forward AATGCCGTCTACACCCACTG 20 
202 Cγ Reverse AATCGTGTTGCTCTTCTTTTCTT 23 
 Round 
2C 
   number name sequence n 
203 Vγ9 Forward GGTGGATAGGATACCTGAAACG 22 
204 Vγ10 Forward AATTCTCAAACTCTCACTTCAATCC 25 
205 Vγ11 Forward ATGTCTTCTTGACAATCTCTGCTC 23 
202 Cγ Reverse AATCGTGTTGCTCTTCTTTTCTT 23 
 
Table 2.1:  Single cell PCR T cell receptor primers 
Two round nested PCR to determine CDR3 sequence of gamma delta T cell TCR.  First round PCR 
products were used as template for second round primers, grouped into three reactions 
depending on optimal annealing temperature 
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2.5 Statistical analysis 
 
All compiled data were analysed in Graphpad PRISM 7 (Graphpad Software Inc, USA) and 
NGS-based TCR sequencing data by VDJTools.  After assessing normality using Shapiro-
Wilko tests, either two-tailed Student’s T tests or Mann-Whitney U-tests were used to 
identify differences between groups of normally distributed or non-parametric data, 
respectively. 
 
Where more than two groups were to be analysed simultaneously, one-way ANOVA with 
Holm-sidak’s post-tests or with Kruskal–Wallis ANOVA and Dunn’s post-tests were used 
to identify differences between normal and non-parametrically distributed data 
respectively. Two-way ANOVA was used when comparing groups with independent 
variables. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, as indicated in relevant 
figures.  Normally distributed data were assessed for correlation with Pearson’s 
correlation coefficient, while Spearman correlation was employed for non-parametric 
data. 
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3 
 
Intrahepatic gamma delta T cells in health 
and disease:  prevalence and localisation 
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3.1 Introduction 
 
In healthy liver, oxygen-rich blood from the hepatic artery and nutrient-rich blood from 
the hepatic portal vein drains into the tissue in a series of evenly spaced arterioles that, 
together with the bile ducts, form the portal triads – the corners of the classically 
hexagonally shaped liver lobules.  From these portal triads, very narrow specialised 
capillaries termed sinusoids carry efferent blood through the parenchyma of the liver 
towards central venules and eventual egress from the tissue via the hepatic vein.  During 
this transit through the sinusoids, physical constriction reduces blood flow rate to ~100–
400 μm s−1, increases shear stress and forces cellular components of the blood into close 
contact with the parenchymal cells of the hepatic lobes (Sironi et al., 2014).  These factors 
combine with the uniquely fenestrated structure of the hepatic sinusoidal endothelial 
cells (HSEC) to allow lingering and direct interactions between leucocytes and platelets of 
the blood and the primary component of the liver parenchyma, the hepatocytes, as well 
as the immunologically critical HSEC, hepatic stellate cells (HSC), and liver-resident 
leucocytes such as Kupffer cells and dendritic cells (Braet and Wisse, 2002).  By this 
method gut-derived antigen can be sensed by liver parenchymal cells, either directly via 
cell surface receptors such as TLRs or indirectly via contact with blood derived myeloid 
cells.  In the case of commonly encountered non-harmful antigen the antigen-presenting 
capability of the liver parenchymal cells will then normally tolerise local T cell populations 
through priming via MHC without signal 2 or in the presence of immunosuppressive 
cytokines such as TGF-β and IL-10 (Jenne and Kubes, 2013). 
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In chronically inflamed livers, irrespective of the initial cause of the injury, whether it be 
autoimmune, metabolic dysregulation or viral in nature, leucocytes are recruited from 
the blood via upregulation of pro-inflammatory chemotactic cues such as chemokine 
ligands CXCL9, 10 and 11 and accumulate in the liver at abnormally high frequencies 
(Borchers et al., 2009).  Retention and positioning of these lymphocytes within the liver 
microanatomy is determined by further chemotactic signals and upregulation of 
activation associated adhesion molecules on both lymphocyte and stromal cells (Oo et al., 
2010).  Previous studies have demonstrated that this accumulation is particularly 
prevalent where chronic attempts to repair damaged tissue has resulted in the formation 
of excessive collagenous fibrous septa, which commonly occurs in the areas around the 
portal tracts and the along the boundaries between portal tracts that form the edges of 
the liver lobules (interface hepatitis) often driven by high expression of matrix protein 
binding integrins such as CD49d (Patsenker and Stickel, 2011).   
 
Since the liver is composed of such a heterogeneous population of different cell types 
that normally work in harmony to ensure effective immune regulation, identifying 
precisely where in the microanatomy lymphocytes are localising, and therefore what 
other cells they are likely to be interacting with, can provide a valuable insight into the 
role of the lymphocytes in both health and progression of pathology.  Accordingly, the 
aim of this chapter was to elucidate 1) the scale of γδ T cell infiltration in normal and 
diseased livers, and also 2) identify where liver-associated γδ T cells are found in the 
context of the liver microanatomy.  
 
 
67 
Although the general T cell population has been extensively researched in this context in 
many different disease settings, the only study to date on intrahepatic gamma delta T cell 
localisation focussed on Hepatitis C virus (HCV) infection (Kasper et al., 2009).  Using 
immunohistochemical analysis of frozen sections, the authors found no discernible 
difference in number of liver-infiltrating gamma delta T cells between HCV, HBV or 
autoimmune hepatitis cases and found that those cells that were infiltrating were 
predominantly associated with the portal inflammation and not in contact with 
hepatocytes.  This study did not examine normal tissue infiltration however. 
 
Two techniques enable localisation of specific subsets of cells within tissue sections, 
immunohistochemistry (IHC), which relies on antibody-based detection of proteins within 
the tissue sections, and in-situ hybridisation (ISH), which uses complementary nucleic 
acid probes for specific detection of RNA sequences within tissue.  This study attempted 
to incorporate both methods. 
3.2 Analysis of infiltration of liver tissue by gamma delta T cells by IHC 
3.2.1 Method 
 
Immunohistochemistry has been used as a technique to identify proteins in tissues since 
the 1940s.  It relies on recognition of a specific target protein antigen by a primary 
antibody raised in an animal in response to that antigen administered exogenously.  As 
long as the tissue section to be stained is correctly prepared, antibodies in solution will 
bind with exposed antigen in the tissue.  Visualisation can take a number of forms, but all 
use a secondary antibody raised against the isotype of the primary antibody, and these 
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are usually conjugated, either to an enzyme that catalyses breakdown of a substrate to 
form a chromogen which can be visualised by light microscopy, or a fluorophore to allow 
visualisation by fluorescence microscopy. 
 
Working within the Centre for Liver Research, a large depository of formalin-fixed 
paraffin embedded (FFPE) tissue blocks from all chronic liver disease aetiologies, as well 
as normal liver sections from unused donor livers was available for this study.  FFPE 
sections exhibit superior tissue morphology and clarity compared with frozen sections, so 
for these reasons were chosen for this study. 
 
IHC as a technique relies predominantly on the quality of the primary antibody.  At the 
time these experiments were performed, there were only a handful of antibodies 
commercially available for identification of the human γδ TCR, and few of them had been 
convincingly validated in published work.  After an initial pilot test performed using 
historical FFPE human tonsil sections, the H-20 clone supplied by Santa Cruz 
Biotechnology gave the most encouraging results (not shown), and so all further 
optimisation was performed using this primary.  Tonsil was chosen as a positive control 
tissue throughout the localisation studies since relatively high frequencies of gamma 
delta T cells are found there, and the tissue is relatively easy to work with in that it 
contains few tissue specific elements that can cause non-specific signal, such as liver 
associated bile and auto-fluorescent hepatocytes.  Representative examples of positive 
staining in the liver sections were verified by a senior pathologist at Queen Elizabeth 
Hospital, Birmingham, Prof. Stefan Hubscher, during the antibody validation phase of the 
study.   
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A critical element to successful IHC using FFPE sections is antigen retrieval – that is, 
unmasking of the protein epitopes from the cross-linked matrix that preserved the 
sample during FFPE fixation.  There are a number of methods for this, which generally use 
heat, proteases or a combination of the two.  During this study an antigen retrieval 
protocol developed in the Centre for Liver Research was followed with optimisation of 
heat pre-treatment time to maximise final staining while maintaining optimum tissue 
morphology, since over-treating the sections at this stage leads to degradation of the 
section.  
 
Although using bright-field visualisation allows clear and relatively straightforward 
enumeration of one or two epitopes of interest in tissue sections, for example, using DAB 
and alkaline phosphatase for brown and red staining on a single section, it is not suitable 
for use imaging multiple targets and close cell-cell interactions.   Confocal fluorescent 
microscopy allows simultaneous use of multiple colours due to the variety of 
fluorophores available, as well as enhanced optical resolution and contrast compared 
with bright-field.  To identify possible important cellular interactions of intrahepatic 
gamma delta T cells, the H-20 clone antibody was used with a fluorescein isothiocyanate-
conjugated secondary and photographed on a Leica DM6000 microscope (Figure 3.1).  
However, despite attempts to improve the signal to noise of the resulting images by 
varying the antibody concentration and incubation time/ temperature, consistent 
positive staining of liver tissue was not achieved.  This was likely due to the combination 
of naturally high background auto-fluorescence of liver parenchymal cells and the fact 
that the primary antibody was a polyclonal goat-derived antibody with quite a high 
  
 
70 
 
 
 
 
 
 
Figure 3.1:  Fluorescent IHC staining of γδ T cells in human liver 
FITC-conjugated γδ-TCR specific antibody labelling of portal area of liver from a patient 
with non-alcoholic steatotic hepatitis.  Examples of positively stained (green) cells are 
highlighted with white arrows.  Examples of non-specific non-cellular staining are 
highlighted with red arrows.  Counterstaining was performed using DAPI.  40x 
magnification. 
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degree of non-specific staining, which while reasonable under bright-field visualisation 
became problematic when using the increased sensitivity of confocal imaging. 
3.2.2 γδ T cell localisation in liver tissue 
 
Two liver tissue sections isolated from explanted livers from five individuals from each of 
the following disease groups were stained using immunohistochemistry, visualised using 
the DAB method:  ALD, NAFLD, PBC, PSC, AIH, HCV and HBV.  Liver tissue sections from 
five normal donors were also analysed.   The first section was incubated with a primary 
antibody specific for the delta-chain of the gamma delta TCR, while the second sequential 
section was incubated with a primary antibody specific for CD3, part of the T cell receptor 
complex.  In all cases the same area of the section was identified on the two sections as 
accurately as possible to allow direct comparison of γδ TCR+ and CD3+ staining (Figure 
3.2). 
 
Previous studies have shown the human liver gamma delta T cell population is 
somewhere between 3% and 15% of the total CD3+ T cell population (Kenna et al., 2004).  
By counting positively stained cells from three random high-power fields from each 
section stained and comparing the number of γδ TCR+ to the number of CD3+, in diseased 
livers taken as a whole, γδ TCR+ cells represented 11.1% of the total T cell infiltration, 
whilst strikingly, in normal individuals this rose to 26.7% (Figure 3.3a).  This represents a 
significant increase when compared with the disease group (p<0.001, Mann-Whitney U-
test). 
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Figure 3.2:  γδ T cells are enriched in parenchyma of human liver 
Representative images of sequential FFPE sections from parenchymal (upper panels) and 
portal (lower panels) areas of liver explanted from a NASH patient, stained by IHC and 
visualised using DAB for γδ-TCR (right panels) and CD3 (left panels).  Examples of 
positively stained (brown) cells are highlighted with black arrows.  40x magnification. 
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Figure 3.3:  γδ T cells are enriched in normal liver 
a) Proportion of γδ-TCR+ cells identified as a ratio of CD3+ cells from IHC staining of 
sequential FFPE sections using γδ-TCR and CD3 specific antibodies, from normal (n=21) 
and diseased (n= 62) livers.  (p<0.0001, Mann-Whitney U-test) 
b) Proportion of γδ-TCR+ cells identified as a ratio of CD3+ cells from IHC staining of 
sequential FFPE sections using γδ-TCR and CD3 specific antibodies, from normal (n=21) 
and various chronically diseased livers (n=12).  (p<0.0001, 1way ANOVA, Kruskal Wallis 
test) 
 
b 
a 
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Figure 3.3b shows these data for each disease subtype, as well as normal liver.  There was 
no significant difference in the average percentages of γδ TCR+ cells between any of the 
inflammatory disease states compared with each other (PSC – 17.0%; PBC – 8,9%, ALD – 
11.8%, NASH – 10.4%, HBV/ HCV - 7.6%, p=0.48, 1-way ANOVA, Kruskal Wallis test), 
although all are significantly reduced when compared with normal liver (p=0.0001, 1-way 
ANOVA, Kruskal Wallis test). 
 
As well as measuring the frequency of γδ TCR+ cells as a percentage of total CD3+ cells, it 
was also possible to determine absolute numbers of infiltrating cells per field in normal 
and diseased livers.  These data are illustrated in Figure 3.4a.  In diseased livers, when 
examining the group as a whole, there was a greater than 5-fold increase in absolute 
numbers of infiltrating CD3+ T cells in inflamed conditions compared with normal livers 
(213 cells/ field vs 41 cells/ field, p<0.001, Mann Whitney U test).  However, a similar 
comparison for the γδ TCR+ cells shows no such increase in inflamed conditions compared 
with normal liver (21 cells/ field vs 16 cells/ field, p>0.05).  Additionally, no particular 
disease state showed any significant change from this paradigm, with CD3+ enrichments 
of greater than 5-fold in autoimmune (PSC, PBC and AIH), fatty liver (ALD + NASH) and 
viral liver disease (HCV and HBV) patients compared with normal liver (Figure 3.4b).  As a 
whole, these data were suggestive of a scenario where gamma delta T cells are relatively 
abundant in normal liver compared with the total number of T cells present, but that 
during the course of chronic inflammation, a large infiltration of non-gamma delta T cells 
occurs while the number of γδ T cells does not significantly change.  This therefore results 
in a reduction in the observed percentage of gamma delta T cells compared with CD3+ T 
cells in disease compared with normal livers. 
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Figure 3.4:  Liver disease is not associated with increased infiltration of γδ T cells 
a) Liver infiltration of CD3+ and γδ-TCR+ cells identified as positively stained cells per high 
power field following IHC staining of sequential FFPE sections using γδ-TCR and CD3 
specific antibodies, from normal (n=21) and diseased (n= 62) livers.  (p<0.0001, 1-way 
ANOVA, Dunn’s multiple comparison test)   
b) Liver infiltration of CD3+ and γδ-TCR+ cells identified as positively stained cells per high 
power field following IHC staining of sequential FFPE sections using γδ-TCR and CD3 
specific antibodies, from normal (n=21) and chronically diseased livers of varying 
aetiology (n=12).  (p<0.0001, 1way ANOVA, Kruskal Wallis test)   
a 
b 
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In addition to determining the absolute frequencies of infiltrating γδ T cells in the liver, 
use of IHC allowed quantification of where in the liver microanatomy these cells were 
most abundant.  Upon counting, the location of the positive cell was noted as either a) 
parenchymal, that is, in association with the hepatocytes or b) portal, that is, in 
association with the portal triad or area of fibrosis and interface hepatitis surrounding the 
triad (Figure 3.5).  An average of 33.3 CD3+ cells per field was present in the parenchyma 
of normal livers, with no significant difference in disease (35.5 cells/ field).  48.4 CD3+ 
cells/ field were present in normal portal areas, rising to 301.7 cells/field in diseased 
livers, a 6.23-fold increase (p<0.001, Mann Whitney U test).  γδ TCR+ cells were not 
enriched in disease parenchyma (17.6 cells/ field vs 23.4 cells/ field, p=0.057 Mann 
Whitney U test) but, as for CD3+ cells, were significantly enriched in portal areas (23.4 
cells/ field vs 7.9 cells/ field, p<0.001).  Interestingly, while CD3+ cells were significantly 
enriched in diseased portal areas compared with diseased parenchyma (p<0.001), γδ 
TCR+ cells were not, suggesting that the large increase in CD3+ T cells in disease is mainly 
due to non-gamma delta T cells infiltrating the portal areas of the liver, while the 
parenchyma is relatively enriched for gamma delta T cells in both health and disease 
states.  
 
The parenchymal enrichment of gamma delta T cells becomes strikingly apparent when 
the frequency of γδ T cells is viewed as a percentage of CD3+ T cells present (Figure 3.6a).  
In normal liver, 66.2 ± 1.54% of CD3+ were γδ TCR+ in the parenchyma, dropping to 53.4 ± 
2.54% in diseased livers (p>0.05).  In the portal areas, 18.2 ± 1.43% of CD3+ were γδ TCR+ 
in normal liver, 8.3 ± 0.2% in diseased (p<0.001).  As with overall infiltration, localisation 
of intrahepatic gamma delta T cells shows no discernible variation between individual 
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Figure 3.5:  Portal regions are enriched for CD3+ and γδ T cells in liver disease 
Liver infiltration of CD3+ and γδ-TCR+ cells, identified as positively stained cells per high power 
field following IHC staining of sequential FFPE sections using γδ-TCR and CD3 specific antibodies, 
from normal (n=21) and diseased (n= 30) livers.  Each cell counted was associated with either liver 
parenchyma or portal regions.  *p<0.05, **p<0.01, ****p<0.0001, 1-way ANOVA, Dunn’s multiple 
comparison test. 
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Figure 3.6:  Localised γδ T cells proportion of liver infiltrating T cells by IHC analysis  
a) Proportion of γδ-TCR+ cells identified as a percentage of CD3+ cells infiltrating either 
parenchymal or portal areas of normal (n=21) and diseased (n= 30) livers by IHC staining 
of sequential FFPE sections using γδ-TCR and CD3 specific antibodies.   
b) Proportion of γδ-TCR+ cells identified as a percentage of CD3+ cells infiltrating either 
parenchymal or portal areas of normal (n=21) and diseased livers of various aetiologies 
(n=6) by IHC staining of sequential FFPE sections using γδ-TCR and CD3 specific 
antibodies.  **p<0.01, ***p<0.001,  1-way ANOVA, Dunn’s multiple comparison test. 
a 
b 
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disease groups, with the parenchymal areas being dominated by gamma delta T cells in 
all cases (Figure 3.6b). 
3.3 Analysis of liver infiltrating gamma delta T cells by ISH 
3.3.1 Background  
 
A significant drawback to IHC as a technique is that it relies on antibody detection of 
target epitopes and therefore if no antibody is available for the target of interest, IHC is 
impossible.  In-situ hybridisation (ISH) is an alternative technique for visualisation of 
targets within tissues that has been used since the late 1960s but has recently been 
refined as a commercial product by AffymetrixTM and Advanced Cell DiagnosticsTM.  
Instead of antibody detection of a protein epitope, ISH uses oligonucleotide probes 
complementary to the mRNA target sequence to provide initial target recognition and 
then a series of hybridisation steps to adjacent oligonucleotides to amplify the bound 
probes to produce a visible readout.  As with IHC, visualisation can be either bright field 
or fluorescent, but in this case as long as the mRNA target sequence is known and there 
are sufficient intact lengths of sequence present in the tissue, ISH probes can be designed 
for any target without need to develop and validate specific antibodies, a costly and often 
difficult process. 
 
The antibody used in the IHC-based study was specific for TCR delta-chain constant region 
and therefore can only be used to assess “pan-γδ”-positive T cells.  However, this 
provided no information as to the TCR chain usage of the gamma delta T cells present.  
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Previous studies have suggested that the classically tissue-associated Vδ1+ and Vδ3+ γδ T 
cells are likely enriched in human liver (Kenna et al., 2004), and so to quantify these cells 
and assess whether they are localised differently to the classically blood-associated Vδ2+ 
γδ T cells, an ISH-based method was employed using oligonucleotide probes specific to 
the variable delta-chain regions specific to each individual TCR subset (Vδ1, Vδ2 and Vδ3).  
Additionally, by using an ISH duplex kit developed for co-staining two markers of interest, 
it should be possible to probe for TCR Vδ mRNA transcripts on the same section as CD3, 
thereby negating the requirement to use sequential sections for pan-γδ TCR and CD3, and 
providing a more reliable quantification of γδ T cells and CD3+ cells than the IHC dataset.  
 
While proteins tend to be fairly robust and withstand the fixation, embedding and de-
paraffinisation involved in pre-treatment, mRNA is a lot more sensitive to degradation, 
particularly at the point of tissue collection and initial fixation.  While every effort is made 
to process explanted tissues as quickly as possible, there is always a delay between the 
organ being removed from the donor in theatre and the tissue being processed for 
fixation, either in the hospital pathology department or in the Centre for Liver Research 
laboratories.  mRNA degradation can therefore be an issue for sensitivity, particularly for 
low copy number mRNA transcripts.  Additionally, since it is mRNA that is targeted using 
ISH, the technique relies on expression of that mRNA at the time of fixation, which may 
not be the case for all targets.  TCR mRNA expression is relatively stable but increases 
upon cell activation (Uppenkamp et al., 1993), meaning this method may not be as 
sensitive to resting T cells as IHC, where protein level expression generally decreases 
upon prolonged stimulation (Schrum et al., 2003). 
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3.3.2 Development of ISH protocol for Vδ1/ Vδ2/ Vδ3 visualisation 
3.3.2.1 ViewRNA protocol 
 
The first attempt to use ISH to visualise gamma delta TCR mRNA in liver tissue used 
Affymetrix’ ViewRNA ISH Tissue 2-plex Assay.  Probes were designed for CD3, the 
constant region of the TCR delta-chain (Cδ), Vδ1 and Vδ2.  Probes for CD3 and Cδ already 
existed in the manufacturer’s library but new probes were designed for the variable-chain 
regions of gamma delta TCRs.   
 
Before using the gamma delta TCR probes however, the method was validated using 
positive control sections and probes supplied by the manufacturer, which ensured 
reagents and equipment used were capable of yielding positive results.   These consisted 
of rat kidney FFPE sections mounted on positively charged slides with low expression rat 
osteopontin (Spp1) and highly expressed ubiquitin C (Ubc) probe sets.  The test probe 
sets were also used on tonsil tissue, as with the IHC protocol, since the frequency of 
positive gamma delta staining in liver tissue was unknown, while tonsil contains a 
relatively high number of γδ T cells. 
 
In brief, the protocol required baking slides to fully dry them out and remove the majority 
of the embedding wax, deparaffinisation in xylene followed by dehydration in ethanol.  
The next two steps, heat pre-treatment and protease digestion, equivalent to IHC antigen 
retrieval, were according to the manufacturers the only steps that require optimisation.  
For liver tissue, best results were achieved using a pretreatment time of 30 minutes and a 
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protease digestion of an hour – both longer than the time recommended by the 
manufacturer.   
 
Following pre-treatment the sections were incubated with the relevant oligonucleotide 
probes, with both probes added simultaneously.  Each probe set consisted of between 7 
and 20 engineered nucleotide sequences that form a “Z” shape molecule.  These probes 
hybridised along their “lower” region to corresponding lengths of target mRNA sequence.  
Since this was a duplex assay, each probe was designed with one of two signal 
amplification systems – either Type 1 or Type 6.  This meant any probe with Type 1 
amplification could be used with any other probe with Type 6, but two Type 1 or Type 6 
probes could not be used simultaneously.    The lower region of each Z-shaped probe is 
linked to an upper region specific to the Type 1 or Type 6 amplification system.  Sections 
were then washed and incubated with a preamplifier.  These preamplifiers hybridise to 
the “upper” region of the oligonucleotide probes and form a branched DNA framework 
for the amplifiers, added in the next incubation step.  The amplifiers consisted of long 
DNA chains with multiple hybridisation sites for the alkaline phosphatase conjugated 
label probes, either Type 1, which catalysed Fast Red substrate to produce red staining, 
or Type 6, which catalysed Fast Blue substrate to produce blue staining (illustrated in 
Figure 3.7).  Each red or blue dot formed on the tissue corresponds to probes binding to a 
single RNA molecule.      
 
Each assay incorporated a negative control to determine the level of background staining 
– in each case a slide from the same case was stained in full but without the target probe 
set (Figure 3.8a).  Positive controls used included GAPD and CD3 (Figure 3.8b).  Before 
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Figure 3.7:  Illustration of Affymetrix ViewRNA Tissue 2-plex assay 
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duplex staining was attempted using gamma delta probes however, 1-plex staining was 
attempted for the Type 1 probes by omitting the Type 6 probes from the target probe 
mix.  This was to ensure each probe worked consistently without the possibility of 
methodological issues involved in the visualisation step of the 2-plex assay causing 
problems.  Since the Fast Blue and Fast Red substrates are sequentially developed in this 
assay, the Fast Blue precipitates that are formed first have the potential to partially block 
subsequent hybridization of the TYPE 1 Label Probe, by masking its binding sites on a 
nearby/co-localized target and consequently affecting the development of the Fast Red 
signal.  Another issue discovered was that the Fast Blue was often difficult to distinguish 
from the haematoxylin counterstain, which is dark blue/ purple in colour.  It was difficult 
to determine whether either potential issue may have been a problem in this experiment 
however, as single-plex staining did not prove satisfactory.  
 
Results of 1-plex staining in tonsil tissue were generally in line expectations based on 
previous IHC of tonsil sections, with positive staining noted for GAPD, CD3, Vδ1 and Vδ2, 
although these results were not achieved every time (Figure 3.8c).  In liver tissue, the 
success rate was considerably lower, even for the GAPD positive control, although 
positive results were achieved (Figure 3.9). 
 
A number of factors could have contributed to this problem.  The protocol had over 150 
individual steps and took 2 days to perform and therefore is quite susceptible to variation 
in the multiple pipetting and washing stages of the protocol.  A second issue that didn’t 
become apparent until midway through the study was that when liver tissue was 
collected in the Centre for Liver Research and fixed in formalin, the length of time it was 
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Figure 3.8:  Single-plex staining of tonsil sections using Affymetrix ViewRNA in-situ 
hybridisation 
Representative images of FFPE human tonsil sections stained using ISH probes specific for: a) 
negative control (no probe), b) GAPD, c) CD3, d) Vδ1 and e) Vδ2.  Positively stained cells (red) are 
identified with black arrows.  Sections were counter-stained using haematoxylin.  Magnification 
for a-c, 40x and for d-e 20x. 
a b 
c d 
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Figure 3.9:  Single-plex staining of liver sections using Affymetrix ViewRNA in-situ hybridisation 
Representative images of FFPE human liver derived sections stained using ISH probes specific for: 
GAPD (left) and Vδ2 (right).  Positively staining (red) is identified with black arrows, however not 
all cells are stained positive for the GAPD control and the “cells” marked as positive in the Vδ2 
image do not appear to have nuclei.  Sections were counter-stained using haematoxylin.  
Magnification 40x. 
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fixed for often varied significantly – from 48 hours to over 3 weeks.  That meant that each 
individual case would likely require differing pre-treatment for varying fixation times.  
While this is possible for IHC-based approaches, the significant cost and complexity of the 
ISH assay meant optimisation for individual cases became impractical.  It did appear that 
some tissue blocks had been over-fixed, since the pre-treatment times were longer than 
those recommended and the tissue architecture generally remained good even at longer 
heat/ protease exposure.  This issue could be addressed by using samples obtained from 
a set fixation period, such as QEHB pathology labs.  Bile accumulation in chronic 
cholestatic disease also formed an unwanted source of interference in both the IHC and 
ISH-based protocols, forming non-specific “blobs” of staining that potentially masked 
areas of the section from being correctly stained. 
3.3.2.2 RNAscope protocol 
 
Results from the Affymetrix protocol were encouraging but consistency was proving a 
major challenge.  To address this issue, an alternative kit was identified from Advanced 
Cell Diagnostics (ACD) that had been developed for use with a Leica Bond RX automated 
system – the RNAscope® 2.5  LS Automated Assay.  Liver tissue samples were acquired 
from the Queen Elizabeth Hospital pathology department rather than the Centre for Liver 
Research, which would provide a more consistent fixation time, preventing over-fixation 
of tissue samples and standardising pre-treatment times. 
 
The Bond RX staining protocol was supplied by ACD, and in essence was very similar to 
the ViewRNA protocol but all incubations and washes were performed by robot rather 
than by hand.  As with the ViewRNA kit, a manufacturer supplied positive control kit was 
 
88 
used to validate the method on our equipment, and the results were in line with the 
manufacturer’s criteria, with the low expression control peptidyl-prolyl cis-trans 
isomerase B (PPIB) and high expression control RNA polymerase II subunit A (Polr2A) 
visualised correctly in the brightly coloured red and DAB brown respectively (Figure 
3.10a).   
 
As before, the gamma delta probes were then tested on tonsil tissue as a positive control 
tissue (Figure 3.10b), with positive staining observed for the CD3 and Cδ probes.  Each 
gamma delta TCR probe, in this case Vδ1, Vδ2, Vγ9 and Cδ, was then tested in duplex 
with CD3 in liver tissue sections.  Three cases were selected to be stained based on 
previous flow cytometry-based frequency analysis from the same tissue, with all three 
having 5-10% of their CD3+ T cell population represented by γδ T cells, of which roughly 
half were Vδ1+ in each case.  Of the three cases tested using the Bond RX autostainer, 
only one case had significant positive staining for all of the gamma delta TCR probes used, 
and would be used as a positive control tissue henceforth (Figure 3.11). 
 
In order to elucidate close cell-cell interactions between γδ T cells and other cells in the 
hepatic microenvironment, a combination of ISH to stain the γδ T cells and fluorescence 
IHC was employed.  To label the ISH probes with a fluorescent tag, the protocol was 
modified to include addition of a tyramide signal amplification (TSA) step.  However, since 
this work was carried out, ACD have released their own Multiplex Fluorescent Assay kit 
that allows combination of ISH and IHC analysis on the same tissue, using a similar 
approach. 
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Figure 3.10:  2-plex staining of tonsil sections using ACD RNAscope in-situ hybridisation 
a) Representative images of FFPE human tonsil derived sections stained using ISH probes 
specific for: negative control (left) and PPIB (red) + PolR2A (brown) (right).  Sections were 
counter-stained using haematoxylin.  Magnification 20x (left) 40x (right).  
b) Representative image of FFPE human tonsil derived section stained using ISH probes 
specific for CD3 (brown) and constant-region δ chain (red – highlighted with arrows).  
Sections were counter-stained using haematoxylin.  Magnification 40x. 
 
 
 
a 
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Figure 3.11:  2-plex staining of liver sections using ACD RNAscope in-situ hybridisation  
Representative images of FFPE human liver derived sections stained using ISH probes specific for: 
in all cases CD3 (brown) + TRCD (a), Vδ1 (b), Vδ2 (c) and Vγ9 (d) (red).  Positively staining of 
gamma delta TCR probes (red) is identified with black arrows.  Sections were counter-stained 
using haematoxylin.  Magnification 40x. 
 
 
 
a b 
c d 
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Firstly, to assess how good the ISH staining was for analysis of individual cells under  high 
levels of magnification (40x), the CD3 ISH probe was stained in conjunction with a CD3 
antibody on the same section (Figure 3.12).  While a high level of co-staining was 
observed in CD3+ cells, the punctate, intracellular nature of the ISH staining was clearly 
not as useful for staining cell-cell interactions as the cell surface IHC staining.  
Nevertheless, this did highlight the possibility of using a combination of ISH and IHC on 
the same sections, which would potentially allow for a wide variety of conventional cell 
surface protein targets to be stained in multiple fluorescent colours by IHC in 
combination with gamma delta T cell specific ISH probes, then visualised using multi-
channel imaging technology such as the Vectra 3.0 Automated Imaging Platform 
(PerkinElmer).  Additionally, since the number of fluorescent tags for ISH probes is much 
greater than the colours available for bright-field visualisation, this opened the possibility 
of combining more than two ISH targets in the same tissue, thereby allowing localisation 
analysis of the three main γδ T cell subsets; Vδ1, Vδ2 and Vδ3; in the same tissue.   
 
Next, duplex staining of two ISH probes visualised in fluorescence was performed in tonsil 
sections and the slides were scanned digitally using the Vectra platform and analysed 
using the Definiens Tissue Studio software (Figure 3.13).  Using this analysis Vδ1+ cells 
were found to account for 2.52% of tonsil cells while Vδ2+ cells accounted for 4.85%.  
While this was considered a successful attempt to use digital scoring to analyse ISH 
results, something that would be very important for this study going forward, there was 
some concern over the signal to background noise ratio.  According to the manufacturer, 
as long as the washes are performed correctly, there should be no positive signalling if 
there is no hybridisation of the probes to their target.  With the bright-field analysis,  
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Figure 3.12:  Dual IHC and ISH staining of liver sections 
Representative images of FFPE human liver derived sections stained using IHC αCD3 antibody 
(upper) (red) and ISH probes specific for CD3 (centre) (green), and combined (lower).  Sections 
were counter-stained using DAPI.  Magnification 40x. 
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Figure 3.13:  Definiens analysis of gamma delta T cell staining in human liver 
Example of images generated using Definiens tissue analysis software.  Top left:  example field of 
liver section stained using RNAscope probes specific to CD3 (brown) and TRDC (red).  Bottom left:  
the same field with staining scored using Definiens software – yellow dots are negatively stained 
cells, red dots are CD3+ cells, blue dots are TRDC+ and CD3+ cells.  Top right:  liver tissue coloured 
according to histology – red areas are parenchyma, blue areas are portal and green areas are 
fibrous septa.  Bottom right:  Overlay image including histology, cell identification and cellar 
boundaries (indicated in dark green colour).  Sections were counter-stained using haematoxylin.  
Magnification 40x. 
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background did generally seem low, so differing concentrations of the TSA tags were used 
in an attempt to reduce fluorescence background, which essentially seemed to consist of 
random dots of colour in areas that were clearly not positive, such as outside cell 
boundaries.  However, no reduction in the number of false positive background dots 
could be achieved.  Clearly non-specific “positive” dots, even at low level, would cause 
over estimation of staining by the scoring software.  This was exacerbated by the 
generally low level of staining observed for the variable-δ and –γ chain probes, which 
were only 7 oligonucleotides in length rather than the manufacturer’s preferred 20, 
which the strongly staining CD3 probe was. 
 
To investigate whether the variable-region TCR probes were working effectively enough 
to raise positive staining above background noise, critical to the success of any scoring 
analysis, paraffin embedded tissue blocks were prepared from two T cell lines that had 
been transfected with either a Vδ1+ TCR clone or a Vδ2+ TCR clone.  The blocks were 
sectioned and stained as per the RNAscope protocol.  In addition to determining the level 
of staining, this would also provide a good control for probe specificity, since none of the 
assays performed thus far used tissue with precisely known frequencies of gamma delta T 
cells (Figure 3.14). 
 
While there was no Vδ2+ staining on the Vδ1+ tissue block when the Vδ2 probes were 
used, and vice-versa, comparison of the CD3 staining and both Vδ1 and Vδ2 showed that 
while CD3 staining was clearly evident in all cells, many cells that were known to be 
positive for a given variable-region were often very dimly or negatively stained.  
Considering the mRNA levels in these transfected cells was likely to be higher than cells in  
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Figure 3.14:  Fluorescent ISH assessment of Vδ1- and Vδ2-specific probes using transfected cell 
lines 
Representative images of ISH staining of sectioned paraffin-embedded Jurkat cell lines 
transfected with either a Vδ1+ TCR clone (left) or a Vδ2+ TCR clone (right).  Top:  Probes specific to 
the alternate TCR were used to assess potential non-specific binding.  Middle:  CD3+ staining using 
ISH probe.  Lower:  Vδ1+ or Vδ2+ positive staining, with image intensity increased by 300% in post-
processing.  Sections were counter-stained using DAPI.  Magnification 20x.  
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vivo, and that the fixation of these cells was very quick after harvesting, minimising RNA 
degradation, it seems likely that these probes are not sensitive enough to stain enough of 
their targets to produce a reliable, quantifiable result.  Since the CD3 probes did work 
consistently, it can be speculated that the reduced number of oligonucleotide sequences 
targeted by the variable-region probe sets, a necessity due to their short overall length, is 
the primary reason for this shortcoming.  While this may not be an issue if the target cells 
were high in frequency, the relative paucity of them in liver tissue meant in the context of 
this study this technique would ultimately be flawed and not likely to yield useful results. 
3.4 Gamma delta T cells interaction with HSEC in vitro 
 
Through the use of IHC and ISH-based tissue visualisation methods, a high frequency of 
gamma delta T cells has been observed apparently localised in, our adjacent to, the 
hepatic sinusoids. Additionally, they represent a very high proportion of infiltrating CD3+ 
T cells here.  To determine whether interactions of gamma delta T cells with the 
dominant stromal subset of the sinusoids, the hepatic endothelium, may influence this 
apparent accumulation, adhesion and transmigration assays using primary human HSEC 
and PBMC-derived gamma delta T cells were performed. 
3.4.1 Static adhesion assay 
 
Firstly, a static adhesion assay was used to assess potential preferential adhesion of 
PBMC-derived gamma delta T cells to a monolayer of HSEC.  This was performed using 
both unstimulated HSEC, to represent normal liver, and HSEC stimulated prior to the 
assay with pro-inflammatory TNF and IFNγ, exposure to both of which has been 
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demonstrated to upregulate expression of lymphotactic adhesion molecules in HSEC 
(Lalor et al., 2002) and a factor in chronic liver inflammation (Curbishley et al., 2005).  
Magnetically sorted CD3+ cells were added to the monolayer and incubated for 15 
minutes.  In both stimulated and unstimulated conditions, the proportion of gamma delta 
T cells amongst adherent CD3+ T cells increased (+16.1% ± 12.2% unstimulated, +58.5% ± 
15.1% stimulated, n=3), suggestive of increased adherence to HSEC for these cells 
compared with non-gamma delta CD3+ T cells, even in “non-inflamed” conditions where 
the HSEC are not activated by pro-inflammatory cytokines (Figure 3.15a).  Interestingly, 
the Vδ2+ population appeared to adhere better to HSEC than the Vδ2- gamma delta T 
cells in both conditions (+19.0% vs. +3.8% unstimulated, +61.8% vs. +45.0% stimulated), 
but this was not statistically significant. 
 
3.4.2 Transmigration assay 
 
Having demonstrated superior adhesion of gamma delta T cells to primary HSEC 
compared with non-gamma delta T cells, transmigration across an endothelial monolayer 
assessed using a transwell assay.  Here, PBMC-derived T cells were added to the upper 
chamber of the transwell system cells and then were harvested from both upper and 
lower chambers of the transwell system following 48 hour incubation.  The enrichment of 
gamma delta T cells in the lower chamber compared with the upper chamber following 
the assay was determined (Figure 3.15b).  As with the static assay, in both stimulated and 
unstimulated conditions the proportion of gamma delta T cells in the lower well (i.e. 
having successfully transmigrated) increased relative to non-gamma delta  
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Figure 3.15:  Interaction of γδ T cells with HSEC 
a) Static adhesion of PBMC-derived γδ T cells to a monolayer of primary human 
unstimulated and stimulated hepatic sinusoidal endothelial cells (HSEC).  Bars represent 
the increase in percentage of γδ T cell subsets as a proportion of CD3+ cells in the HSEC-
associated lymphocyte population after 15 minute incubation with HSEC (n=3 blood and 3 
HSEC donors).  
b) Transmigration of PBMC-derived γδ T cell subsets across an unstimulated and stimulated 
primary human HSEC monolayer in a transwell system.  Bars represent the fold 
enrichment of γδ T cell subsets as a proportion of CD3+ T cells in the upper (non-migrated) 
and lower (migrated) chamber of the transwell after 48 hours incubation (n=3 blood and 
3 HSEC donors).  Error bars = SEM. 
a 
b 
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T cells.  Contrary to the static assay, in this experiment a significantly increased migration 
of gamma delta T cells was noted in unstimulated conditions (2.71-fold increase across 
unstimulated HSEC, 1.56-fold increase across stimulated HSEC, n=3, p=0.03).  Vδ2+ cells 
migrated more readily into the lower chamber than Vδ2-, although this was more notable 
in unstimulated conditions (2.97-fold increase vs. 1.5-fold increase) than stimulated 
(1.63-fold vs. 1.27-fold).   
 
3.4.3 Immunophenotyping of intrahepatic gamma delta T cells 
 
To highlight potential molecular mechanisms that may explain these observations, 
surface expression of lymphocyte function-associated antigen-1 (LFA-1), platelet 
endothelial cell adhesion molecule (CD31) and killer cell lectin like receptor B1 (CD161) 
and αE integrin (CD103) on intrahepatic αβ TCR
+, Vδ2neg and Vδ2+ T cells were analysed by 
flow cytometry.  Expression of LFA-1 on CD8+ liver infiltrating T cells has been implicated 
in association with HSEC (McNamara et al., 2017), while CD31 and CD161 have been 
implicated in endothelial transmigration of Vδ1+ and Vδ2+ cells respectively (Poggi et al., 
2002, Poggi et al., 1999) and CD103 is expressed by memory CD8+ T cells to retain them 
within tissues (Strauch et al., 2001). Vδ2neg cells had significantly increased surface 
expression of CD31 (68.7% ± 3.9%) compared with αβ T cells (29.5% ± 3.0%, p=0.0004) 
and were slightly enriched for LFA-1 expression, which was very high in Vδ2neg T cells 
overall (91.5% ± 2.8%).  Vδ2+ cells expressed similarly high levels of CD161 (90.8% ± 
2.8%), while gamma delta T cells did not express high levels of CD103 (Vδ2neg: 6.96% ± 
2.17%; Vδ2+: 4.39% ± 0.88%).  These data suggest that LFA-1 and/ or CD31  
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Figure 3.16:  Intrahepatic gamma delta T cells are enriched for various adhesion/ transmigration 
molecules 
Comparison of mean ± s.e.m expression of various surface markers previously implicated in cell 
adhesion and/or transmigration across endothelium in liver-derived αβ TCR+, Vδ2+ and Vδ2neg T 
cell subsets, measured by flow cytometry.  n=7-10 ALD, NASH, PSC and PBC explants, **p<0.01, 
***p<0.001, 1-way ANOVA 
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expression may be important factors in retention of Vδ2neg T cells in the hepatic 
sinusoids. 
3.5 Discussion  
 
Despite several previous studies having highlighted the relative enrichment of gamma 
delta T cells in human liver compared with the periphery, few studies have investigated 
where within the liver microanatomy these cells are distributed.  Since the role of gamma 
delta T cells in liver biology and chronic inflammation is poorly understood, knowledge of 
the localisation of these cells within the liver could be crucial in determining which cells 
will be interacting with these unconventional lymphocytes and therefore provide clues as 
to their function. 
 
Two methods were adopted to investigate this question, IHC and ISH.  Although a robust 
dataset was generated from the IHC in terms of infiltration and gross localisation, due to 
limitations with the primary antibody and the liver tissue itself, fluorescence based 
confocal IHC, which would have ideally allowed detailed co-localisation analysis using 
multiple fluorophores, was not possible, which does limit the scale of this study.  
Although convincing results were obtained, the polyclonal goat H-20 antibody used has 
since been discontinued by the manufacturer.  A new monoclonal antibody has been 
made available in its stead, and it would be interesting to see if better results would be 
achievable with fluorescence IHC for future co-localisation studies.   The problem with 
varying fixation times of the tissue blocks before sectioning, which was not realised until 
the ISH protocol was being used, may well have caused the not infrequent problems 
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encountered when using the H-20 clone.  Additionally, it should be remembered that 
these data were obtained from staining of sequential sections, rather than simultaneous 
γδ and CD3 staining on the same section, and is therefore subject to some error.  More 
extensive use of the ISH would solve this, although the cost involved was too high 
considering the IHC dataset was relatively robust. 
 
The IHC dataset suggested a relatively high burden of gamma delta T cells as a percentage 
of total infiltrating CD3+ T cells,.  While these figures are in line with previously published 
data, it is important to assess whether there may be any systematic reasons for the high 
percentages noted here.  Firstly, the majority of the frequency data published have been 
generated from flow cytometry analysis of bulk tissue that has been mechanically and/or 
enzymatically disrupted to isolate lymphocytes.  Since many of the gamma delta T cells 
identified via IHC in this study were parenchymally associated, that is, either in the liver 
sinusoids or having migrated across the sinusoidal endothelium, it is possible that these 
cells are more firmly “tissue associated” than transiently passing “blood associated” cells 
of the portal tract areas.  Therefore one could envisage these cells may be harder to 
extract from bulk liver tissue than portally associated αβ T cells when isolating cells for 
flow cytometry analysis, and therefore decreasing the apparent percentage of total T 
cells represented by gamma delta TCR+ cells.  This phenomenon has been reported in 
studies of tissue associated CD8+ T cells in mice (Steinert et al., 2015). 
 
Another potential possibility is that since the antibody used was specific for a δ-chain 
epitope, it was staining positive for αβT cells that also express δ-chain TCR.  Cells 
expressing the constant δ-chain and an αβ TCR are rare, however (Pellicci et al., 2014).  
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This could be addressed by co-staining with an anti-αβ TCR antibody on the same section 
as the pan-γδ antibody, which would be possible using a two-stage protocol and 
visualising with two fluorophores, for example DAB and alkaline phosphatase. 
 
Despite this, a clear finding from this study is that normal liver contains a higher 
frequency of gamma delta T cells than diseased liver.   Why this occurs is not entirely 
clear.  It is known that circulating gamma delta T cells, particularly those with the Vδ2+ 
TCR, express high levels of inflammation associated chemokine receptors such as CXCR3 
(Glatzel et al., 2002).  One may expect that on instigation of a chronic inflammatory 
event, these cells would be more readily recruited to the site of inflammation, in this case 
the liver, than the more abundant circulating CXCR3lo naïve and memory αβ T cells, and 
thereby increase in relative numbers in disease.  What was particularly interesting though 
was the suggestion that the overall number of infiltrating γδ lymphocytes did not 
numerically increase during disease, particularly in parenchymal areas, while non-γδ, 
assumed to be αβ TCR+ cells, did.  This may hint at dilution of a pre-existing γδ T cell 
population present in parenchymal areas of the liver of healthy livers by infiltrating 
periphery-associated T cells in disease.  Since the burden of gamma delta T cells in these 
regions is clearly much higher than in the periphery, where typical healthy adults may 
have 2-5% of their T cell population as γδ TCR+, it would follow that non-selective 
recruitment and retention of all peripheral T cells in chronic inflammation would by its 
nature dilute the number of γδ T cells present in the liver, irrespective of inflammation 
induced cell recruitment.  Whether this means the “pre-existing” parenchymal population 
is a resident population requires further study, and explored further in Chapter 5 of this 
thesis. 
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The data obtained from the in vitro migration assays is intriguing, as it suggests gamma 
delta T cells in circulation are likely to be better at both adhering to and transmigrating 
across the hepatic endothelium compared with other CD3+ T cells.  Additionally, this 
observation held whether the endothelium was inflamed using pro-inflammatory 
exogenous recombinant cytokines or not.  It could be hypothesized that enhanced 
recruitment and/or retention of gamma delta T cells from the periphery to the hepatic 
endothelium may, at least in part, be responsible for the observed high levels of 
parenchymally associated liver-infiltrating gamma delta T cells in both health and disease, 
although the precise molecular mechanism behind such an observation is unclear.  
Previous research on lymphocyte adhesion and recruitment in the liver has highlighted a 
number of molecular interactions important to these processes, including LFA-1-ICAM 
and vascular adhesion protein-1 (VAP-1).  Gamma delta T cells express high surface levels 
of CXCR3, CD31, LFA-1 and VLA-4, all of which have been implicated in trans-endothelial 
recruitment of lymphocytes into tissues (Chosay et al., 1998, Lalor et al., 2002, Tuncer et 
al., 2013).  Further research using blocking antibodies and G-protein coupled receptor 
inhibitors could shed further light on this, as well as flow-based adhesion assays that 
would be more representative of physiological conditions and may be important in 
upregulation of certain adhesion molecules (Shetty et al., 2014, Lawrence et al., 1997).  A 
critical observation from this study however, was that relative transmigration of gamma 
delta T cells was significantly higher in unstimulated conditions compared with across 
stimulated HSEC.  This supports the hypothesis that inflammation may drive a general T 
cell recruitment upshift that ultimately may reduce the overall proportion of gamma 
delta T cells in the liver, compared with normal physiological conditions.  Clearly, further 
efforts to distinguish between recruitment-based enrichment of intrahepatic gamma 
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delta T cells and potential tissue residency of these cells are required to more thoroughly 
assess the biology of these cells in the liver. 
 
The parenchymally dominated distribution of the intrahepatic gamma delta T cell 
population is interesting, and has not previously been reported.  Kupffer cells are located 
in the liver sinusoids, where they are capable of capturing bacteria directly from the 
blood flow (Jenne and Kubes, 2013).  Lymphocytic cells such as CD8+ αβ T cells and NKT 
cells have been demonstrated to remain within the sinusoids rather than extravasate into 
the parenchymal areas (Guidotti et al., 2015, Geissmann et al., 2005), where it is posited 
that contact with the parenchymal hepatocytes is enabled by the fenestrations in the 
sinusoidal endothelium.  Although confocal fluorescence imaging of these tissue sections 
may have helped to determine whether the gamma delta T cells identified in the liver 
parenchyma had truly migrated across the endothelium or were still within the sinusoids, 
without a mouse model such as those used to image NKT and CD8+ cells in previous 
studies, it is very hard to prove.  Nevertheless, one could speculate that gamma delta T 
cells likely share a similar biology to these other T cell subsets, and via close proximity to 
both gut derived antigen in the portal blood flow and perhaps more pertinently close 
proximity to sinusoidal Kupffer cells and the cytokines they secrete, may form part of the 
liver associated “firewall”, capable of responding quickly to gut associated antigen 
(Balmer et al., 2014).  This scenario is given credence by the fact that healthy liver is 
heavily enriched for these cells, as this process is clearly a vital one in maintaining 
immunosurveillance in normal conditions. 
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While the results obtained with the ISH method were not ultimately successful here, the 
ability to distinguish between different subsets of gamma delta T cells based on V-chain 
usage in human tissue sections would represent a fundamental step forward in human γδ 
T cell biology, and should be pursued.  Although the probe sets used here seemed 
insufficiently sensitive, the methods did prove to be fundamentally sound, with positive 
staining detected for each of the three most common variable-δ chain TCRs.  It may be 
that ACD’s new BaseScopeTM technology will prove a successful route to achieving this, 
being designed for detection of shorter RNA targets than RNAscope, with increased signal 
amplification.  Indeed, the manufacturers claim to have used it to stain for specific CDR3 
regions of TCR clonotypes. It will not be cheap but should prove more consistent than the 
poor quality IHC-based options available to the gamma delta T cell research community 
currently available.  
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4.1 Introduction 
 
One of the most significant unresolved questions concerning gamma delta T cell biology is 
the extent of the role of the T cell receptor (TCR) in the physiological function of these 
cells.  Two primary issues are currently under investigation – firstly, what role does TCR 
signalling play in the function of gamma delta T cells, and secondly, what antigens are γδ 
TCRs capable of recognising?  Through improved understanding of the nature of the TCR 
repertoire, particularly in the poorly understood context of human solid tissues, this 
study will attempt to shed light on this important issue. 
Somatic recombination of the variable (V), diversity (D) and joining (J) gene segments of 
the TCR locus to form antigen receptors is a crucial feature of adaptive immunity.  In 
addition to these recombination events, further diversity is generated through non-
templated addition (n-addition) or exonuclease mediated deletion of nucleotides at the 
interface of segment recombinations.  Upon successful recombination and, in the case of 
αβ T cells, positive selection from thymic epithelial cells, mature immunocompetent T 
cells enter the circulation and form part of that individual’s T cell repertoire.  The αβ TCR 
repertoire diversity has been demonstrated to be extremely large (Zarnitsyna et al., 
2013), allowing potential recognition of a huge number of epitopes. 
The recombined junction of V, D and J segments forms the complementarity determining 
region 3 (CDR3).  This area comprises the main contact patch with antigenic epitopes, and 
therefore is crucial in directing specific antigen recognition by the TCR (Davis et al., 1998, 
Jorgensen et al., 1992).  Some VDJ rearrangements are simpler to generate than others, 
potentially leading to convergent overlap in easily recombined CDR3 regions (Madi et al., 
 
109 
2014), however the huge number of theoretical CDR3s in any naïve T cell repertoire 
means the vast majority are likely to be unique for each T cell.  Proliferating T cells retain 
their clonotypic TCRs, therefore any expansion, whether due to TCR independent 
homeostasis or TCR dependent antigen driven response results in a clonal population of 
cells with identical CDR3s.  Such clonal expansions can be detected in αβ T cell vaccine 
responses and lymphoproliferative disorders such as lymphoma (Gong et al., 2017), as 
well as in responses to viral infection, such as CMV (Butz and Bevan, 1998). 
Human γδ T cells exhibit a more restricted repertoire of V and J gene segment use than 
αβ T cells, with just three conventional Vδ genes embedded in the α-TCR gene locus; Vδ1, 
Vδ2 and Vδ3 (Figure 4.1).   A handful of Vα genes are occasionally recombined to form a 
δ-chain:  Vδ4 (Vα14), Vδ5 (Vα29), Vδ6 (Vα23), Vδ7 (Vα36), and Vδ8 (Vα38).  Similarly, the 
human Vγ repertoire consists of only 12 Vγ genes, and of these 5 are pseudogenes, 
leaving just seven functional.   Additionally, gamma delta TCRs draw from a total of just 
nine J gene segments, contrasting with 72 from the α and β loci.  The apparent lack of 
potential diversity of gamma delta TCRs compared with αβ T cells has been attributed to 
their recognition of conserved self-antigens (Janeway et al., 1988). 
However, although there are few V and J gene segments used in the γδ TCR, unlike αβ 
TCRs, the γδ TCR often incorporates multiple D segments, which can recombine in 
forward or reverse frame and often without stop codons.  This plasticity in D segment 
usage confers incredible diversity on to the amino acid sequence of the CDR3δ loop, 
indeed it is the most diverse loop found in any rearranged receptor (Davis and Bjorkman, 
1988).  Quite what the impact of this ultra-variable antigen binding loop in the γδ TCR is 
on the nature of its targets is currently unclear. 
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Figure 4.1: Rearrangement of V, D and J segments to form the γδ TCR 
Representation of the V-D-J recombination to produce the δ-chain and V-J recombination to 
produce the γ-chain of the γδ TCR, with CDR1, 2 and 3 loops denoted.  Adapted from (Kazen and 
Adams, 2011). 
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Despite the vast array of potential αβ TCRs, several subsets of T cells have been identified 
that express an invariant α-chain, including invariant natural killer T (iNKT) cells, which 
express Vα24-Jα18 paired with a limited range of β-chains in humans and recognise α-
galactosylceramide presented by the monomorphic MHC-like CD1d (Lantz and Bendelac, 
1994, Exley et al., 1997).  Mucosal associated invariant T (MAIT) cells express a semi-
invariant α-chain, TRAV1-2/TRAJ12/20/33, and recognise bacterial riboflavin metabolites 
presented by the MHC-like MR1 molecule (Treiner et al., 2005).  As such, T cells such as 
these, which recognise conserved ligand via relatively non-polymorphic presentation 
machinery have been termed innate-like T cells, functioning via PAMP-like recognition in 
contrast to the stochastically recombined αβ TCR recognition of polymorphic MHC/ 
peptide complexes, or antibody recognition of polymorphic three-dimensional protein 
antigens.  
Which paradigm gamma delta T cells fit into is currently debated.  Although murine 
gamma delta T cell subsets are not homologous with human, a great deal of work has 
been performed using mouse models to investigate gamma delta T cell development and 
function.  Early studies identified a VγJγ1Cγ-Vδ1 TCR bearing population of dendritic 
epidermal T cells (DETC) in the epidermis of mice (Asarnow et al., 1988, Havran et al., 
1989).  Other tissues in mice, including uterus, lamina propria and liver (Itohara et al., 
1990, Sheridan et al., 2013, Hamada et al., 2008) are home to gamma delta T cells 
bearing the same Vδ1 chain as DETC, this time paired with an invariant Vγ6Jγ1Cγ1 TCR.  
Of relevance to the liver, an IL-4 producing subset has been identified in mice bearing a 
semi-invariant Vγ1Jγ4Cγ4 -Vδ6Dδ2Jδ1 TCR (Gerber et al., 1999).  In many cases the use of 
specific γδ TCRs in murine tissues is linked with specific functional capability, such as 
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interferon-γ or IL-17 production (O'Brien and Born, 2010, Kashani et al., 2015).  This 
restriction in diversity is highly suggestive of recognition of conserved, often self-encoded 
ligand and an essentially innate-like biology. 
In humans, the traditionally blood-associated Vδ2+ gamma delta T cells appear to 
conform to an innate-like paradigm.  Featuring a conserved chain pairing of Vδ2 and Vγ9, 
they also display restricted CDR3 region diversity with a common amino acid motif found 
in most cells (Sherwood et al., 2011) that is indicative of reactivity to pyrophosphate 
antigens.  Universal activation by bacterially derived phosphoantigens, dependent on 
interaction with butyrophilin-like molecule BTN3A1 (Rhodes et al., 2016) is highly 
suggestive of a similar biology to the established innate-like T cell subsets. 
In contrast, the non Vδ2+ gamma delta T cells in humans (Vδ2neg) do not appear to exhibit 
the same degree of chain pairing restriction and to date no conserved family of antigen 
has been discovered, although following CMV infection in utero a germline encoded 
Vγ8Vδ1 TCR was identified in multiple individuals and has subsequently been identified in 
other donors (Vermijlen et al., 2010).  Vδ2neg gamma delta T cells have also been 
demonstrated to respond to other viruses including Epstein-Barr virus (Farnault et al., 
2013), and cancer cell lines (Halary et al., 2005).  Despite this, other work has determined 
that while functionally active Vδ2+ gamma delta T cells are dominant in the second 
trimester foetus (Dimova et al., 2015), Vδ2neg T cells are present at very low frequencies 
at birth, suggestive of post-natal expansion in response to antigenic stimulation (Morita 
et al., 1994).  
Previous studies of human liver-derived gamma delta T cells have indicated that the liver 
is enriched for both Vδ1+ and Vδ3+ TCRs compared with the periphery (Agrati et al., 2001, 
 
113 
Kenna et al., 2004).  However, both these studies were conducted either in a specific 
inflammatory context, namely HCV infection, or on a relatively low number of donor 
livers.  In addition, no detailed analysis of TCR repertoire beyond γ- and δ-chain use has 
been conducted.  The aim of the study in this chapter was to assess human intrahepatic 
and peripheral gamma delta T cell TCR repertoire using next generation sequencing 
techniques, with the intention of shedding light not only on TCR chain usage but also 
specific CDR3 composition within these samples, allowing assessment of clonality and 
sample diversity, focussing on the tissue associated Vδ2neg population. 
4.2 Method  
4.2.1 Tissue acquisition 
 
Throughout this study, comparison is made between “normal” and “diseased” liver.  
Genuinely normal liver tissue is challenging to obtain, since healthy functioning tissue is 
transplanted into an unwell recipient wherever possible.  Occasionally livers are too big 
for their recipient, often in the case of children receiving livers from adult donors, in 
which case “cut-downs” are sometimes available for research purposes.  On other 
occasions mis-handling of the donor liver during retrieval can leave it unsuitable for 
transplantation.  Liver tissue obtained from hepatectomy for tumour removal was only 
used if no radio- or chemo-therapeutic regimen had been undertaken by the donor prior 
to resection, and if there was no chronic liver disease background.  Since primary 
hepatocellular carcinoma (HCC) is fairly rare on a non-inflamed background, the primary 
source of resected liver material that was considered “normal” was from patients 
undergoing surgery to remove colorectal metastases.  The most common reason for the 
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Centre for Liver Research to obtain “normal” liver, however, is if it was rejected for 
transplantation because it was deemed too steatotic.  In these cases, which often may be 
undiagnosed fatty liver disease, the liver was inspected visually – if it was markedly 
discoloured or fatty it was not used in this study.  At the time of processing, all patient 
data were fully anonymised in accordance with the ethics protocols established in the 
Centre for Liver Research. 
4.2.2 Lymphocyte Isolation 
 
Isolation of lymphocytes from human liver has been performed routinely in the Centre 
for Liver Research for many years (Eksteen et al., 2004) by mechanical digestion.  
Although use of collagenases to break down extracellular matrix has been employed 
elsewhere for intrahepatic lymphocyte isolation, some surface antigens are susceptible to 
enzymatic cleavage.  Additionally, since a large mass of tissue is generally obtained from 
explanted livers, the superior cellular yield obtained from enzymatic digestion is not 
strictly needed to isolate enough lymphocytes for these studies. For studies requiring 
RNA isolation, samples needed to be processed as quickly as possible to prevent RNA 
degradation.  Accordingly, the quicker and cheaper mechanical digestion approach was 
adopted here.   
 
4.2.3 TCR Repertoire Analysis 
 
T cell receptor characterisation in its most basic form can be performed using antibodies 
specific to TCR V-regions and analysed by flow cytometry.  In the case of αβ T cells this 
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requires a large panel of antibodies, and even though the number of V-regions for delta- 
and gamma-chains is considerably smaller, commercial antibodies are currently only 
available for Vδ1, Vδ2 and Vγ9.  This does cover a large percentage of human γδ TCRs and 
is most straightforward to perform, whilst also allowing assessment of cell surface 
protein expression, and accordingly was the first method used in this study. However, 
clearly this method provides limited information, both in terms of the number of V 
regions analysed and the lack of informational regarding individual clonotypes.  
Therefore, a more fundamental analysis of the TCR repertoire was desired in order to 
shed light not only on the full diversity of V-regions present (particularly relevant for the 
liver, where populations using δ-chain V-regions other than Vδ1 and Vδ2 may be highly 
prevalent (Kenna et al., 2004), but also on clonotypic diversity.  There are several 
molecular approaches that have been used to investigate TCR repertoire previously, 
which provide information on different clonotypes.   
4.2.3.1 Spectratyping 
 
Once RNA has been isolated from the cells of interest, cDNA can be generated by 
amplifying across the CDR3 regions using suitable PCR primers that anneal at fixed 
positions in the 5’ and 3’ ends.  The sizes of the PCR products can then be determined 
using electrophoresis and plotted against signal intensity to yield a size distribution that 
reflects the varying CDR3 lengths in the sample – a technique referred to as spectratyping 
(Pannetier et al., 1993).  Due to the highly varied nature of our T cell repertoire, and the 
stochastic recombination events that form it, most healthy donors tend to exhibit a 
normal bell-shaped distribution of CDR3 lengths in their αβ T cell repertoire.  Any 
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significant deviation from this can be attributed to a more focussed repertoire with over-
representation of CDR3s of specific lengths, likely driven by clonal expansion (Pannetier 
et al., 1995).  Spectratyping has been conducted on Vδ2- gamma delta T cell populations 
in the context of reactivation of CMV infection (Knight et al., 2010). 
Spectratyping does not yield the frequency of cells expressing a given V-region however.  
Multiplex PCR using a pool of V- and/or J-region specific primers can generate chain use 
data alongside CDR3 length analysis (Du et al., 2006), yielding greater resolution to 
spectratyping data, and has been performed to analyse murine gamma delta T cells 
responding to M. tuberculosis infection (Huang et al., 2012).  This method still does not 
give a genuine insight into clonality however – to tackle this next generation sequencing 
(NGS) protocols have been developed. 
4.3.2.2 High throughput/Next Generation Sequencing analyses 
 
High throughput sequencing allows simultaneous sequencing of potentially millions of 
individual CDR3 region amplicons from a single sample (Voelkerding et al., 2009).  
Profiling of actual nucleotide sequences in this manner enables compilation of a huge 
quantity of high resolution information, allowing identification of large expanded 
clonotypes across samples in cases of disease or vaccination.  TCR deep sequencing has 
been used in previous studies to estimate the repertoire size in human αβ T cell 
populations (Robins et al., 2009), as well as to define the effect of T cell differentiation 
from naïve to effector on the TCR diversity as a function of ageing (Qi et al., 2014). 
Additionally, the effect of disease on TCR repertoire has been assessed in an analysis of 
tumour-infiltrating T cells (Emerson et al., 2013).  Examination of the TCR repertoire in 
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healthy individuals has furthered understanding of public clonotypes and convergent 
CDR3 recombination, brought about by a molecular bias in TCR formation (Dziubianau et 
al., 2013). 
NGS TCR repertoire profiling can be performed using both DNA and RNA as a starting 
template. DNA-based approaches, such as the immunoSEQ platform marketed by 
Adaptive Biosystems, amplify recombined genomic DNA regions using V and J region 
specific primers (Robins et al., 2009).  Resulting PCR products are then sequenced.  RNA-
based approaches include amplicon-rescued multiplex PCR (arm-PCR) wherein nested 
primers specific for each TCR V region are used in the initial PCR round. Then a second 
exponential phase round of PCR is performed with the addition of fresh communal 
primers recognizing the shared tag sequence already introduced during the first round of 
amplification (Wang et al., 2010, Han et al., 2006).  Analysis of genomic DNA is 
methodologically simpler and can be performed from bulk tissue (Liaskou et al., 2016), 
and in addition gDNA results will not be skewed by expression levels within cells analysed 
– each cell should only contain one copy of the TCR of interest.  However, after VDJ 
rearrangement, those V and J segments not involved in the recombination will still be in 
the genome and can serve as binding sites for the PCR primers. Binding at these sites may 
generate background amplifications, exhaust primers, and introduce bias.  Additionally, 
the RNA reagent systems developed by iRepertoire to create the cDNA template from 
sample RNA is “immune-specific” –supposedly thereby minimising the amount of non-
targeted RNA and gDNA in the template cDNA for the PCR reaction, thereby gaining a 
potentially improved read depth compared with DNA-based approaches.  Additionally, 
the RNA-based deep sequencing approach can be combined elegantly with in-house 
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single cell TCR PCR for validation purposes and to confirm chain pairings.  For this reason 
the RNA based TCR repertoire profiling used by iRepertoire was used in this study. 
4.3.2.3 NGS Error Correction 
 
In common with all NGS-based technology, dataset biases and errors caused by the PCR-
based preparation of samples and the sequencing itself can be a major problem.  
iRepertoire’s software did employ an error correction algorithm, but to investigate the 
quality of this and ensure a quality dataset, the MiXCR software was employed (in 
collaboration with the software’s authors based in Russia), to ensure high quality 
sequencing data (Figure 4.2) (Bolotin et al., 2015).  According to the authors, “MiXCR 
employs an advanced alignment algorithm that processes tens of millions of reads within 
minutes, with accurate alignment of gene segments even in a severely hypermutated 
context.  In paired-end sequencing analysis, MiXCR aligns both reads and aggregates 
information from both alignments to achieve high V and J gene assignment accuracy.  It 
handles mismatches and indels and thus is suitable even for sequences with many errors 
and hypermutations.  MiXCR employs a built-in library of reference germline V, D, J and C 
gene sequences for human and mouse based on corresponding loci from GenBan” 
(Bolotin et al., 2015).  The importance of this error correction was noted by pre- and post-
analysis of the same dataset from this study, illustrated by an example in Figure 4.3.  A high 
number of apparently Vδ3+ CDR3 sequences were removed from the iRepertoire dataset by the 
MiXCR software that, on closer inspection, are clearly sequencing errors, consisting of only single 
nucleotide differences in most cases (Table 4.1).  This led to over-representation of Vδ3+ usage in 
the final plot, an important observation since identification of repeated TCR usage with very 
similar CDR3 composition could easily be mis-interpreted as conserved or semi-invariant TCR  
 
119 
 
 
 
 
Figure 4.2: Illustration of MiXCR pipeline 
From Bolotin et al, 2015 
 
  
 
120 
usage. 
 
4.2.3.4 γδ T cell ontogeny and NGS sample preparation 
 
Since γ-chain recombination occurs early in T cell development, concurrent with β- and δ-
chain rearrangement, some αβ T cells also express a recombined γ-chain.  To prevent 
contamination of the γ-chain dataset by γ-chain data from ostensibly αβ T cells, it is 
important to remove αβ T cells from the sample before isolating RNA.  Additionally, an 
important facet of this study was to investigate intrahepatic Vδ2neg gamma delta T cells.  
Since the arm-PCR technology used by iRepertoire used primers for all V region 
sequences it was necessary to remove Vδ2+ cells prior to cDNA formation, especially since 
the data obtained from this technique does not give matched γ- and δ- chain pairings.  
This means that although it is simple to remove Vδ2+ sequences from the final dataset, 
the corresponding γ-chains are considerably harder to remove post-processing.  To 
isolate Vδ2neg gamma delta T cells, samples were cell sorted by FACS, using a CD3+, pan-
γδ TCR+, Vδ2neg strategy (Figure 4.3).  In some samples, Vδ2 TCR contamination was 
noted.  Subsequent to these sorts being performed, it was noted that certain Vδ2-specific 
antibodies “clash” with the pan-γδ TCR antibody if incubated simultaneously.  Possibly 
due to steric hindrance, pan-γδ and Vδ2 antibodies would not bind some TCRs together, 
and therefore some Vδ2+ cells may have remained unstained and been included in the 
Vδ2neg gate for sorting and subsequent repertoire analysis.  This problem was reduced by 
incubating with the anti-Vδ2 antibody first and then adding the pan-γδ TCR antibody to 
the incubation mix later, however, Vδ2+ contamination was not completely abrogated, 
for reasons that will be investigated later in this thesis. 
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Figure 4.3:  MiXCR error correction 
Liver sample L02 Vδ chain usage determined by iRepertoire (left) and MiXCR (right) error 
correction algorithms.  Vδ1 = green Vδ3 = blue Vδ4 = yellow. 
 
CDR3δ amino acid sequence 
ACRFGYWGSTDKLI hTRDV3*01 
ASLGLPTGLGEKLI hTRDV3*01 
ALINLHPGGGAGYTDKLI hTRDV3*01 
AYRFGYWGSTDKLI hTRDV3*01 
ACRFGYWGPTDKLI hTRDV3*01 
ASLGLPTRLGEKLI hTRDV3*01 
ACRFGY*GSTDKLI hTRDV3*01 
ACRFGYWGSADKLI hTRDV3*01 
ACRFGYRGSTDKLI hTRDV3*01 
ACRFGYWGSTDKLI hTRDV3*01 
ASLGPPTGLGEKLI hTRDV3*01 
ACRFGHWGSTDKLI hTRDV3*01 
ACRFGCWGSTDKLI hTRDV3*01 
 
Table 4.1:  L02 Top 13 CDR3δ amino acid sequences determined by iRepertoire deep sequencing 
The 13 highest frequency CDR3 amino acid sequences for sample L02 as determined by 
iRepertoire algorithms following NGS TCR sequencing.  The three highest frequency sequences, 
(red box) are distinct, but the following 10 sequences are all likely derived from sequencing errors 
of one of the “parent” top three sequences.  Homology is indicated by grey shading. 
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Figure 4.4: Gating strategy for identifying and sorting Vδ2neg gamma delta TCR sequencing 
Representative flow cytometry plots show the gating strategy used to identify single live 
lymphocytes and CD3+ γδ+ TCR Vδ2neg cells for TCR repertoire sequencing.  Plots representative of 
10 liver donors and 8 blood donors. 
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4.3 Results 
4.3.1 Flow cytometry repertoire analysis 
 
To examine the frequencies of the liver infiltrating γδ T cell population, human explanted 
liver from healthy donors (n=15) and diseased donors (n=45) was analysed by flow 
cytometry .  An antibody specific to a constant region of the δ-chain was used, as well as 
a live dead marker and CD3 to confirm T cell status.  Corroborating the 
immunohistochemistry data displayed in the previous chapter, a significantly higher 
proportion of the CD3+ T cell compartment was comprised of γδ T cells in healthy liver 
(12.5% ± 2.6% SEM) compared with diseased liver (4.6% ± 0.62% SEM, p=0.007, student’s 
T test) (Figure 4.5a).  When the diseased liver cohort was separated into specific disease 
subtypes (PSC, PBC, ALD, NASH and virally originating disease (HCV and HBV)) no 
significant difference between γδ TCR+ frequencies as a percentage of CD3+ T cells was 
observed, other than for PBC, which was significantly reduced compared with PSC 
derived intrahepatic lymphocytes (Figure 4.5b). 
To assess the impact of chronic liver disease on circulating gamma delta T cell burden, 
blood from patients with autoimmune hepatitis (AIH) (n=19) was also analysed by flow 
cytometry, and compared with blood obtained from a cohort of patients undergoing 
venesection to treat ongoing haemochromatosis (HFE) (n=13).  This HFE cohort was 
selected as they were likely to be age matched with both the liver and blood donors and 
HFE is not an immune mediated disorder.  Studies have suggested that HFE may have an 
impact on circulating T cells however, specifically CD8+ T cells (Macedo et al., 2010, Costa 
et al., 2015).   
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Figure 4.5: Gamma delta T cell proportions in human normal and diseased liver explants. 
a) Proportion of gamma delta T cells in intrahepatic T cell populations determined by flow 
cytometry.  n = 15 normal liver, 45 diseased liver, ****p<0.0001, Mann-Whitney U test. 
b) Proportion of gamma delta T cells in intrahepatic T cell populations determined by flow 
cytometry.  n = 15 normal liver, 6-12 each diseased liver, ***p<0.001 1-way ANOVA, 
Kruskal-Wallis test. 
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Accordingly, circulating gamma delta T cell burden was also analysed in a healthy cohort 
(n=20), although the mean age of this group (donors ranged from 20 – 30 years in age) 
was likely lower than that of the explanted liver cohort. 
Healthy liver was significantly enriched for gamma delta T cells compared with aged 
matched HFE blood (12.5% ± 2.1% vs. 3.1% ± 0.6%, p=0.002), and the AIH liver disease 
group (4.9% ± 1.2% p=0.0014) but not younger healthy blood donors (7.2% ± 0.8%, 
p>0.99) (Figure 4.6).  Diseased liver was not significantly enriched with gamma delta T 
cells compared with any blood donor cohorts.  In our cohort, young healthy donors had 
significantly higher frequencies of gamma delta T cells than the older HFE cohort 
(p=0.02), in line with previous observations (Roux et al., 2013).  No significant differences 
in peripheral gamma delta T cell frequencies were determined between AIH and HFE 
blood donors. 
Commercial antibodies are available that are specific for Vδ1, Vδ2 and Vγ9 TCR chains, 
allowing limited repertoire analysis by flow cytometry.  First, the percentage of Vδ2neg 
cells was analysed as a percentage of the total gamma delta T cell population (Figure 4.7).  
These were found to be in the majority in both normal and diseased livers (66.4% ± 4.7% 
normal, 72.62% ± 3.5% diseased, p>0.05).  Healthy blood was dominated by Vδ2+ gamma 
delta T cells as expected from previous studies, with 21.8% ± 3.3% Vδ2neg, and a similar 
result was observed for the HFE patient derived cohort (18.9% ± 3.4%).  Interestingly 
however, AIH-derived blood, despite not having higher overall frequencies of gamma 
delta T cells, was dominated by the Vδ2neg compartment (63.0% ± 6.5%), a similar 
distribution to that observed in the intrahepatic gamma delta T cell population. 
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Figure 4.6:  Gamma delta T cell proportion in liver and the periphery 
Proportion of gamma delta T cells in intrahepatic and peripheral blood derived T cell populations 
determined by flow cytometry.  n = 15 normal liver, 45 diseased liver, 13 HFE, 19 AIH, 20 normal 
blood. ***p<0.001, 1-way ANOVA) 
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Figure 4.7:  Vδ2+ proportion among γδ T cells in liver and the periphery 
Proportion of Vδ2neg and Vδ2+ T cells of total gamma delta T cells determined by flow cytometry.  
n = 15 normal liver, 45 diseased liver, 13 HFE, 19 AIH, 20 normal blood. **p<0.01, 1-way ANOVA) 
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In the explanted liver cohort, of the Vδ2neg population the dominant TCR chain usage was 
Vδ1 in all sample groups analysed with appropriate antibodies, with between 10.2% and 
32.7% comprised of other TCR-δ chains with no available antibody (Figure 4.8a).  The 
largest Vδ2negVδ1neg population was observed in diseased livers (32.7% ± 5.7%), 
compared with normal liver (24.4% ± 5.6%) although the number of normal livers stained 
in this manner was low (n=5).  In healthy blood donors this percentage dropped to 21.6% 
± 3.5%, (p=0.65 vs. diseased liver), 17.9% ± 3.5% in AIH donors and  10.2% ± 5.0% in HFE 
donors (n=8).  Although no significant difference was observed between any of these 
groups, when analysed as a whole, liver was significantly enriched for Vδ2negVδ1neg 
gamma delta T cells compared with blood (30.7% ± 4.6% vs 18.8% ± 23.%, p=0.03, Mann-
Whitney U test) (Figure 4.8b).  
Of the Vδ1+ population, 17.2% ± 4.7% of intrahepatic gamma delta T cells also expressed 
the Vγ9 TCR chain (Figure 4.9).  This was significantly lower than the frequency of 
Vγ9+Vδ1+ cells in the healthy blood cohort (38.1% ± 6.6%, p=0.008), although there was a 
wide range of expression of this chain pairing in both groups. 
Autoimmune hepatitis is a chronic auto-inflammatory disease with an undefined cause.  
Patients often have a number of autoantibodies present in serum, including α-smooth 
muscle antibody (SMA) and α-mitochondrial antibody (AMA), although several subtypes 
of the disease have been identified.  No cure is currently available, with standard therapy 
consisting of life-long immunosuppressive agents such as the glucocorticoid prednisone, 
azathioprine, tacrolimus and mycophenalate (Liberal et al., 2016).  Although remission 
rates are reasonably high, relapse often occurs.  The majority of samples in this study 
were obtained from patients undergoing immunosuppression therapy and in remission  
 
129 
N o r m a l D is e a s e H F E AIH H e a lth y
0
2 0
4 0
6 0
8 0
1 0 0
%
V

2
n
e
g
V

1
n
e
g
 T
 c
e
ll
s
V  2
n e g
L iv e r P B M C
L iv e r B lo o d  
0
2 0
4 0
6 0
8 0
1 0 0
%
V

2
n
e
g
V

1
n
e
g
 T
 c
e
ll
s
*
V  2
n e g
 
 
Figure 4.8:  Vδ2negVδ1neg gamma delta T cells in liver and the periphery 
a) Proportion of Vδ2negVδ1neg as a percentage of liver and blood-derived Vδ2neg gamma delta 
T cells determined by flow cytometry, n=5-20 
b) Grouped proportion of Vδ2negVδ1neg as a percentage of liver and blood-derived Vδ2neg 
gamma delta T cells determined by flow cytometry, n=21 – 36, *p<0.05, Stundent’s T test 
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Figure 4.9:  Vδ2negVγ9+ gamma delta T cells are enriched in healthy peripheral blood compared 
with liver 
Proportion of Vγ9+ cells as a percentage of liver and blood-derived Vδ2neg gamma delta T cells 
determined by flow cytometry, n=25 **p<0.01, Mann-Whitney U test 
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for the disease, however, several were in relapse, with active disease.  When split into 
the two groups (remission and active disease), the active disease group had a significantly 
higher overall proportion of circulating gamma delta T cells than both the remission 
group and HFE group (8.3% ± 2.5% vs. 2.4% ± 0.39%) (Figure 4.10a), and slightly higher 
proportion of Vδ2neg than the remission group (Figure 4.10b).  Flow cytometry analysis of 
surface differentiation and activation markers CD27 and CD69 from these AIH remission 
(n=14) and active disease (n=8) groups was then performed.  In contrast to autologous αβ 
T cells and Vδ2+ gamma delta T cells, both AIH patient group’s Vδ2neg populations 
exhibited significantly higher surface expression of early activation marker CD69 when 
compared with age-matched healthy donors (Remission:  26.1% ± 5.1%; Active Disease: 
31.3% ± 4.5% vs. Healthy 8.1% ± 3.8%, p= 0.01 Kruskal Wallis) (Figure 4.10c).  In addition, 
Vδ2neg gamma delta T cells isolated from the AIH active disease cohort demonstrated a 
significant loss of CD27, an indicator of gain of effector function, in comparison with HFE 
age-matched donors (CD27+ 15.0% ± 4.44% vs. 89.5% ±2.9%, p=0.0004).  This is strongly 
indicative of an activated phenotype for these numerically increased Vδ2neg gamma delta 
T cells in the periphery of AIH patients (Figure 4.10d). 
4.3.2 Deep sequencing repertoire analysis 
 
Having established a V-region level repertoire analysis of human liver and blood by flow 
cytometry, a deeper insight of both TCR chain usage and CDR3 composition was gained 
through next generation sequencing analysis of selected samples, performed by 
iRepertoire Inc.  10,000 – 50,000 Vδ2neg gamma delta T cells were sorted from 10 
explanted livers and 4 autoimmune hepatitis blood samples by fluorescence activated cell 
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Figure 4.10:  AIH patient’s blood is enriched for activated, effector phenotype Vδ2neg gamma 
delta T cells 
a) Proportion of γδ TCR+ cells as a percentage of blood-derived CD3+ T cells from AIH 
patients, determined by flow cytometry, n=8-11,  *p<0.05 
b) Proportion of Vδ2neg T cells  as a percentage of blood-derived γδ TCR+ T cells from AIH and 
HFE patients, determined by flow cytometry, **p<0.01 
c) Proportion of cells with positive surface expression of CD69 for various T cell subsets 
among three donor groups, n=6-14, *p<0.05 
d) Proportion of cells with negative surface expression of CD27 (CD27lo) for various T cell 
subsets among three donor groups, n=6-14, *p<0.05 
a b 
c d 
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sorting into RNAlater according to the strategy denoted in section 4.2.3.4.  Total RNA was 
then extracted from these cells before shipping to iRepertoire for cDNA synthesis, 
amplification, NGS library preparation and sequencing.  V, D and J gene usage was 
identified using iRepertoire’s in house software; iRweb tools (Yang et al., 2015). 
A mean sequencing depth of 455307 ± 52273 reads per sample was achieved with an 
average of 676 ± 189 unique CDR3 sequences for TCRδ and TCRγ from the liver samples 
(Table 4.2).  However, there were significantly fewer reads obtained from the AIH blood 
cohort (Figure 4.11a).  Despite this, no correlation was observed between sequencing 
depth and the number of unique CDR3s assigned in any group (overall, r=0.33 p=0.08 
Spearman correlation) (Figure 4.11b).  This is important as it suggests that the diversity of 
the repertoire, in terms of unique CDR3s sequenced, did not depend on sequencing 
depth, which in turn can be dependent on the number of cells and/or quality of the RNA 
isolated from the cells, thereby suggesting that no obvious methodological bias may be 
skewing this dataset.  
To investigate the potential effect of chronic disease on TCR repertoire, 5 samples were 
obtained from normal livers and 5 from chronically diseased liver (2 PBC, 2 NASH, 1 PSC).  
Several samples contained varying quantities of TCR sequences using Vδ2.  Since these 
were considered to be contaminants from poor Vδ2+ antibody staining during the cell 
sorting, these sequences were removed from the dataset post-processing.  Additionally, 
TCRγ9 sequences containing the JγP joining region were also removed post-processing as 
these are almost exclusively used by Vδ2Vγ9 phosphoantigen-reactive gamma delta T 
cells (Borst et al., 1989) and should not therefore be encountered in a Vδ2neg selected  
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Donor TCR chain Sequencing Reads Total CDR3 Unique CDR3 Cell Number 
L01 TRD 557760 546240 1009 25 
Healthy TRG 860902 815056 357 25 
L02 TRD 634718 631791 266 25 
NASH TRG 604316 557532 113 25 
L03 TRD 489938 452517 993 20 
Healthy TRG 785366 618012 305 20 
L04 TRD 547244 534933 969 20 
PSC TRG 854254 831961 885 20 
L05 TRD 265300 262093 84 50 
Healthy TRG 92176 83410 103 50 
L06 TRD 423150 389541 472 10 
PBC TRG 185020 171971 283 10 
L07 TRD 61576 55269 210 10 
ALD TRG 175619 159579 240 10 
L08 TRD 464215 456542 388 23 
NASH TRG 556388 484058 242 23 
L09 TRD 365394 362765 450 50 
Healthy TRG 512875 478983 263 50 
L10 TRD 283825 255658 3450 25 
Healthy TRG 386109 351065 2433 25 
L0106 TRD 49738 49459 178 15 
AIH Blood TRG 145535 134257 200 15 
L0107 TRD 61046 57705 215 31 
AIH Blood TRG 137275 84014 304 31 
L0109 TRD 66364 60450 1394 15 
AIH Blood TRG 137269 117064 824 15 
L0111 TRD 59353 56126 273 50 
AIH Blood TRG 85917 61097 110 50 
 
Table 4.2:  Raw TCR sequencing data 
Total sequencing reads, total CDR3s determined, unique CDR3s determined and cell 
number for each sample. L0106 – L0111 were derived from PBMCs of AIH patients.   
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Figure 4.11:  NGS read depth did not alter unique CDR3 sequences obtained 
a) Mean ± s.e.m. read depth of NGS samples of total sequencing reads for each donor 
grouping, n=8-10, **p<0.01  
b) Comparison of total sequencing reads against the number of unique CDR3s determined 
for each donor in this study, Spearman correlation 
  
a 
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population.  Consistent with the flow cytometry analysis (section 4.3.1), in 8 of the 10 
samples, Vδ1 was the dominant δ-chain, with 76.1% ± 9.8% of the total δ-chain repertoire 
represented by Vδ1 (Figure 4.12a), significantly higher than any other chain (p<0.0001, 1-
way ANOVA Friedman test).  Significant usage of the Vδ3 chain was observed, with Vδ3+ 
clonotypes comprising the dominant δ-chain in 2 of the 10 samples and accounting for 
22.7% ± 10.0% of the total Vδ repertoire overall.  Use of Vδ4 (0.78% ± 0.64%) and Vδ8 
(0.35% ± 0.24%) was also observed in some individuals.  There was no statistically 
significant difference in use of any δ-chain between the healthy and diseased sample 
groups (p>0.99) (Figure 4.12b).  Interestingly, highly consistent Vδ-region usage was 
observed across all liver samples when plotted unweighted by clonotype proportion – i.e. 
each individual sequence was only counted once, irrespective of how many times in 
occurred in the repertoire (Figure 4.13).   
As for Vδ2+ sequences, TCRγ9 sequences containing the JγP joining region and the 
glutamate-leucine-glycine amino acid CDR3 motif were also removed post-processing as 
these are almost exclusively used by Vδ2Vγ9 phosphoantigen-reactive gamma delta T 
cells and should not therefore be encountered in a Vδ2neg selected population.  Unlike for 
the delta-chain, there was no predominant Vγ chain usage (p=0.18, 1-way ANOVA, 
Friedman test), with the liver samples demonstrating a wide range of Vγ9 expression, 
from 0.2% in sample L05 to 80.7% in sample L02, representing the largest represented Vγ 
chain across all samples, with 22.4% (Figure 4.14a).  All other functional γ-chains were 
identified in at least one sample and expression levels were highly heterogeneous:  Vγ2 -
15.1%, Vγ3 – 9.7%, Vγ4 - 20.3%, Vγ5 - 14.7% and Vγ8 – 17.4% overall.  As with δ-chain 
usage, no significant difference in γ-chain usage was observed between healthy and  
 
137 
 
 
 
 
 
 
 
 
 
 
 
 
 
V

1
V

3
V

4
V

5
V

8
V

1
V

3
V

4
V

5
V

8
0
2 0
4 0
6 0
8 0
1 0 0
%
V

 r
e
p
e
r
to
ir
e
N o rm a l D is e a s e
n .s .
 
 
Figure 4.12:  TCRδ repertoire of intrahepatic Vδ2neg gamma delta T cells 
a) Vδ chain usage by gamma delta TCR sequences from Vδ2neg sorted T cells from human 
liver 
b) Summary of TCRδ chain usage amongst intrahepatic Vδ2neg samples (n=5 normal, 5 
disease, p>0.99, 1-way ANOVA, Dunn’s multiple comparisons test) 
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Figure 4.13:  Normalised TCRδ chain usage for liver samples 
TCRδ chain usage for normal and diseased liver cohorts normalised to remove weighting by clonal 
size (n=5) 
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Figure 4.14:  TCRγ repertoire of intrahepatic Vδ2neg gamma delta T cells 
a) Vγ chain usage in gamma delta TCR sequences from Vδ2neg sorted T cells from human liver 
b) Summary of TCRγ chain usage amongst intrahepatic Vδ2neg samples (n=5 normal, 5 
disease, p>0.99, 1-way ANOVA, Dunn’s multiple comparisons test) 
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diseased sample groups (p>0.99) (Figure 4.14b). 
For TCRδ, the dominant J region usage was Jδ1 (91.4%) although some samples did have 
δ-chains that incorporated Jδ2, Jδ3 and Jδ4 (Figure 4.15a).  TCRγ J region usage was a 
little more heterogeneous, with the dominant J region being Jγ1 in all samples (83.6%) 
but with a significant number of Jγ2, JγP1 and JγP2 also being detected in several samples 
(Figure 4.15b). 
Flow cytometry analysis had previously shown that many AIH patients have an increased 
percentage of their T cell population occupied by Vδ2neg gamma delta T cells compared 
with healthy donors, and that these cells had a more activated phenotype.  To investigate 
whether these cells expressed a different TCR repertoire to healthy donors and to 
compare with the repertoire identified in liver samples, 4 AIH patient blood samples were 
analysed by deep sequencing; 3 patients were in remission and one was undergoing 
active disease (Figure 4.16a).  TCRδ usage was, as with liver, dominated by Vδ1 which 
occupied 68.6% ± 4.5% of the repertoire across all the samples, while Vδ3+ TCRs were 
also present in 24.9% ± 5.5% of the sequences read and Vδ4, Vδ5 and Vδ8 also 
represented at low levels (4.4%, 9.7% and 11.5% respectively).  TCRγ was again more 
heterogeneous than δ-chain usage, with both Vγ4 (37.3% ± 4.1%) and Vγ9 (24.4% ± 6.1%) 
strongly represented with all other chains also observed (Vγ2 - 10.23% Vγ3 - 9.375% Vγ5 - 
9.475% Vγ8 - 9.25%) (Figure 4.16b).  To assess whether there was a difference in TCR 
chain usage compared with healthy blood donors, this data was compared with four 
PBMC-derived samples that were sorted using the same Vδ2neg strategy                          
(Davey et al., 2017), which all exhibited very low frequencies of Vδ3+ chain usage (Figure 
4.16c).  Although the sample size was too small to make any direct implications, this is  
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Figure 4.15:  J-region usage of intrahepatic Vδ2neg gamma delta T cells 
Comparison of J-region usage for both TCRδ (top) and TCRγ (lower) for intrahepatic Vδ2neg gamma 
delta T cells isolated from normal and chronically diseased explanted human liver. n=5 normal, 5 
disease, p>0.99 1-way ANOVA, Kruskal-Wallis test. 
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Figure 4.16:  V-region usage of AIH patient PBMC –derived Vδ2neg gamma delta T cells 
a) Vδ (upper) and Vγ (lower) chain usage in gamma delta TCR sequences from Vδ2neg sorted 
T cells from PBMCs of autoimmune hepatitis patients 
b) Summary of TCRδ (left) and TCRγ (right) chain usage amongst AIH patient PBMC-derived 
Vδ2neg samples (n=4) 
c) Vδ chain usage in Vδ2neg sorted cells from healthy donors (n=4) (from Davey et al, 2017) 
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suggestive of an enrichment of Vδ3+ clonotypes in the periphery of patients with AIH to 
similar proportions as that found in the liver. 
4.3.3 CDR3 analysis 
 
The key research advantage that can be gained by deep sequencing-based TCR repertoire 
profiling compared with any other method is full exploration of the nature of the 
complementarity determining region 3 sequences present in the population of cells being 
analysed.  Each individual CDR3 represents a different clonotype, so the number and 
variety of CDR3s obtained from a population informs on the size and scope of the TCR 
repertoire.  Since CDR3 regions are critical in defining T cell antigen specificities, 
knowledge of CDR3 sequences can yield insight into the nature of the antigenic influence 
on the repertoire of the population analysed, and possibly, the nature of the antigen 
itself.   
The iRweb Tools software developed by iRepertoire generates “tree maps” to visualise 
the CDR3 repertoire for each sample.  Tree maps show each unique CDR3 as a coloured 
rectangle, where the size of each rectangle corresponds to the abundance of each CDR3 
within the repertoire.  The positioning of each rectangle is then grouped according to the 
V region usage.  Figure 4.17 shows tree maps for the 10 liver samples analysed in this 
study for both the γ- and δ-chains.  Strikingly apparent from these plots is the very large 
contribution of a small number of clonotypes to the repertoire in the majority of the 
samples. 
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Figure 4.17:  The intrahepatic Vδ2neg TCR repertoire is dominated by clonal expansions 
Tree maps show CDR3 clonotype usage in relation to total repertoire size (each CDR3 colour is 
chosen randomly and does not match between plots).  This data is representative of the raw 
iRepertoire data and has not undergone MiXCR error correction. 
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The contribution to the total repertoire of just the top ten most frequent clonotypes was 
plotted post error correction, cumulatively, for each sample for both TCRγ and TCRδ 
(Figure 4.18).  In 8 of the 10 samples the most prevalent CDR3s accounted for at least 
50% of the entire repertoire sequenced, with one dominant clone representing in excess 
of 50% of the entire repertoire in 4 of the 10 donors.  This was evident for both TCRγ and 
TCRδ chains.  7 of the 10 samples included a single clonotype that represented over 3 
times the number of copies represented by any other clonotype.   The 2 samples where 
the 10 most prevalent CDR3s did not account for over 50% of the repertoire were both 
from normal livers, but both normal and diseased liver cohorts contained samples with a 
high degree of clonal focussing.   
While these samples were dominated by Vδ1+ TCRs, there was also a significant 
proportion of Vδ3+ cells present.  Cumulative frequency plots generated using only Vδ3+ 
sequences demonstrated that Vδ3+ cells also exhibited strong clonal focussing, as for the 
total Vδ2neg population (Figure 4.19a). The repertoire focussing present in the top 10 
Vδ1+ and Vδ3+ clonotypes from liver was equivalent to that observed in “focussed” 
individuals’ healthy blood but much greater than that observed for Vδ1+ T cells isolated 
from cord blood in a study conducted previously by this group (Figure 4.19b) (Davey et 
al., 2017). 
In addition to clear strong clonal focussing, the total number of clonotypes identified in 
these samples was in general very low.  In Figure 4.20a, δ- and γ-chain frequencies are 
plotted for the top 100 clonotypes found in each sample.  As predicted from Figure 4.18, 
in 9/10 samples liver-derived samples, 100% of the repertoire is represented by the top 
100 TCRδ clonotypes determined, but of note in 4/10 samples there were fewer than 100  
 
146 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18:  Clonal focussing of intrahepatic Vδ2neg gamma delta T cells 
Individual clone frequency (left y axis) and accumulated frequency (right y axis) for the first 10 
most prevalent clonotypes  identified by deep sequencing of Vδ2neg intrahepatic gamma delta T 
cells in normal and chronically diseased explanted livers. 
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  Figure 4.19:  Clonal focussing of intrahepatic Vδ3+ gamma delta T cells 
a) Individual clone frequency (left y axis) and accumulated frequency (right y axis) for the 
first 10 most prevalent Vδ3+ clonotypes  identified by deep sequencing of intrahepatic 
gamma delta T cells in normal and chronically diseased explanted livers, where the 
Vδ3+ population represented greater than 5% of the total Vδ2neg population. 
b) Comparison of frequency of top 10 most prevalent clonotypes across all liver samples for 
Vδ1+ (blue) Vδ3+ (red), as well as “focussed” healthy adult blood donors (black) and cord 
blood (grey) (from Davey et al, 2017). 
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Figure 4.20:  Clonal focussing of intrahepatic and diseased blood Vδ2neg gamma delta T cells 
a) Accumulated frequency for the first 100 most prevalent clonotypes identified by deep 
sequencing of intrahepatic Vδ2neg gamma delta T cells in normal and chronically diseased 
explanted livers, for TCRδ (green) and TCRγ (blue). 
b) Accumulated frequency for the first 100 most prevalent clonotypes identified by deep 
sequencing of diseased blood Vδ2neg gamma delta T cells for TCRδ (green) and TCRγ 
(blue). 
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clonotypes identified in total (L02, L05, L08 and L09).  While only one of the blood-
derived samples demonstrated this, the repertoire was also strongly focussed in these 
samples, with 100% of the TCRδ repertoire being composed of the top 100 clonotypes by 
frequency observed in 3 of the 4 AIH-patient samples (Figure 4.20b).  To further 
investigate the potential size of the repertoire, the non-parametric abundance based 
Chao1 index was used.  This metric is based on the work of biodiversity researchers but 
can be applied to any population to extrapolate estimated population sizes (Chao, 1984), 
and uses the following equation:   
 
where Sobs is the number of species in the sample, F1 is the number of singly-occurring 
sequences in the sample and F2 is the number of doubly-occurring sequences.  
Rarefaction of the TCR sequence dataset was conducted computationally using randomly 
selected batches of sequences using the VDJtools software developed by Chudakov et al, 
where it has been demonstrated to be a robust metric for TCR repertoire size analysis 
(Shugay et al., 2015).  The Chao1 estimated population (S1) from the TCR δ-chain liver- 
and blood-derived sample groups normalised by read depth is shown in Figure 4.21.  The 
diseased liver population had a mean Chao1 of just 201.5, compared with 397 in healthy 
liver, 420 in AIH-derived blood and 1,583 in healthy blood.  While this metric should not 
be used as a direct measurement of population size, and no statistically significant 
differences in Chao1 were observed between any the sample groups, it is clear that for 
Vδ2neg cells in general there are strikingly few different clonotypes observed even  
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Figure 4.21:  Intrahepatic and peripheral Vδ2neg population size estimation 
Chao1 estimated population size from TCRδ sequencing of Vδ2neg gamma delta T cell subset for 
normal and diseased liver (n=5) (upper) and AIH patient and healthy donor blood (n=4) (lower). 
C
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in healthy blood, and that the liver may contain fewer still.  By comparison, analysis of a 
human blood-derived TCRβ sequence dataset (Putintseva et al., 2013) using the Chao1-
based algorithm determined the TCRβ population to be between 1.2 × 107 and 5.4 × 107 
unique amino acid CDR3s (Shugay et al., 2013). 
To assess the diversity of the TCR repertoire identified in these samples, two diversity 
metrics were used; the Shannon-Weiner index and the D75 metric.  The Shannon-Weiner 
index accounts for both the abundance and “evenness” of the sequences identified – that 
is, how frequently each sequence is encountered relative to one another.  The proportion 
of sequences (i) relative to the total number of sequences (pi) is calculated, and then 
multiplied by the natural logarithm of this proportion (ln pi). The resulting product is 
summed across sequences identified, and multiplied by -1: 
 
The Shannon Wiener diversity (H) scores, normalised to read depth for each sample, are 
plotted for the liver and blood TCRδ sequences in Figure 4.22.  Again, no significant 
difference was observed between any of the populations, although the diseased liver 
cohort did trend towards a lower Shannon diversity than the healthy liver, AIH blood and 
healthy blood cohorts, which were all equivalent. 
An additional method of calculating diversity is to use D75, that is, the percentage of 
unique sequences required to account for 75% of total reads.  This method highlights the 
effect of large clonal expansions on the overall diversity of the population, since the 
lowest frequency quarter of the repertoire is effectively ignored, and was used in a recent  
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Figure 4.22:  Intrahepatic and peripheral Vδ2neg population diversity estimation 
Shannon-Weiner diversity estimation for TCRδ sequences from Vδ2neg gamma delta T cell subset 
for normal and diseased liver (n=5) (upper) and AIH patient and healthy donor blood (n=4) (lower) 
normalised by read count. 
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study investigating the repertoire of Vδ1+ T cells in adult and cord blood (Davey et al., 
2017).  Here, average D75 for the diseased livers was 2.1%, healthy liver 3.0%, AIH blood 
6.8% and healthy blood 5.6% (Figure 4.23a).  No significant difference was observed 
between any group, but these data again highlight the clonotypic focussing present in this 
population, since only 2-3% of all the CDR3s identified accounted for at least 75% of the 
total repertoire.  Interestingly, one sample (L10) exhibited a much higher D75 (10.7) than 
observed in any other liver sample.  Similarly, a proportion of adults also appear to 
exhibit a more diverse CDRδ1+ TCR repertoire in peripheral blood than commonly 
observed (Davey et al., 2017).  Although absence of CMV infection did not appear to be a 
driving factor in this scenario, in as much as CMV positivity did not always induce a 
“focussed” repertoire in otherwise healthy adult donors, it is unclear what does drive the 
Vδ2neg repertoire focussing observed in most blood and liver donors.  However, this does 
suggest that the liver may not be populated by large clonotypic expansions by default, 
and that perhaps whatever drives the expansions in the periphery may also contribute to 
the expansions present in most adult livers. 
Although no statistically significant difference in diversity was observed between blood 
and liver using both Shannon and D75 metrics, an alternative analysis using only 
Vδ1+ sequences identified in this study combined with that of Davey et al, 2017 did 
display a significant difference in the number of unique CDR3 regions identified by deep 
sequencing in liver and blood per 10,000 CDR3s sequenced (Figure 4.23b).  Combined 
blood samples contained an average of 622 Vδ1+ CDR3 sequences per 10,000 sequences 
while liver samples averaged only 135 unique CDR3s per 10,000 sequences (p=0.0005).   
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Figure 4.23:  Intrahepatic and peripheral Vδ2neg population diversity estimation 
a) D75 diversity estimation for TCRδ sequences from Vδ2neg gamma delta T cell subset for 
normal and diseased liver (n=5) and AIH patient and healthy donor blood (n=4)  (p>0.05, 
student’s T test) 
b) Number of unique CDR3 sequences identified for each liver (n=10) and blood sample 
(n=14) per 105 sequences obtained.  Blood data includes Vδ1+ sequences identified in 
Davey et al, 2017. (p=0.0005, student’s T test).  
  
a 
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This suggests that while both compartments are dominated by large clonotypes the 
periphery has a greater pool of non-expanded clonotypes than the liver. 
Next, the composition of the CDR3 itself was analysed.  When the frequency of individual 
clonotypes was accounted for, all liver samples, perhaps with the exception of L10, 
displayed highly skewed CDR3δ spectratypes (Figure 4.24a).  This is indicative of non-
stochastic expansion of certain clonotypes of varying CDR3 length.  However, there was 
no specific CDR3δ length favoured across all samples, with each being dominated by 
clonotypes of differing CDRδ length.  This suggests that the expanded clonotypes 
observed are specific to each individual, i.e. the CDR3δ repertoire is private.  Additionally, 
when the spectratypes were combined there was no significant CDR3 length profile 
observed for healthy donor cohort compared with diseased donor cohort, suggesting that 
chronic liver disease does not alter the CDR3δ repertoire, at least in terms of CDR3 length 
(Figure 4.24b).  Interestingly, when segregated by Vδ-region, Vδ1+ CDR3s were 
significantly longer than Vδ3+ Vδ5+  and Vδ8+ CDR3s, at 54 nucleotides vs. 45 nucleotides 
(p<0.0001) (Figure 4.24c). 
The most expanded Vδ1+ and Vδ3+ clonotype from each donor exhibited significant 
divergence from germline CDR3δ sequences, with most including extensive n-and p-
nucleotide addition, resulting from rare recombination events (Table 4.3).  Analysis of the 
entire CDR3δ dataset from all donors sequenced revealed just 3 shared CDR3δ - 
CACRFGYWGSTDKLIF (liver samples L02 and L06), CALGELPDKLIF (blood samples donor22 
and L0109) and CALGELRLGDTFTDKLIF (blood samples donor012 and L0109).  All three 
sequences were present at low frequencies in both donors and exhibited extensive  
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Figure 4.24:  Skewed distribution of CDR3δ lengths in intrahepatic Vδ2neg T cells 
a) An NGS based approach was used to determine CDR3 length of intrahepatic Vδ2neg T cells.  
Comparison of non-normalized CDR3δ length spectratyping is displayed here for healthy 
(n=5) and diseased (n=5) liver donors 
b) Comparison of mean + s.e.m. CDR3δ spectratypes of Vδ2neg T cells from all (left), normal 
(centre) and diseased livers (right) 
c) Comparison of mean + s.e.m. CDR3 lengths for all liver samples based on V-region usage, 
****p<0.0001 
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modification from germ-line encoding in the case of the first and last noted above.  The 
highly private and complex nature of the Vδ2neg CDR3δ repertoire in human liver is 
suggestive of non-stochastic selection of specific clonotypes unique in each individual, 
consistent with antigenic stimulation. 
In the CDR3γ repertoire however, some evidence of sequence commonality both within 
and between individuals was observed across the combined liver and blood derived 
dataset.   The D metric represents the number of shared sequences divided by (diversity 
of clonotypes in sample 1 * diversity of clonotypes in sample 2) to normalize for 
sequencing depth.  D values, allowing for one amino acid mismatch, for each sample 
amongst liver- and blood-derived samples is plotted in Figure 4.25a, as well as clonotypes 
identified shared, with up to one amino acid mismatch, among both compartments.  The 
liver displayed significantly fewer overlapping CDR3γ clonotypes than blood although in 
both compartments this represented a very small percentage of the total repertoire 
(D=0.0017% vs. 0.0038%).  Analysis of the overlapping sequences in both liver and blood 
revealed that the shared clonotypes were less variable in CDR3 length than private 
sequences in both compartments, and in liver were significantly shorter in amino acid 
(aa) sequence (12 aa vs. 14 aa) (Figure 4.25b).  Furthermore, analysis of the shared CDR3γ 
specific amino acid sequence revealed a relatively constant structure over 12 amino acids 
with only aa at position 6 and 7 displaying significant divergence across the population 
(Figure 4.25c).  This suggests that shared CDRγ sequences are likely simple to rearrange 
“germline”-like in nature with few if any n- and p-nucleotide additions which are more 
prevalent in the periphery than the liver.  This is consistent with the putative existence of 
a non-antigenically selected “naïve” population of Vδ2neg cells that possess easily  
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Figure 4.25:  Clonal overlap in CDRγ sequences in liver and blood derived Vδ2neg T cells 
a) Extent of clonal overlap in CDR3γ sequences within liver, blood and between the two 
compartments.  Each dot corresponds to a specific sequence identified in more than one 
sample, and what proportion of the repertoire said sequence occupies in each sample it is 
found in 
b) Comparison of shared (blue) and private (green) clonotype CDR3γ lengths in liver and 
blood 
c) Visual representation of amino acid enrichment at each position in shared sequence 
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recombined CDR3γ chains common to multiple individuals.  Such a population has been 
identified in Vδ1+ gamma delta T cells in healthy blood donors (Davey et al, 2017). 
4.3.4 Single cell TCR PCR analysis  
 
To confirm that the large clonal expansions identified by deep sequencing were genuine 
and not simply a reflection of disproportionate amplification of overexpressed TCR mRNA 
transcripts, single cell TCR sequencing was performed on Vδ1+ and Vδ3+ cells isolated 
from explanted human liver (n=3).  In the samples analysed, clear dominance of specific 
TCR CDR3δ chains was observed for both Vδ1 and Vδ3 bearing cells, with between 56% 
and 94% of Vδ1+ cells sorted and between 83% and 100% of Vδ3+ cells sharing CDR3δ 
sequences with at least one other sorted cell (Figure 4.26).  This data also confirms the 
strong clonal expansions present in the Vδ3+ subset within the liver.  
In summary, these results are consistent with the selective retention and/or expansion of 
Vδ2neg gamma delta T cells in the liver of both chronically inflamed but also healthy 
donors.   These populations are generally composed of massively expanded clonotypes, 
concomitant with a focussed repertoire lacking in overall diversity.  The expanded TCRs 
identified are highly private in nature, with no significant overlap between individuals and 
exhibiting extensive recombinational modification, consistent with non-stochastic 
antigen-specific expansion.  While chronic inflammation did not appear to alter the 
overall shape of the observed Vδ2neg repertoire in liver, patients undergoing therapy for 
autoimmune hepatitis did exhibit perturbed expansions of phenotypically activated 
clonotypically focussed Vδ2neg T cells in the periphery. 
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Figure 4.26:  Single cell PCR TCR sequencing of intrahepatic Vδ2neg T cells 
Vδ1+ (upper) and Vδ3+ (lower) cells were singly sorted and the CDR3 sequenced by single cell PCR 
(n= 16 – 44).  Each colour represents a unique CDR3δ sequence, listed below each chart with 
corresponding Vγ-chain usage.  “Diverse” notation corresponds to cells with CDR3δ not identified 
in any other cell. 
 
CAFHSSYWGMNTDKLIF        Vγ9Jγ1/2 
CAFSGGRPWDTRQMFF        Vγ3Jγ1/2 
CAFLLPTVWGDDKLIF     Vγ4/Jγ1/2 
diverse  
CAFWPGTKLIF           ND 
CAFKRGVTPRQMFF           Vγ5  
CASGGDTPWDTRQMFF           Vγ4 
CASKPGPPTMILYWGIPTNKLIF  Vγ4 
CAFSGGYGVTFDKLIF            Vγ3 
CASLRAFRLTAFTDKLIF 
Diverse  
CALGELRWGKIDKLIF  Vγ3 
CALGEPSSPPYIGVYTDKLIF Vγ4 
CALGLTGGEDTDKLIF  Vγ9 
CALGELLGRATKSPLNLKGRDRGAQLFF  nd 
CALGVPLYERPWDQTYTDKLIF nd 
CALILVGLGNTESIPTDKLIF  nd 
diverse  
CALGELRWGIIDKLIF         Vγ3/Jg1/2 
CALGDRFPDSTDKLIF         Vγ8/JgP2 
CALGEQFFRRLPSYTMLTAQLFF Vγ5 
CALGGPSKYWGLPYTDKLIF       Vγ3/Jγ1/2 
diverse  
CALGVFPARYTDKLIF                nd 
CALGEKEPVLGDRGDKLIF               nd 
CALGELALLRTGGYWPLIF               nd 
CALGERLQLHEVAGGWGYTDKLIF  nd 
diverse   
1445 0860 1410 
2008 2002 2038 
Vδ1+ 
Vδ3+ 
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4.4 Discussion 
 
This chapter focussed on the assessment of human intrahepatic and peripheral gamma 
delta T cell TCR chain usage, composition of the CDR3 and analysis of clonality in health 
and chronic liver disease.  This was achieved using a combination of flow cytometry and 
NGS-based TCR sequencing.  The Vδ2neg repertoire elucidated from the samples in this 
study suggested highly clonally focussed expanded clonotypes constructed from highly 
variable, private CDR3 regions for both CDR3γ and CDR3δ.  This presents a stark contrast 
to the repertoire determined for two innate like T cells populations in humans;  MAIT 
cells, which exhibited a high degree of publicity and distinct bias in CDR3β length 
distribution (Lepore et al., 2014) and Vδ2+ gamma delta T cells, which are also highly 
public and restricted in CDR3 composition (Davey et al, unpublished). 
Interestingly, although δ-chain usage strongly favoured Vδ1 in the majority of samples 
analysed, γ-chain use was highly heterogeneous in all patient cohorts analysed.  This 
throws these cells into sharp contrast with murine gamma delta T cells, where specific 
tissues, including the liver, are associated with accumulation of γ-chain restricted TCRs.  
Recent work from Hayday et al suggested that gut resident Vδ2neg T cells favoured 
expression of Vγ4, and that these cells could be selectively regulated by intestinal 
epithelium expression of butyrophilin-like family members 3 and 8 (Di Marco Barros et 
al., 2016).  Contrary to these findings, no Vγ-chain specific enrichment was observed in 
human livers, although the potential for regulation of Vδ2neg cells by BTNL family 
molecules in humans remains an intriguing prospect.  It is also possible that the more 
significant physical compartmentalisation of intra-epithelial gamma delta lymphocytes in 
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the gut by the lamina propria may promote an accumulation of enriched Vγ-chain specific 
populations in the gut that is not observed in the less physically restrained liver-tissue 
associated gamma delta T cell population. 
The analysis of clonotypic cumulative frequency primarily supported the observation that 
very few clonotypes contributed to the overwhelming majority of the entire repertoire in 
most of the donors.  However, in several donors the cumulative frequency of the TCRγ 
did not match that of the TCRδ.  Later analysis of shared clonotypes suggested that there 
was a greater publicity of TCRγ sequences than TCRδ, which contained just three 
overlapping clonotypes amongst all 18 donors.  These data seem to be slightly 
contradictory, since in order for there to be shared gamma-chain clonotypes but not 
delta-chain, “psuedoclonotypes” must exist with common TCRγ paired with diverse TCRδ 
sequences.  However, if that were the case, one may expect the diversity of the CDR3γ to 
be less than CDR3δ, which is contrary to the slower accumulation of TCRγ clonotypes in 
the cumulative frequency plots.  It is unclear what the reason for this is, but further 
analysis of this and other datasets may help provide answers.    
One possible explanation for the increased publicity within the CDRγ sequences 
compared with the CDR3δ sequences is the presence of contaminating Vγ9JγP region 
sequences specifically used by the semi-invariant Vδ2Vγ9 phosphoantigen-reactive 
gamma delta T cells, and despite post-processing removal of these sequences it is still 
possible that some CDRγ sequences expressed by contaminating Vδ2+ cells may have 
been present in the population analysed, since paired chain data is not available from 
these analyses.  However, analysis of CDR3 length and amino acid sequence suggested 
that CDR3γ public clonotypes were very similar and relatively simple compared with 
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private sequences, as well as representing a very low proportion of the repertoire.  An 
attractive explanatory hypothesis may be that this represents the use of simple gamma-
chain recombinations that have yet to undergo antigenic stimulation and expansion, 
consistent with their low overall frequency.  Further study of the impact of clonal 
selection by specific stimuli such as CMV infection is warranted to establish whether 
Vδ2neg gamma delta T cells genuinely act in an adaptive manner. 
What implications this research has for the field of chronic liver disease research is 
perhaps debatable.  No significant differences between healthy and diseased livers were 
observed in chain usages, CDR3 lengths or complexity.  Additionally no disease-related 
clonotypes were identified.  Clearly, the pathologies of the various chronic liver diseases 
are highly diverse, with some diseases associated with antigen specific responses, and 
other yet to be.   For example, in PBC patients CD4+ αβ T cells specific for the E2 
component of the pyruvate dehydrogenase complex have been discovered (Van de 
Water et al., 1995), while PSC has been linked with HLA haplotype (Schrumpf et al., 
1982), suggesting a specific T cell related contribution to disease progression.   An NGS-
based study of TCRβ repertoire in PBC and PSC livers discovered several apparently 
disease-specific clonotypes (Liaskou et al., 2016), although whether these are reactive to 
disease specific antigens is unclear as many of them have also been identified as public 
TCRβ sequences in other studies (Britanova et al., 2014).  Accordingly, the grouping of 
livers of multiple disease aetiologies as a “disease liver” cohort was unlikely to highlight 
any disease specific clonotypes, but it did suggest that there was no significant 
contribution of general chronic inflammation to the repertoire of intrahepatic Vδ2neg T 
cells, consistent with the findings of the previous chapter that suggested chronic disease 
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did not significantly impact gamma delta T cell infiltration into livers.  In order to 
ascertain the genuine potential for disease related Vδ2neg expansions, one would need to 
analyse considerably more samples than used in this study, but based on the findings 
here and in previous work conducted on peripheral Vδ1+ cells, it seems highly likely that 
the tremendously diverse focussing of the Vδ2neg repertoire in many adults may preclude 
the possibility of ever identifying common sequences present at high frequencies in 
response to disease-specific stimuli in a setting such as the liver. 
This being said, there is a clear perturbation in the frequencies and phenotype of 
circulating Vδ2neg T cells in autoimmune hepatitis patients.  Similar perturbations have 
been described in PSC (Martins et al., 1996) and PBC (Hua et al., 2016).  In addition to an 
inversion of the usual Vδ1/Vδ2 ratio observed in most healthy adults, the frequency of 
Vδ1negVδneg cells was also increased in these samples compared with healthy donor 
blood.  In addition, they expressed higher CD69 and lower CD27, suggestive of induced 
effector function, which is indicative of potential TCR engagement.  Once more, no 
significant differences were observed in the nature of the repertoire between diseased 
and healthy donors, providing no evidence of disease-specific reaction within the 
repertoire to AIH.  However, since even healthy individuals often possess highly focussed 
Vδ2neg repertoires, it cannot be ruled out that a change in the frequency of specific 
disease-related clonotypes has not taken place in these individuals.  Longitudinal study of 
AIH patients before, during and after therapy, perhaps also including relapse, may help 
address this question, although there is an obvious difficulty in getting blood samples 
from patients pre-diagnosis.  In the case of AIH, it is also difficult to distinguish whether it 
is the disease or the treatment that leads to the observed fluctuations in circulating 
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gamma delta T cells, as many immunosuppressive regimens will impact circulating T cell 
populations, as has been demonstrated with azathioprine and Vδ2+ cells (McCarthy et al., 
2015).  A full study using patients undergoing different immunosuppression and perhaps 
including a cohort of blood donors from non-immunosuppressed chronic liver disease 
patients (such as NASH) may start to unpick the apparent complexities of this scenario.  
Additionally, further examination of a cohort of this nature could provide insight into 
whether the observations made in this study and others are related to a general systemic 
response of gamma delta T cells to the increased permeability of the gut to microbes and 
microbial antigen, often associated with non-viral chronic liver inflammation (Martinez-
Esparza et al., 2015, Szabo, 2015).  
Vδ3+ gamma delta T cells have been associated with the human liver by studies 
performed over the last 15 years (Kenna et al., 2004, Mangan et al., 2013) and also 
comprised the most frequent gamma delta T cell subset in a study of healthy human 
colon (Dunne et al., 2013).  Here, enrichment of liver with these cells was confirmed 
indirectly by flow cytometry and directly by deep sequencing.  Additionally, isolation of 
Vδ3+ sequences from repertoire data and single cell PCR of Vδ3+ cells demonstrated that 
these cells are equally as dominated by clonal expansions as Vδ1+ cells.  It is unclear 
whether these cells are responsive to liver associated antigen, but the parallels between 
these cells and Vδ1+ gamma delta T cells, in terms of repertoire at least, are clear, 
suggestive of an adaptive-like immunobiology for Vδ3+ cells also.  Ex vivo expanded 
human blood derived Vδ3+ cells have been demonstrated to kill CD1d-expressing cells in a 
CD1d non-αGalCer dependent fashion (Mangan et al., 2013).  Whether the liver derived 
Vδ3+ populations described in this study were CD1d reactive is unclear, but the strong 
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clonotypic expansions of diverse complex CDR3 region bearing Vδ3+ cells is unlike the TCR 
composition exhibited by other generally innate like CD1d-reactive T cells.  Unlike in 
rodents that have high constitutive expression of CD1d and large intrahepatic iNKT 
populations, healthy human hepatocytes express CD1d intracellularly only at very low 
levels, although it is upregulated in certain chronic liver diseases, such as HCV 
(Yanagisawa et al., 2013) and PBC (Tsuneyama et al., 1998).  Despite this, it is possible 
that the enrichment of these cells in the liver may be driven by recognition of stress-
induced CD1d upregulation and subsequent TCR-mediated binding of CD1d presented 
glycolipids, however, considerably more work would be required to prove the biological 
significance of such an interaction. 
While the iRepertoire approach was chosen for several reasons, it was not perfect in 
some aspects, such as repertoire size estimation.   In a comparison of various non-
parametric population estimators, Asquith et al showed that TCR repertoire size 
estimators are biased by sample size, which would likely change the results based on the 
number of cells sequenced or the quality of the RNA and subsequent sequencing itself 
(Laydon et al., 2014).  They also strongly suggested that these estimates, including Chao1 
used in this study, underestimate diversity.  The Chao1 results obtained here were indeed 
very low, and while it is clear that they do reflect a genuinely focussed repertoire, the use 
of molecular barcoding of samples such as MIGEC (molecular identifier groups–based 
error correction) (Shugay et al., 2014) during sequencing has been proposed to eliminate 
sequencing errors and hugely improve the accuracy of diversity assessments.  Future 
analyses such as this would therefore benefit from being performed in house using 
barcoding protocols such as this. 
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In summary, the work presented in this chapter represents, to the author’s knowledge, 
the first detailed repertoire analysis of Vδ2neg gamma delta T cells in any human solid 
tissue, and has highlighted the remarkably private and clonally focussed repertoire that 
bears the hallmarks of association with an adaptive-like immune response. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
169 
 
 
 
 
 
 
 
5 
 
Intrahepatic gamma delta T cells: the 
relationship between phenotype, clonotype 
and function 
 
 
 
 
 
 
 
170 
5.1 Introduction 
5.1.1 Tissue-resident T cells  
 
In the previous chapters, evidence for the presence of Vδ2neg gamma delta T cells 
enriched with large, complex and private TCR clonotypes in the liver was presented.  
Immunohistochemical analysis highlighted the predominantly parenchymal localisation of 
gamma delta T cells, and combined with flow cytometry analysis of ex vivo lymphocytes, 
suggested that Vδ2neg T cells were present at high proportion in normal liver tissue.  A 
question that arose from this is whether these intrahepatic Vδ2neg T cells were enriched 
due to enhanced recruitment from the periphery or whether a pool of these cells may be 
genuinely liver resident. 
The topic of tissue residency of lymphocytes has received a lot of attention in the 
scientific literature over recent years.  Once naïve T cells have recognised cognate antigen 
they proliferate and upregulate homing receptors that allow re-distribution of these cells 
from the periphery and into tissues, where they mount an effective localised response.  
While some clonal daughter cells remain in circulation as memory cells, others remain at 
the site of response as tissue resident memory cells (TRM) and do not re-enter circulation.  
First identified using mouse models (Masopust et al., 2001), TRM have since been 
demonstrated to exist throughout the human body (Thome and Farber, 2015). 
Naïve αβ T cells express CCR7, which facilitates migration into lymph nodes from the 
periphery (Bromley et al., 2005). A study by Lanzavecchia’s group determined that 
expression of this surface molecule is a defining element of T cell naivety (Sallusto et al., 
1999), and definitively linked migrational capability with memory status.  Other surface 
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proteins have since also been ascribed to differentiation status, including isoforms of 
CD45, CD62L, the TCR co-stimulatory CD27 and CD28 and CD127, the IL-7 receptor.  Naïve 
T cells (TN) express CD45RA, which is lost in circulating central memory T cells (TCM).  
Effector memory cells (TEM) lose expression of lymph node associated CCR7, CD62L and 
homeostasis associated CD127, as well as CD27 and CD28 (Obar and Lefrancois, 2010).  
Terminally differentiated T cells (TEMRA) re-acquire expression of CD45RA, with each step 
in differentiation controlled by a variety of transcription factors including TCF7, Tbet 
(Szabo et al., 2000), Eomes and Blimp-1 (Kallies, 2008).  Regulation of the transcription 
factors is not fully understood, but a dominant factor is clearly TCR-mediated T cell 
activation, as well as cytokine exposure and other stimuli.  In general, naïve and central 
memory T cells have a higher proliferative capacity and produce IL-2, while effector T 
cells have a low proliferative capacity and produce effector cytokines such as interferon-γ 
(IFNγ) and tumour necrosis factor α (TNFα). 
The question of whether memory cells continue to circulate through blood and 
lymphatics while surveying tissues or are retained within tissues was initially addressed 
using murine models of infection and monitoring antigen-specific T cell responses 
following procedures such as adoptive T cell transfer (Masopust et al., 2004) and 
parabiosis – surgical splicing of two mouse circulatory systems (Klonowski et al., 2004).  
Local infection generated a non-migratory site-specific T cell response in a number of 
tissues that, importantly, was capable of mounting a quick response to re-challenge by 
the same initial pathogen.  These studies also highlighted a degree of phenotypic 
commonality amongst TRM, specifically expression of the early-activation marker CD69 
and epithelial αE integrin CD103. 
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In human studies, these markers have also been attributed with populations of memory 
cells that do not recirculate, although the level of expression does vary somewhat 
depending on tissue and T cell subset.  CD4+ T cells rarely express CD103, but CD8+ T cells 
do, especially in epithelial and mucosal tissues such as skin, lung and intestine (Mackay et 
al., 2012).  Both subsets express CD69, although again CD4+ T cells not as highly as CD8+.  
As well as being upregulated swiftly after TCR and cytokine stimulation, CD69 has been 
demonstrated to sequester the sphingosine-1-phosphate receptor (S1PR1), which in turn 
is a vital requirement in lymphocyte egress from tissues (Matloubian et al., 2004) 2004).  
Therefore CD69 may be involved in retention of memory cells in tissues (Mackay et al., 
2015).  
Although no experimental system in humans can be quite as conclusive as murine 
models, several studies have implicated the presence of local memory T cell populations 
capable of withstanding circulatory T cell depletion during organ transplantation 
(Watanabe et al., 2015, Turner et al., 2014). In addition, sites including lung and bone 
marrow have been demonstrated to be enriched for memory phenotype T cells specific 
toward pathogens such as influenza (Purwar et al., 2011) and other chronic viruses 
(Okhrimenko et al., 2014) that are not present in peripheral blood.  Although these 
studies utilised pathogen specific epitope tetramers, NGS based αβT cell TCR sequencing 
has also revealed clonal expansions present in colorectal tumours that are not found in 
adjacent tissue, suggestive of tumour-specific expansions (Sherwood et al., 2013) and 
cerebrospinal fluid-specific clones not shared with blood in multiple sclerosis patients 
(Lossius et al., 2014).  Combined, this research not only demonstrates tissue localised 
 
173 
memory T cells that are distinct from circulatory populations, but also the potential 
power of TCR sequencing in furthering our understanding of this field. 
5.1.2 Lymphocyte residency in the liver 
 
The liver is an interesting organ physiologically as there is no basement membrane to 
physically separate the tissue from the peripheral blood supply, and the endothelium that 
permeates the liver is highly fenestrated, allowing relatively free movement of blood- and 
tissue-associated cells between the two compartments (Racanelli and Rehermann, 2006).  
Nevertheless, an expanding body of work suggests that the liver is home to a number of 
resident lymphocyte populations (Peng and Tian, 2015, McNamara and Cockburn, 2016).  
Murine parabiosis experiments have highlighted several lymphocyte populations that, 
when joined with the circulation of another mouse, stay within the liver of the original 
mouse, thereby providing clear evidence that they are truly resident.  Liver resident NKT 
cells in mice do not express high surface levels of CD103 but instead appear to be 
anchored in the tissue by high expression of lymphocyte functional antigen-1 (LFA-1) and 
interaction of this molecule with tissue-expressed intercellular cellular adhesion 
molecule-1 (ICAM-1) (Thomas et al., 2011).  Additionally, the surface expression of the 
chemokine receptor CXCR6 has been demonstrated to be involved in mediating murine 
NKT recruitment, a feature apparently shared by many intrahepatic lymphocyte subsets 
in both mice and humans (Geissmann et al., 2005, Hudspeth et al., 2016, Stegmann et al., 
2016). 
As with NKT cells, murine liver NK cells have been demonstrated not to recirculate in 
parabiosis experiments (Peng et al., 2013).  A CD56hi CD16neg population of intrahepatic 
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NK cells that express the integrin CD49a, which pairs with CD29 to form very late antigen-
1 (VLA-1), has been demonstrated to be resident in humans by analysis of afferent and 
efferent blood sampling simultaneously with liver biopsy (Marquardt et al., 2015).  These 
cells displayed distinctive functional aspects, with low degranulation and high cytokine 
production compared with the non-resident populations. 
Both NKT and NK cells are enriched in the human liver compared with the periphery.  
Another lymphocyte subset enriched in the liver is CD8+ T cells (Norris et al., 1998).  Using 
a mouse model of vaccination, Heath and colleagues identified by parabiosis liver 
resident CD8+ T cells which displayed a TRM gene expression signature when analysed by 
microarray analysis (Fernandez-Ruiz et al., 2016).  A number of genes form this signature, 
including CXCR3, CXCR6, BTLA, CD25, CD31, & CD127 amongst others.  A recently 
published study on human liver corroborated the existence of a CD45RAneg CD69+ 
CD103+ CD8+ T cell population that is seemingly liver resident (Pallett et al., 2017).  
Analysis of transcription factors expressed by this population suggested that the liver 
resident CD8+ population identified was T-betlo Eomeslo Blimp-1hi Hobitlo, consistent with 
previous findings in mice (Mackay et al., 2016) and human tonsil (Vieira Braga et al., 
2015).  Additionally, these cells were generally less cytotoxic than non-resident effector 
CD8 + cells and seemed to play a role in controlling HBV infection through non-cytotoxic 
cytokine production (Pallett et al., 2017). 
5.1.3 Tissue Resident Gamma Delta T cells 
 
Although tissue residency, as defined in the previous section, has been demonstrated in 
humans for CD4+ and CD8+ αβ T cells to occur in many tissues (Zaid et al., 2014), the 
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picture for gamma delta T cells is less clear.  This is because in mice, gamma delta T cells 
have been demonstrated to home to tissues as a result of a hard-wired developmental 
process (Bandeira et al., 1990, Haas et al., 2012), where the role of the TCR and extra-
thymic ligand recognition is unclear (Munoz-Ruiz et al., 2016) other than in the case of 
DETC selection by Skint-1 (Salim et al., 2016).  Accordingly, much of the research into 
tissue-associated gamma delta T cells has focussed on mice in attempts to understand 
these processes and discover what relevance they may have in the human system. 
Combined with the difficulty in accessing human solid tissue for many labs, there is a 
distinct paucity of human data on this topic in the literature. 
The aim of this chapter was therefore to investigate differences between liver- and 
periphery-associated gamma delta T cell populations, focussing on frequencies, 
phenotype and TCR repertoire.  Any populations considered liver-specific would then be 
characterised functionally to attempt to discern the potential role for these cells within 
the liver.  To do this, matched blood from patients undergoing liver transplant was taken 
and lymphocyte populations from both blood and liver analysed. 
5.2 Results 
5.2.1 Frequencies of Vδ1+ T cells in donor matched blood and liver 
 
Sampling peripheral blood from individuals undergoing liver transplantation allowed a 
comprehensive comparison of intrahepatic and peripheral gamma delta T cells 
populations from within the same donor.  Since autoimmune liver disorders have been 
associated with perturbations in circulating gamma delta T cell frequencies (Martins et 
al., 1996, Hua et al., 2016), as well as in this study, perhaps due to therapy regimes 
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(McCarthy et al., 2015), samples were taken from 8 individuals undergoing 
transplantation for non-autoimmune based chronic liver disease, including ALD, NASH 
and polycystic liver disease.  To corroborate the findings in Chapter 3, frequencies of 
lymphocyte populations of interest were analysed by flow cytometry.  Firstly, the 
frequency of circulating gamma delta T cells amongst CD3+ cells was increased in liver 
compared with blood, from 3.4% ± 1.8% in blood to 7.77% ± 4.2% in liver (p=0.04) (Figure 
5.1a & 5.1b).  Within this subset, both Vδ1+ and Vδ2negVδ1neg cells increased as a 
proportion of CD3+ lymphocytes, from 1.13% to 3.31% (p=0.008) and 0.23% to 1.59% 
(p=0.005) respectively (Figure 5.2a), representing a 2.9-fold increase of Vδ1+ and a 6.9-
fold increase in Vδ2negVδ1neg cells in the liver.   Interestingly, Vδ2+ cells were not 
significantly increased in liver as a proportion of CD3+ T cells, but neither did they 
decrease (2.04% to 2.87%, p=0.38), suggestive of a slight preferential tissue retention of 
these cells that form the dominant subset in the periphery.  The samples in this cohort 
also demonstrated the enrichment of liver for CD8+ αβ T cells, which formed the 
dominant T cell subset in the liver (25.6% ± 6.1% of CD3+ in blood, 50.5% ± 5.2% of 
CD3+ in liver, p=0.011), which is in line with previous studies (Benechet and Iannacone, 
2017) (Figure 5.1c).  As a proportion of infiltrating gamma delta T cells, Vδ1+ formed the 
majority (50.7% ± 7.25%), with Vδ2negVδ1neg cells the second largest group (27.1% ± 5.7%) 
and Vδ2+ in the minority (21.3 ±6.1%), contrasting with the blood where Vδ2+ cells were 
the largest subset present (64.4 ± 5.3%) (Figure 5.2b).  Since they represented the largest 
subset present in the liver, and were easily classified due to the availability of a specific 
monoclonal antibody, subsequent phenotypic analysis focussed on the Vδ1+ subset of 
gamma delta T cells. The similarly tissue-enriched CD8+ αβ T cells represented a point of 
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Figure 5.1: Matched blood and liver lymphocyte frequencies 
a) Representative flow cytometry plots gated on CD3+ cells showing typical distribution of 
Vδ1+ and Vδ2+ cells in matched blood and liver from two donors 
b) Frequency of pan-γδ TCR+ cells as a proportion of all CD3+ T cells in blood and matched 
donor liver (n=8, p=0.04 Wilcoxon test) 
c) Frequency of CD8+ T cells as a proportion of all CD3+ T cells in blood and matched donor 
liver (n=8, p=0.01 Wilcoxon test) (2 NASH, 2 ALD, 2 PSC, 2 non-inflammatory) 
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Figure 5.2:  Matched blood and liver TCRδ chain usage 
a) Frequency of Vδ1+, Vδ2+ and Vδ1negVδ2neg gamma delta T cells as a proportion of CD3+ T 
cells in blood and matched liver donors with mean + s.e.m. (n=8, p=0.08 1-way ANOVA) 
b) Frequency of all Vδ1+, Vδ2+ and Vδ1negVδ2neg gamma delta T cells as a proportion of the 
total TCRδ repertoire in blood and matched liver donors with s.e.m. (n=8) (2 NASH, 2 ALD, 
2 PSC, 2 non-inflammatory) 
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 comparison during this study. 
5.2.2 Differentiation of Vδ1+ T cells in donor matched blood and liver 
 
A critical step in the development of tissue resident T cells is antigen recognition and 
concomitant transcriptional re-profiling of clonal daughter cells to adopt a memory 
phenotype and track into tissues to mount an effective response to subsequent antigenic 
exposure.  Recent work from this laboratory has correlated clonal expansion with loss of 
naïve status in Vδ1+ blood-derived T cells (Davey et al., 2017). Accordingly, classical 
surface markers of T cell naivety were analysed by flow cytometry.  CD27, a TNF receptor 
superfamily member, is involved in co-stimulation of the TCR and surface expression is 
lost after TCR engagement.  Loss of expression of CD27 has been associated with gain of 
effector memory status for both gamma delta and αβ T cells in previous studies (Dieli et 
al., 2003, Fritsch et al., 2005, Wirth et al., 2010).  CD62L (L-selectin) is a cell adhesion 
molecule that mediates interaction with endothelium, particularly important in the entry 
of naïve and central memory lymphocytes into lymphoid organs via the high endothelial 
venules (Stamenkovic, 1995).  Loss of expression of CD62L prevents this and therefore 
forms part of the expression pattern of non-circulatory effector memory T cells.  CCR7 is a 
chemokine receptor expressed by naïve T cells and used to home to lymphoid structures 
due to local secretion of its ligands CCL19 and CCL21 by stromal lymphoid cells with 
expression of CCR7 also lost in non-circulatory cells (Ebert et al., 2005). 
When analysing CD27 expression in both blood and liver by flow cytometry, a distinction 
became apparent based on the level of expression, with some cells exhibiting a CD27hi 
phenotype, others a CD27int phenotype, and others truly CD27neg (Figure 5.3a).  Previous 
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work from the Willcox group has demonstrated that the CD27hi population of Vδ1+ cells in 
blood are in fact highly polyclonal and resemble genuinely naïve conventional T cells 
phenotypically and functionally (Davey et al., 2017).  Accordingly, the proportion of 
CD27hi Vδ1+ T cells was focussed on here as a potential marker of true naivety.  
The percentage of cells with CD27hi expression was significantly higher in blood-derived 
Vδ1+ gamma delta T cells than liver (27% ± 7.1% vs. 4.7% ± 1.1%, p=0.008) (Figure 5.3b 
and Figure 5.3c).  In addition, co-expression of CD62L and CCR7 reduced from 21.5% ± 
7.6% in blood to 1.5% ± 0.5% in matched liver (p=0.004) (Figure 5.3d).  These results are 
consistent with a loss of the naïve and central memory compartments, present in 
circulating Vδ1+ T cells, in liver tissue. 
Analysis of peripheral gamma delta T cells in previous studies has used co-expression of 
CD27 and CD45RA as an indicator of differentiation status.  Cells expressing both CD27 
(CD27hi) and CD45RA are phenotypically and functionally equivalent to naïve αβ T cells, 
while cells lacking CD27 expression become phenotypically and functionally equivalent to 
effector αβ T cells.  Finally, in Vδ1+ cells lacking expression of CD27 but also expressing 
CD45RA, the high cytotoxicity and phenotype of terminally differentiated (TEMRA) αβ T 
cells was noted (Davey et al., 2017).  While this paradigm has also been demonstrated for 
αβ T cells, higher expression of CCR7 and CD28 in αβ T cells has led most studies of these 
cells to use these as typical surface markers of naivety in combination with either CD45RA 
or CD45RO.  Historically, the picture has been muddied for gamma delta T cell research 
by the lack of distinction between Vδ1+ and Vδ2+ cells, as Vδ2+ cells do not appear to 
conform to this differentiation pathway in quite as distinct a way as Vδ1+ cells (DeBarros 
et al., 2011). 
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Figure 5.3:  Blood has a higher frequency of phenotypically naïve Vδ1+ cells than matched liver 
a) Representative flow cytometry plots of CD27 expression by Vδ1+ gamma delta T cells, 
showing CD27hi, int and lo populations in blood and matched donor liver 
b) Comparison of CD27, CD62L and CCR7 expression for blood and liver derived Vδ1+ T cells 
and CD8+ T cells.  Histograms from one representative donor 
c) CD27hi Vδ1+ cells in blood and matched liver with mean + s.e.m., n=9, p=0.008, Wilcoxon 
test 
d) CD62L+CCR7+ Vδ1+ cells in blood and matched liver with mean + s.e.m., n=9, p=0.004, 
Wilcoxon test 
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As with CD27 expression, CD45RA expression seemed to categorise three sub-
populations; CD45RA+, CD45RAint and CD45RAneg (Figure 5.4a).  For the rest of this study, 
cells both negative and intermediate for CD27 expression will be termed CD27lo/neg and 
cells negative and intermediate for CD45RA expression will be termed CD45RAlo/neg.  The 
majority of Vδ1+ T cells in both blood and liver were CD27lo/neg and also CD45RA+, and 
therefore by αβ T cell convention would be classified as TEMRA (77.0% ± 7.2% in blood, 
73.1% ± 5.7% in liver, p=0.65) (Figure 5.4b and Figure 5.4c).  This is in contrast to CD8+ αβ 
T cells, where the largest subset in liver was CD27lo/negCD45RAlo/neg TEM-like (51.7% ± 
3.4%), a subset significantly enriched compared with matched blood, where they 
comprised only 11.8% ± 4.3% (p=0.03, Wilcoxon test) (Figure 5.4c).  As with Vδ1+ T cells, 
there was only a minor, statistically insignificant, change in the proportion of CD8+ 
CD27lo/negCD45RA+ cells between the periphery and liver (9.5% ± 3.0% vs. 16.5% ± 5.9%, 
p=0.44).  Interestingly, the CD27lo/negCD45RAlo/neg subset was also significantly enriched in 
Vδ1+  T cells despite not forming the majority population, going from 3.58% ± 1.1% of 
PBMC-derived Vδ1+ T cells to 21.3% ± 5.0% in liver (p=0.004, Wilcoxon test) (Figure 5.4c), 
and has been demonstrated to comprise tissue-resident CD8+ T cells in previous studies of 
the liver (Pallett et al., 2017). 
To summarise, peripheral blood Vδ1+ gamma delta T cells contain a proportion of CD27hi 
cells that are not present in the liver, while both compartments exhibit a dominant 
proportion of Vδ1+ cells with a CD27lo/negCD45RA+ phenotype.  However, the liver Vδ1+ 
population also contains a phenotypically distinct CD27lo/negCD45RAlo/neg population that 
is not observed in the periphery. 
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Figure 5.4:  Liver has a higher frequency of TEM-like Vδ1
+ and CD8+ cells compared with the 
periphery 
a) Representative flow cytometry plots of CD45RA expression by Vδ1+ gamma delta T cells, 
showing CD45RAhi, int and lo populations in liver 
b) Representative flow cytometry plots gated on Vδ1+ showing typical distribution of CD27 
and CD45RA expression in cells  isolated from matched blood and liver from two donors 
c) Frequency of CD27hi, CD27lo/negCD45RAlo/neg and CD27lo/negCD45RA+ populations as a 
proportion of total Vδ1+ (left) and CD8+ (right) cells from blood and donor matched livers, 
with s.e.m. (2 NASH, 2 ALD, 2 PSC, 2 non-inflammatory) 
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5.2.3 The relationship between differentiation and clonality in donor 
matched blood and liver Vδ1+ T cells. 
 
Having established the loss of a phenotypically naïve population between transition from 
the periphery into liver tissue and the formation of a minor but significantly enriched 
CD27lo/negCD45RAlo/neg population in intrahepatic Vδ1+ T cells, we wanted to explore how 
the high degree of clonal focussing observed in Chapter 4 mapped onto these 
phenotypically distinct populations.  To do this, single cell polymerase chain reaction (sc-
PCR) techniques were used on individual cells sorted from blood and liver-derived Vδ1+ T 
cells, using primers specific to both delta- and gamma-chains to sequence the complete 
CDR3 region of the TCR expressed by each cell.  Although the number of cells analysed 
using this method is orders of magnitude lower than the deep sequencing approach 
adopted in Chapter 4, it had the advantage of being considerably cheaper, performed in-
house and is able to generate complete CDR3 sequences including both gamma- and 
delta-chains of the TCR, important for both stringent identification of clonality and also 
potentially useful in future ligand identification processes.  In addition, the data from the 
deep-sequencing suggested that the dominant clonotypes would be frequent enough to 
be identified in even a small number of sampled cells, allowing identification of dominant 
clonotypes common to both liver and blood, should they be present.  The key research 
advantage of the sc-PCR technique however was the ability to link the TCR sequence with 
phenotype by index sorting. 
To ensure that sampling as few as 30 Vδ1+cells would allow identification of clonal 
expansions, cells were sorted initially from a normal liver donor.  Critical to this technique 
was index sorting, that is, using conjugated antibody staining to not only define the cell 
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population of interest for sorting purposes but to also to phenotype relevant surface 
markers that could later be used to identify distinct sub-populations of the sorted cells.  
In this case, sorted cells were indexed with CD27 and CD45RA specific antibodies, 
allowing correlation of differentiation phenotype with TCR clonotype.  Figure 5.5 shows 
the results of this experiment, including the phenotypic differentiation of the bulk 
population of Vδ1+ cells in this sample.  As observed in the matched liver and blood 
samples, there was very little expression of CD27, with approximately equal distribution 
of cells between the CD45RA+ and CD45RAlo/neg populations.  There were a total of four 
clonotypes identified from the 30 cells sequenced, representative of a strikingly focussed 
repertoire, and critically both the CD45RA+ and CD45RAlo/neg compartments were almost 
completely monoclonal and clonotypically distinct.  This was consistent with previous 
deep sequencing data that demonstrated strong clonal focussing in the liver (Chapter 4). 
When this pilot study was extended to the matched blood and liver samples, both the 
CD27lo/negCD45RA+ and CD27lo/negCD45RAlo/neg compartments predominantly consisted of 
expanded clonotypes – that is, clonotypes exhibited by more than one cell within the 
same sample (68.5% ± 6.4% and 56.9% ± 9.2% respectively) (Figure 5.6a).  Considering the 
relatively small sample sizes (between 10 and 36 cells per compartment per sample) the 
degree of clonality exhibited here is striking.  Within the blood derived cells, the 
CD45RA+ subset was equally as clonally dominated as the liver, 75.4% ± 5.8% of cells 
sharing CDR3 sequence with at least one other cell, while the CD27hi subset, not present 
within the liver, had only 5.7% ± 2.6% of cells sharing CDR3 regions, suggestive of a 
distinctly more polyclonal nature (Figure 5.6b). 
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Figure 5.5:  Highly focused clonal expansions in liver 0802 revealed by sc-PCR 
Donor liver 0802 was index sorted for single cell PCR analysis of TCR sequences.  Distribution of 
bulk Vδ1+ cells according to surface expression of CD27 and CD45RA is shown (upper).  Identified 
clonotypes were grouped according to classification as CD27lo/negCD45RAlo/neg (orange), 
CD27lo/negCD45RA+ (grey) (lower) or total Vδ1+. CDR3 sequence for each TCRδ clonotype 
determined is shown below with γ-chain pairing. 
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Figure 5.6:  A high degree of clonal focussing is present in all CD27lo/negCD45RAlo/neg and 
CD27lo/negCD45RA+ Vδ1+ populations 
a) Intrahepatic Vδ1+ T cells were single cell sorted and TCR sequenced by PCR.  Clonotypes 
were phenotyped by indexing of the sort and the proportion of the total cell number 
within that phenotype that share specific CDR3δ with other cells is plotted here, with 
mean and s.e.m. (n=8) 
b) Peripheral blood Vδ1+ T cells were single cell sorted and TCR sequenced by PCR.  
Clonotypes were phenotyped by indexing of the sort and the proportion of the total cell 
number within that phenotype that share specific CDR3δ with other cells is plotted here, 
with mean and s.e.m. (n=8, ***p<0.001, Wilcoxon test) 
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Next, the degree of clonal overlap between liver and blood was assessed.   The samples 
analysed contained a varying degree of clonotypic sharing between blood and liver.  In 
blood, across all the samples, an average of 57.6% ± 11.0% of cells analysed had identical 
TCR CDR3 also present in the liver (Figure 5.7).  In liver, 39.1% ± 11.0% of cells analysed 
had identical TCR CDR3 also present in the blood.  While not statistically significant 
(p=0.26), likely due to the high degree of variation between samples, the reduction of 
overlapping clonotypes present in the liver is perhaps suggestive of the presence of a 
tissue associated CDR3 repertoire, at least in some individuals.  Within the cohort, 23.4% 
of all liver-derived Vδ1+ cells expressed a TCR not also represented in the blood derived 
sample whilst simultaneously represented by more than one cell within the liver (Figure 
5.7), although it is important to note that 2 of the 8 samples actually had no liver-specific 
clonal populations.  This compares to the blood where unique expanded clonotypes 
comprised only 12.4% of the cells sequenced across all samples, where no blood-specific 
clonal expansions were detected in 3 of the 8 samples.  In both liver and blood, around 
30% of all the cells sequenced had single copy CDR3s not observed in any other cell 
(individual clonotypes), which could represent CD27hi naïve clonotypes in blood or may 
merely reflect the low resolution of the sc-PCR technique in identifying low frequency 
expanded clonotypes in the liver. 
As well as demonstrating the high degree of oligoclonality amongst both 
CD27lo/negCD45RAlo/neg and CD27lo/negCD45RA+ subsets of intrahepatic Vδ1+ T cells, the 
pilot sc-PCR study (Figure 5.5) suggested another intriguing possibility.  Not only was the  
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Figure 5.7:  A high degree of clonal overlap between blood and liver Vδ1+ cells 
 
Analysis of clonality in blood and matched donor liver by sc-PCR.  Each cell was assigned one of 
three categories depending on whether they expressed an individual clonotype not expressed by 
any other cell (dark grey), expressed a clonotype shared only by other cells within that tissue 
(light grey) or expressed clonotypes shared by other cells in both tissues (white). n=8 with mean 
and s.e.m. 
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CD45RAlo/neg population monoclonal in the normal liver sample analysed, it consisted of 
an entirely distinct clonotype from the CD45RA+ cells (δ-chain CDR3 –
CALGASLPSLILGAIQKRFYTDKLIF vs. CALGELYLPPNSNILFFLPLGDDTDKLIF).  Of note here is 
the very long CDR3 sequence (78 and 87 base pairs respectively) which is in concordance 
with the overall long delta-chain CDR3 regions identified amongst this population in 
Chapter 4.  This represents the first suggestion from this study that γδ TCR clonotype and 
cell differentiation, at least on a phenotypic level, may be linked for tissue associated 
Vδ1+ cells.  In addition, it is possible that this CD45RAlo/neg population may be liver-
specific, since although blood was not obtained from this individual, from analysis of the 
matched samples it is clear that the CD45RAlo/neg population is very small or entirely 
absent in peripheral blood. 
Interestingly, when the percentage of all liver-restricted Vδ1+ clonotypes (cells sharing 
CDR3 regions with at least one other cell in only the liver) was plotted against the 
proportion of cells from the sample with the CD27lo/negCD45RAlo/neg phenotype, a strong 
correlation was noted (R2=0.71, p=0.008 Pearson correlation) (Figure 5.8a).  Conversely, 
when the percentage of liver derived Vδ1+ cells with CDR3 regions found in both blood 
and liver was plotted against the proportion of cells from the sample with the 
CD27lo/negCD45RA+ phenotype, a significant correlation was also noted (R2=0.53, p=0.04 
Pearson correlation) (Figure 5.8b).  This suggests that the greater the number of cells 
present in the blood-dominant CD45RA+ group, the more overlap there was between 
clonotypes in blood and liver, and the greater the number of cells in the liver-enriched 
CD45RAlo/neg group, the greater the number of liver-specific clonal expansions. 
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Figure 5.8:  Correlations between clonality and phenotype in matched blood and liver Vδ1+ cells 
 
a) Proportion of intrahepatic CD27lo/negCD45RA+ Vδ1+ T cells plotted as a function of the 
percentage of cells with CDR3δ sequences found in both liver and blood for each sample, 
n=8, Pearson correlation 
b) Proportion of intrahepatic CD27lo/negCD45RAlo/neg Vδ1+ T cells plotted as a function of the 
percentage of cells with CDR3δ sequences found at least twice but only in the liver for 
each sample, n=8, Pearson correlation 
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To determine whether the liver enriched, clonally dominated CD45RAlo/neg populations of 
intrahepatic Vδ1+ cells were indeed liver specific, the indexed cell sorting data was used 
in conjunction with the CDR3 sequences determined by sc-PCR.  Since the well number of 
each cell in the PCR was tracked, the position of each cell, and therefore each clonotype, 
during sorting could be determined on the flow cytometry dot plot, specifically in regards 
to its expression of CD27 and CD45RA.  This way, all the cells with the same clonotype, or 
with clonotypes found in both blood and liver could be assigned a phenotypic 
differentiation status.  An example of such plots is shown in Figure 5.9. 
The left hand side of each plot shows the CD27 vs CD45RA dot plot for both the blood 
and liver derived cells sorted for sc-PCR TCR sequencing.  As previously observed, the 
blood derived Vδ1+ cells are predominantly CD45RA+ in both samples, with a minority of 
cells falling into the CD27hi gate.  In the liver, the CD45RAlo/neg population is enriched.  The 
CD27 vs CD45RA dot plot of cells with only the most frequent clonotype observed in both 
blood and liver is displayed in the middle panels.  Here, the CD27hi population has 
virtually disappeared, as expected since this is likely predominantly polyclonal in nature 
and there are unlikely to be expanded clonotypes with this phenotype considering the 
small number of cells sampled.  Strikingly however, the phenotype of these cells is very 
similar in both blood and liver, localising within the CD45RA+ TEMRA population.  However, 
when only the dots representing the liver-specific clonally expanded cells (i.e. liver-
derived cells sharing a CDR3 region with at least one other cell and not with a cell found 
in the blood) were plotted, they almost uniformly cluster in the CD27lo/negCD45RAlo/neg 
TEM-like population.  These data are summarised as a multi-layer pie chart for multiple 
donors in Figure 5.10a. 
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Figure 5.9:  Single cell index sorting of blood and donor matched liver Vδ1+ T cells 
Representative flow cytometry plots showing distribution of Vδ1+ T cells single cell sorted and TCR 
sequenced by sc-PCR according to expression of CD27 and CD45RA from two donors.  Left hand 
panels show total Vδ1+ population, middle panels show only largest expanded clonotype 
observed in both blood and liver, right hand panel shows all expanded clonotypes identified in 
liver only. 
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Figure 5.10:  Clonotypic expansions, phenotype and extent of sharing in blood and matched 
liver Vδ1+ cells 
a) Inner pies display extent of clonotypic expansion (size of slice) and extent of sharing 
amongst expanded clonotypes – expansions identified in both liver and blood (red), only in 
blood (blue) and only in liver (black).  Single clonotypes are shaded in light grey.  Outer 
pies display phenotype of corresponding cells, according to CD27 and CD45RA expression.  
Data shows 4 donors of 8 in total. 
b) The proportion of all cells with identical CDR3δ found in both blood and liver (left) and 
only in liver (right) as a percentage of all cells of CD45RAlo/neg or CD45RA+ phenotype, mean 
+ s.e.m. (n=8) 
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The same pattern of large clonal expansions either unique to blood or shared between 
blood and liver being CD27lo/negCD45RA+ while clonal expansions unique to liver are 
CD27lo/negCD45RAlo/neg is observed across all the donors analysed in this study.   94.0% ± 
3.1% of all the cells sampled with shared clonotypes were CD27lo/negCD45RA+, while 
81.9% ± 13.8% of all cells sampled with liver-specific expansions were 
CD27lo/negCD45RAlo/neg (Figure 5.10b).  This is compelling evidence that the liver harbours 
a clonally-distinct CD27lo/negCD45RAlo/neg TEM-like population of Vδ1
+ T cells, and that 
there is considerable enrichment of blood-associated CD27lo/negCD45RA+ TEMRA-like 
clonally expanded cells also present within this tissue. 
5.2.4 Clonally distinct Vδ1+ cells exhibit a liver-associated or a vasculature-
associated immunophenotype 
 
Considerable research efforts have been conducted on the nature and significance of 
tissue resident cells in many human tissues including the liver.  Based on findings from 
murine studies and lacking similar model systems in humans, many of the studies 
conducted in humans have used surface markers such as CD69 as surrogates of tissue-
association and/or residency.  Often this has been performed successfully, particularly in 
studies with associated transcriptomic analysis that allow in-depth characterisation of 
tissue-associated phenotype.  Having identified, via TCR sequencing, a likely population of 
tissue-restricted Vδ1+ T cells in human liver and ascribed a general CD27lo/negCD45RAlo/neg 
differentiation phenotype to these cells, further characterisation would allow comparison 
of these cells with previous non-gamma delta T cell datasets to see how they relate to the 
emerging paradigms of human tissue resident lymphocytes. 
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To begin, expression of CD69 a protein intrinsically linked with human lymphocyte 
residency in tissues, was determined.  CD69 expression in general was relatively high 
amongst liver-derived Vδ1+ cells (mean 60.7%), and significantly increased compared with 
the periphery in matched donors (n=10, p<0.0001, 2-way ANOVA) (Figure 5.11a).  Since 
the liver-associated Vδ1+ clonotypes often adopted a CD27lo/negCD45RAlo/neg phenotype, 
the expression of CD69 was determined as a function of CD45RA expression, here gated 
on intrahepatic CD27lo/neg cells (Figure 5.11b).  For the CD45RAlo/neg Vδ1+ cells, 90.0% ± 
4.6% expressed CD69, while for CD45RA+ cells this figure dropped significantly to 47.2% ± 
8.1% (p=0.007).  Similar results were obtained for the intrahepatic CD8+ αβ T cell 
population where CD69 expression in TEM CD8
+ cells has been demonstrated to be a 
characteristic of liver residency in humans.  Since there was a high degree of clonal 
overlap between liver and blood derived cells with the CD45RA+ phenotypes, it is possible 
that this may represent genuine blood-associated cells (CD69neg) and another population 
of cells that may have been transiently activated by local factors within the liver and 
upregulated CD69 accordingly.  To investigate this further, index sorting was again used 
in conjunction with sc-PCR TCR sequencing.  In several samples, CD69 expression was 
high on cells also expressing expanded liver-specific clonotypes, while CD69 expression 
was predominantly low or negative on expanded clonotypes shared between liver and 
blood (Figure 5.12).  Due to cell sampling and methodological restraints, potentially 
corroborative observations from enough donors to prove the hypothesis were not 
obtained.  Nevertheless, these data provide a clear link between TCR clonotype, 
differentiation status and the tissue association marker CD69. 
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Figure 5.11:  Tissue-association cell marker expression in intrahepatic T cells 
a) Mean ± s.e.m. surface expression of tissue-association marker CD69 on intrahepatic (red) 
and matched donor peripheral blood (black) T cell subsets (n=10, 
**p<0.01,****p<0.0001, 2-way ANOVA) 
b) Representative histogram of CD69 expression according to co-expression CD45RA (left).  
Mean ± s.e.m. expression of CD69 on intrahepatic Vδ1+ and CD8+ αβ T cells according to 
co-expression of CD45RA (n=8, **p<0.01, ***p<0.001, 1-way ANOVA, Dunn’s 
comparison) (right) 
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Figure 5.12: Vδ1+ liver specific clonotypes are CD69hi 
Representative flow cytometry dot plot from single cell sorting of one donor showing CD69 
expression of expanded clonotypes found only in liver (left) and expanded clonotypes found in 
both liver and blood (right), highlighted in red as most cells appear on the x-axis. 
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In Chapter 3, surface expression of LFA-1 and CD31, was shown to be constitutively 
elevated in both circulating and intrahepatic Vδ1+ T cells compared with αβ T cells, and it 
was hypothesised that these proteins may be involved in the increased adhesion of 
gamma delta T cells to HSEC in vitro compared with αβ T cells.  However, as well as CD69, 
several other surface proteins involved with cell trafficking have been established to be 
involved in the tissue resident phenotype of lymphocytes.    Surface expression of CXCR3, 
CXCR6 and CX3CR1 was quantified according to CD45RA co-expression by flow cytometry 
(Figure 5.13).  CXCR3 expression was significantly elevated in both Vδ1+ and CD8+ αβ 
CD45RAlo/neg T cells compared with CD45RA+ cells - Vδ1; 87.2% ± 4.0% vs. 29.5% ± 4.8% 
(p=0.007): CD8; 67.0% ± 9.2% vs. 28.0% ± 4.4% (p=0.009).  CXCR6 expression was likewise 
elevated in the CD45RAlo/neg population in both Vδ1+ and CD8+ αβ T cells – Vδ1; 63.8% ± 
9.3% vs. 18.3% ± 8.2% (p=0.009): CD8; 55.2% ± 5.9% vs 18.1% ± 3.2% (p=0.002).  CX3CR1 is 
the receptor for fractalkine, a chemokine secreted by endothelial cells that mediates 
adhesion and migration of lymphocytes.  The significance of CX3CR1 expression in human 
chronic virus-specific TEMRA cells has recently come under scrutiny in CD8
+ (Bottcher et al., 
2015) and CD4+ (Pachnio et al., 2016) populations, where it is linked with endothelial 
homing and vasculature residency (Remmerswaal et al., 2012).  Here, it is the 
CD45RA+ population of both Vδ1+ and CD8+ αβ T cells that expresses higher CX3CR1, 
compared with the CD45RAlo/neg cells – Vδ1; 58.6% ± 8.0% vs. 18.5% ± 6.0% (p=0.009):  
CD8; 65.5% ± 8.7% vs. 12.3% ± 7.4% (p=0.002).  Low affinity immunoglobulin gamma Fc 
region receptor III-A (FcγRIIIA/ CD16) is critical for monocyte and NK cell mediated 
antibody dependent cell-mediated cytotoxicity (ADCC) as it binds the Fc portion of IgG 
antibodies.  Upregulation of CD16 has been associated with adoption of a cytotoxic 
phenotype in human NK cells (Lanier et al., 1986), while low CD16 expression is  
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Figure 5.13:  Chemokine receptor expression in intrahepatic Vδ1+ T cells is associated with 
differentiation status 
Comparison of CXCR3, CXCR6 and CX3CR1 surface expression within Vδ1
+ and CD8+ CD45RAlo/neg 
(orange) and CD45RA+ (grey) T cells. Histograms from one representative donor and graphs show 
mean ± s.e.m. from 6 different donors. Data analysed by Kruskal–Wallis ANOVA with Dunn’s post-
test comparisons, *p<0.05, **p<0.01 and ***p<0.001. 
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attributed with poor cytotoxicity and high cytokine production in CD8 αβ T cells 
(Bjorkstrom et al., 2008).  The same pattern of high CD16 expression has been observed 
in CD8+ “innate-like” lymphocytes (Barbarin et al., 2017).  Comparison of CD16 expression 
between the CD45RAlo and CD45RA+ Vδ1+ T cells demonstrated a significant increase in 
surface expression of this protein in the CD45RA+ population, from 21.5% ± 7.2% to 67.4% 
± 9.4% (n=6, p=0.012 Kruskal-Wallis ANOVA) (Figure 5.14a), which was also reflected in 
the CD8+ αβ T cell population. 
Certain transcription factors have been implicated in the differentiation and effector 
function of T cells.  T-box expressed in T cells (Tbet) has been demonstrated to direct 
naïve T cells toward theTH1, classically anti-viral, subset (Szabo et al., 2000) and is 
important in regulating the function of cytotoxic lymphocytes including NK cells and 
gamma delta T cells.  Eomesodermin (Eomes) is important to the maintenance of CD8 T 
cell effector function, particularly in virus-specific cells (Simonetta et al., 2014), and these 
two transcription factors have a high degree of functional overlap in co-ordinating T cell 
development.  Blimp-1 has been demonstrated to effect cytotoxic development of CD8+ T 
cells (Kallies et al., 2009, Xin et al., 2016), and in conjunction with homologue of Blimp-1 
in T cells (Hobit) has been implicated in formation of quiescent effector T and NK cell 
populations in tissues, including the liver (Vieira Braga et al., 2015, Stelma et al., 2017).  
Analysis of Tbet, Eomes and Hobit in the CD45RAlo/neg intrahepatic Vδ1+ T cell groups 
highlighted generally low expression of these transcription factors, with a trend toward 
an increase in expression in the CD45RA+ population (Figure 5.14b).  This is consistent 
with the findings of Maini’s group in human liver of low expression of these transcription 
factors in the “liver-resident” CD8+ αβ T cell populations (Pallett et al., 2017). 
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Figure 5.14:  CD16 and transcription factor expression in intrahepatic Vδ1+ T cells is associated 
with differentiation status 
a)  CD16 surface expression within Vδ1+ and CD8+ CD45RAlo/neg (orange) and CD45RA+ (grey) 
T cells. Histograms from one representative donor and graphs show mean ± s.e.m. from 6 
different donors. Data analysed by Kruskal–Wallis ANOVA with Dunn’s post-test 
comparisons, *p<0.05. 
b) Intracellular transcription factor expression within Vδ1+ and CD8+ CD45RAlo/neg (orange) 
and CD45RA+ (grey) T cells. Histograms from one representative donor and graphs show 
mean ± s.e.m. from 2-4 different donors. Data analysed by Kruskal–Wallis ANOVA with 
Dunn’s post-test comparisons, p>0.05. 
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These distinct patterns of chemokine receptor and transcription factor use between the 
CD45RA+ and CD45RAlo/neg populations is consistent with previous findings for tissue 
resident CD8+ T cells in the liver and other tissues. 
5.2.5 The function of liver-associated and vasculature-associated 
intrahepatic Vδ1+ T cells 
 
Having established a clonal and phenotypic difference between CD45RA+ and 
CD45RAlo/neg populations of intrahepatic Vδ1+ T cells, functional responses of these cells 
was investigated.  Firstly, T cells were isolated from explanted livers and after magnetic 
sorting were cultured for 72 hours in cell media with various stimuli, including 
recombinant cytokines and TCR-stimulating αCD3/ CD28 beads.  Since the majority of 
these cells expressed CD69 ex vivo, while CD25 was generally poorly expressed, CD25 was 
selected as an activation marker that could be simply analysed via flow cytometry.  
Initially, Vδ1, Vδ2 and CD8+ αβ T cells were analysed in bulk to investigate general 
responses to the stimulation conditions and activation compared with the same subsets 
in non-matched blood-derived cells, where CD69 and CD54 upregulation was measured 
(Figure 5.15).  For blood derived cells, all three subsets responded strongly to TCR 
stimulation via αCD3/ CD28 beads (Vδ1; 77.4% ± 3.2%: Vδ2; 81.6% ± 7.8%: CD8+; 74.9% ± 
4.8%), with varying responses to IL-15 stimulation (Vδ1; 36.6% ± 8.4%: Vδ2; 80.5% ± 4.2%; 
CD8+; 20.0% ± 4.9%).  Interestingly, the only subset to respond strongly to combined 
stimulation with IL-12 and IL-18 was the Vδ2+ gamma delta T cells, (66.6% ± 7.1%), while 
Vδ1+ cells and CD8+ αβ cells did not (8.8% ± 2.0% and 9.1% ± 2.7% respectively).   In the 
liver, the general pattern of responsivity changed, most significantly for the Vδ1+ and 
CD8+ subsets, although this may have been a reflection of the difference in read-out for 
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Figure 5.15:  Activation of intrahepatic and peripheral T cells by exogenous stimulation 
Peripheral and intrahepatic magnetically sorted CD3+ T cells from non-matched donors were 
incubated for 72 hours with cytokines or anti-CD3/CD28 beads. Vδ1+, CD8+ αβ and Vδ2+ T cells 
were then assessed for the upregulation of CD69 and CD54 (blood) or CD25 (liver). Histograms 
from one representative donor and graphs show mean ± s.e.m. for media control, CD3/CD28, IL-
12/IL-18, IL-15 and IL-7 stimulation (liver only) (n=6-9). 
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the assay between the two compartments.  Cell activation by αCD3/ CD28 beads was 
significantly reduced overall for intrahepatic Vδ1+ cells compared with blood Vδ1+ cells, 
to 53.7% ± 11.7% (p=0.035), but there was no significant change in the response of 
CD8+ cells (70.8% ± 11.1%) or Vδ2+ cells (78.1% ± 8.0%).  Response to both IL-15 and IL-
12/IL-18 stimulation increased significantly in liver-derived Vδ1+ T cells.  61.1% ± 8.0% of 
Vδ1+ cells upregulated CD25 post incubation with IL-15 (p=0.025 compared with blood), 
while 41.2% ± 8.8% were activated after incubation with IL-12 and IL-18 (p=0.008 
compared with blood). The same findings were observed for the CD8+ T cells, where 
55.4% ± 7.5% of cells were activated by IL-15, while 38.2% ± 4.2% were activated by IL-
12/IL-18.  Intrahepatic Vδ2+ cells displayed an equally vigorous response to blood-derived 
cells under both stimulatory conditions (IL-15; 83.9% ± 3.8%: IL-12/IL-18; 69.7% ± 7.8%). 
Since phenotyping using putative differentiation markers had previously determined a 
reduction in liver-associated CD27hi Vδ1+ cells and a substantial increase, from virtually 
zero, of CD45RAlo/neg Vδ1+ cells compared with peripheral blood, it is possible to speculate 
that the changes in response to activatory stimuli may be linked with these changes in 
differentiation.  IL-15 has been demonstrated to be involved in the homeostatic 
maintenance of effector T cells, accompanied by increased expression of the IL-15R in 
effector CD8+ T cells (Geginat et al., 2003).  Therefore increased response to this cytokine 
may simply reflect a greater proportion of effector cells within the liver-infiltrating 
population compared with blood.  However, while the same may be possible for IL-12 and 
IL-18 responsivity, the blood exhibits a very weak response to these cytokines and yet has 
a large proportion of Vδ1+ cells that are CD27lo/neg (Davey et al., 2017).  Therefore, the 
response of Vδ1+ cells to IL-12 and IL-18 was assessed in conjunction with their expression 
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of CD45RA.  Since a decrease in TCR-mediated activation was also detected, the same 
was done with αCD3/ CD28 beads as a stimulus (Figure 5.16). 
No significant difference for stimulation with αCD3/ CD28 beads was detected, with an 
average of 52.8% ± 14.0% of CD45RAlo/neg Vδ1+ cells activated, compared with 60.2% ± 
13.5% of CD45RA+ cells.  The same was true for CD8+ T cells, with 70.0% ± 11.5% of 
CD45RAlo/neg cells activating and 62.1% ± 14.2% of CD45RA+ cells.  Interestingly, however, 
for Vδ1+ T cells a significant increase in response to exogenous IL-12 and IL-18 was noted 
between CD45RA+ and CD45RAlo/neg populations, rising from 34.9% ± 6.55 to 73.4% ± 5.1% 
(p=0.004, Mann-Whitney U test).  Although there was also a rise in activation between 
CD45RA+ and CD45RAlo/neg CD8+ populations (27.3% ± 9.3% to 51.8% ± 9.3%, p=0.18, 
Mann-Whitney U test) this was not statistically significant.  These data is highly suggestive 
of increased IL-12 and IL-18 response in the clonally and phenotypically distinct 
CD45RAlo/neg liver-associated Vδ1+ cells.  
Lastly, the cytotoxic potential and cytokine production of intrahepatic Vδ1+ cells was 
assessed with respect to their differentiation status.  Perforin and granzyme B are two 
proteins expressed by cytotoxic killer cells capable of lysing other cells.  Intracellular 
expression of these proteins was therefore analysed using flow cytometry (Figure 5.17).  
For granzyme B, an average of 14.4% ± 3.0% of Vδ1+ CD45RAlo cells were positive for 
expression, significantly decreased from the CD45RA+ cells (50.9% ± 6.9%, p=0.002).  This 
reflected the data for CD8+ αβ T cells, where 22.6% ± 7.4% of CD45RAlo cells expressed 
Granzyme B, compared with 64.7% ± 7.1% of CD45RA+ cells (p=0.01).  A similar pattern 
was observed with perforin expression, with CD45RA+ cells exhibiting higher expression 
for both Vδ1+ and CD8+ αβ cells (Vδ1+ CD45RAlo 23.6% ± 4.2% vs. CD45RA+ 66.0% ± 5.4%: 
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Figure 5.16:  CD45RAlo/neg intrahepatic Vδ1+ T cells are responsive to exogenous IL-12 & IL-18 
cytokines 
Intrahepatic magnetically sorted CD3+ T cells from non-matched donors were incubated for 72 
hours with cytokines or anti-CD3/CD28 beads. Vδ1+ T cells were then assessed for the 
upregulation of CD25 as a function of CD45RA expression.  Histograms from one representative 
donor and graphs show mean ± s.e.m. for media control, CD3/CD28, IL-12/IL-18, IL-15 and IL-7 
stimulation (n=5).  Data analysed by Mann-Whitney U test, *p<0.05. 
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Figure 5.17:  CD45RAlo/neg intrahepatic Vδ1+ and CD8 T cells are have less cytotoxic potential 
than CD45RA+ cells 
Comparison of intracellular granzyme B and perforin expression within Vδ1+ and CD8+ 
CD45RAlo/neg (orange) and CD45RA+ (grey) T cells. Histograms from one representative donor and 
graphs show mean ± s.e.m. from 5-6 different donors. Data analysed by Kruskal–Wallis ANOVA 
with Dunn’s post-test comparisons, *p<0.05, **p<0.01. 
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CD8+ CD45RAlo 15.5% ± 7.3% vs. CD45RA+ 49.8% ± 11.8%).  This suggests the blood-
associated CD45RA+ Vδ1+ cells may have higher cytotoxic potential, which is consistent 
with previous findings in peripheral blood (Davey et al., 2017), but that the liver-
associated CD45RAlo cells have relatively lower cytotoxic potential. 
To assess cytokine production, ex vivo magnetically labelled T cells were sorted and 
cultured overnight before addition of PMA and ionomycin with brefeldin-A to inhibit 
Golgi transport and secretion.  The proinflammatory cytokines interferon-γ (IFN-γ) and 
tumour necrosis factor α (TNFα) were then detected intracellularly by flow cytometry, 
once again with respect to CD45RA expression (Figure 5.18).  For Vδ1+ cells, IFN-γ 
expression was marginally higher overall than TNFα, but expression of both cytokines was 
significantly higher in the CD45RAlo population than the CD45RA+ (IFN-γ; 71.8% ± 9.0% vs. 
37.5% ± 3.5% (p=0.026): TNFα; 64.1% ± 7.1% vs. 34.2% ± 5.2% (p=0.015)).  Cytokine 
expression among the CD8+ cells was consistently around 70% of all cells, regardless of 
phenotype.   IFN-γ was expressed by 74.1% ± 6.3% and 74.3% ± 5.2% of CD45RAlo and 
CD45RA+ cells respectively, while TNFα was expressed by 64.5% ± 8.4% and 72.6% ± 8.1% 
of CD45RAlo and CD45RA+ cells respectively, with no significant difference between sub-
populations. 
Overall, these data suggests that a significant population of clonotypically, phenotypically 
and functionally distinct Vδ1+ T cells exists in human liver that are phenotypically and 
functionally similar to the CD8+ αβ T cells that have previously been described as liver 
resident. 
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Figure 5.18:  CD45RAlo/neg intrahepatic Vδ1+ T cells are higher producers of inflammatory 
cytokines than CD45RA+ cells 
Intrahepatic magnetically sorted CD3+ T cells were stimulated for 4 hours with PMA, ionomycin 
and brefeldin-A.  Vδ1+ T cells were then assessed for the upregulation of intracellular IFN-γ and 
TNFα as a function of CD45RA expression.  Histograms from one representative donor and graphs 
show mean ± s.e.m. (n=5-6).  Data analysed by Kruskal–Wallis ANOVA with Dunn’s post-test 
comparisons, *p<0.05. 
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5.3 Discussion 
 
Although a considerable amount of work has recently gone in to characterising murine 
and human tissue resident T cells, the nature of tissue-associated gamma delta T cells has 
remained unclear.  This is perhaps due to the fact that in mice, where the bulk of gamma 
delta T cell biology research has been conducted, the majority of these cells are 
programmed to track into specific tissues based on thymic TCR recognition, where they 
adopt a generally innate-like function.  In Chapter 4, the TCR repertoire of human 
intrahepatic gamma deltas was found to be highly variable between individuals, in terms 
of both CDR3 regions and chain usage, with highly private, apparently motif-free CDR3s 
and a diverse spectrum of chain usage and pairings, perhaps suggestive of an adaptive-
like repertoire formation.  This is somewhat at odds with the data from mouse studies 
that suggest most tissues in mice have a distinct, restricted chain usage and CDR3 lengths 
in their gamma delta T cell population, more reflective of an innate-like repertoire 
formation (Asarnow et al., 1989) and consistent with innate T cell populations such as 
MAITS (Lepore et al., 2014).  Since previous studies on canonically tissue-associated Vδ1 T 
cells were based exclusively on peripheral blood Vδ1 cells (Davey et al., 2017), 
understanding the immunobiology of solid tissue-associated Vδ1s, often assumed to be 
innate-like, is particularly important. 
Based on this, we wanted to investigate the nature of the human intrahepatic gamma 
delta T cell population and its relationship with the peripheral population, in an attempt 
to define whether or not these cells are indeed tissue associated and potentially resident.  
To do this, peripheral blood was sampled from patients undergoing liver transplant for 
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non-autoimmune chronic liver diseases.  These were chosen as data from this study and 
others has suggested that either autoimmune liver diseases, including AIH, PBC and PSC, 
or the treatment thereof, may induce perturbations of the peripheral gamma delta T cell 
populations.  With only one previous study of gamma delta T cells from matched blood 
and liver from human donors (Kenna et al., 2004), it was important to establish that the 
frequency of gamma delta subsets from these matched donors was consistent with 
previous observations from non-matched liver and blood, which was indeed the case.  
Both Vδ1+ and Vδ2negVδ1neg gamma delta T cells were enriched in liver, both as a 
proportion of the total CD3+ T cell number and of the total pan-γδ TCR+ number.  
Interestingly, Vδ2+ cells, classically associated with the periphery, were also mildly 
enriched in the liver compared with blood as a proportion of CD3+ T cells.  
Comparison of matched liver and blood samples indicated the differentiation status of 
the Vδ2neg T cell subset was distinct in each compartment. Strikingly, liver Vδ2neg T cells 
were uniformly CD27lo/neg, a phenotype previously linked to a clonally expanded effector 
subset present in peripheral blood, and essentially entirely lacked the CD27hi subset, even 
when such populations were relatively prevalent in matched blood.  Previously CD27hi 
Vδ1+ T cells in peripheral blood have been demonstrated as TCR-diverse and naïve in 
phenotype, possessing CCR7 and CD62L required for recirculation between blood and 
lymph.  Consistent with selective exclusion of this clonally diverse CD27hi naive 
population, liver Vδ1+ cells lacked CCR7, CD62L and CD27 present on such naïve 
populations.  Critically, substantial clonotypic overlap between these two populations 
was observed. While the possibility that such hepatic CD27lo/neg cells originated in the 
liver cannot be excluded, these results support the alternative concept that at least some 
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hepatic CD27lo/neg cells may derive from those present in peripheral blood.  Such a 
scenario would fit an adaptive model whereby naive peripheral blood Vδ2neg CD27hi cells, 
which express secondary lymphoid homing markers but are devoid of peripheral homing 
markers, recirculate between blood and lymph, whereas the peripheral blood CD27lo/neg 
population, which is clonally expanded and likely antigen-experienced, is capable of 
accessing solid tissues, consistent with its expression of peripheral homing markers such 
as CXCR6 and constitutive expression of integrins such as LFA-1 and VLA-4. 
A second indication of compartmentalisation was that in addition to being devoid of 
CD27hi naïve cells, the hepatic Vδ2neg T cell compartment comprised both CD45RA+ and 
CD45RAlo/neg subsets. By contrast, the peripheral blood CD27lo/neg Vδ1+ cells are almost 
entirely CD45RA+. Importantly, single cell PCR and phenotyping of paired blood and liver 
samples revealed a striking degree of overlap in CD45RA+ clonotypes between blood and 
liver. Such cells in the periphery express a high level of the endothelial homing receptor 
CX3CR1 (fractalkine receptor) as well as increased CD16, low CD27/28, low CD127, and 
enhanced levels of adhesion molecules relative to naïve CD27hi cells (Davey et al., 2017).  
Studies conducted on cytomegalovirus (CMV)-infected individuals post kidney-transplant 
determined a CMV-specific expansion of Vδ2- TEMRA cells expressing high levels of CX3CR1 
and critically CD16 in the periphery (Couzi et al., 2015), however, other studies have 
confirmed the expansion of such a subset in the periphery of CMV- healthy donors also 
(Davey et al., 2017), and no commonality in TCR repertoire has yet been identified, so the 
antigenic origin of such clonal populations is unclear.  Unfortunately, the CMV status of 
the individuals sampled could not be obtained for liver donors for ethical reasons.  There 
was a wide variety in the proportion of the CD45RAlo/neg population in the liver – from less 
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than 5% of intrahepatic Vδ1+ cells to greater than 50%, and it is tempting to speculate 
that CMV+ individuals may have a lower proportion of CD45RAlo/neg cells than CMV-, 
perhaps due to the CMV-associated CX3CR1
+ TEMRA Vδ1
+ cells accumulating in the 
endothelium-rich sinusoids post-CMV related expansion.  Since fractalkine has been 
demonstrated to be expressed more highly by virally-infected liver cells (Kondo et al., 
2015) and other chronic liver diseases (Shimoda et al., 2010) one may also predict an 
increase in this subset in diseased livers compared with normal livers, but this was not 
the case in this study, suggesting fractalkine-mediated recruitment of TEMRA Vδ1
+ cells 
may not be the sole driving factor in their accumulation in the liver. 
Nevertheless, the concept of ‘vascular residency’, as has been suggested for αβ T cells 
exhibiting the CD27lo/negCD45RA+ CX3CR1
+ phenotype, is intriguing.  Demonstrated for 
virus-specific CD8+ (Remmerswaal et al., 2012) and CD4+ (Pachnio et al., 2016) T cell 
subsets, this is not a concept that has been associated with gamma delta T cells 
previously, but the data presented here does give weight to the idea.  The predominantly 
sinusoidal localisation of gamma delta T cells identified in Chapter 3 is consistent with this 
possibility, as is the striking level of clonal overlap between CD45RA+ cells in the blood 
and the liver, itself a large and complex network of endothelial vasculature.  Although the 
antigenic targets of such Vδ2neg subsets is unclear, the recent report that these include 
clonotypes expanding in response to CMV infection is consistent with a role of the 
unconventional T cell in response to chronic viral infection (Ravens et al., 2017).  
In contrast to CD45RA+ clonotypes and consistent with a reduced proportion of CD45RA+ 
Vδ1+ cells in liver compared to peripheral blood, the same analyses of matched 
blood/liver samples revealed CD45RAlo/neg clonotypes that were typically identified only 
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in the liver samples.  In addition, this liver CD45RAlo/neg compartment frequently 
contained highly clonal expansions.  These cells demonstrate striking phenotypic 
correlation with liver resident lymphocytes identified in previous studies, including 
enhanced expression of CD69, CXCR6 and CXCR3, which has been noted in liver resident 
NK populations (Hudspeth et al., 2016, Stegmann et al., 2016) and CD8+  αβ populations 
(Pallett et al., 2017, Stelma et al., 2017).   Additionally these cells had low expression of 
Tbet, Hobit and Eomes, in contrast with blood- and liver-derived naïve and TEMRA-like 
Vδ1+ cells.  Despite not expressing CD103, which is a defining element of epithelium-
resident CD8+ cells, CD69 expression was clearly high in the liver-associated Vδ1+ 
populations.  However, it was also upregulated in a smaller fraction of the TEMRA-like Vδ1
+ 
cells that were clonally identical to blood-derived cells.  Whether this was due to a 
systemic upregulation of lymphocytic CD69 due to the chronic liver injury, reflective of 
local transient activation by liver-specific factors or whether some of these clonotypes 
shared with blood were in fact resident in the liver, is unclear.  While Vδ1+ CD69 
upregulation was demonstrated for patients undergoing reactivation of AIH in Chapter 3, 
in the matched cohort peripheral CD69 expression was not high for the majority of 
donors.  Incubation of healthy PBMC-derived T cells in liver-derived supernatants did 
induce marked CD69 upregulation (data not shown) but the physiological relevance of 
such supernatants is perhaps dubious since they are highly concentrated and lack the 
homeostatic cellular processing of metabolites, toxins and extracellular proteins.  
Additionally, if due to transient activation, CD69 expression would have to be lost very 
rapidly on exiting the tissue as the liver receives a very large volume of blood every hour 
and one may expect this to raise peripheral expression of CD69. 
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CD27lo/negCD45RAlo/neg Vδ1+ T cells may therefore represent a liver-resident subset, 
although conceivably they may be able to access other solid tissues.  As such clonotypes 
are not present within the blood, their origin is unclear. One possibility is that they 
originate from a subset of blood CD45RA+ cells that alter phenotype once in tissues and 
are retained there, perhaps following activation in the hepatic microenvironment.  
Recent work from the Maini group highlighted the potential for a liver resident 
phenotype to be induced independent of exogenous TCR stimulation in CD8+ αβ T cells via 
IL-15 followed by TGF-β signalling (Pallett et al., 2017), and based on the parallels 
between Vδ1+ and CD8+ αβ T cells identified in this study, a similar mechanism may be at 
work here.  The liver is rich in IL-15 (Golden-Mason et al., 2004) and the contribution of 
this cytokine to induction of tissue residency in NK cells has been proposed (Cuff et al., 
2016).  Activation of all intrahepatic CD27lo/neg Vδ1+ cells by IL-15 was demonstrated in 
this study, and yet it is hard to evaluate the contribution of this cytokine to induction of 
residency in CD45RAlo/neg Vδ1+ cells since they are so highly clonally focussed, with such a 
mechanism presumably being TCR-independent.  An alternative is that they develop 
extra-thymically in response to tissue-specific TCR-mediated cues, potentially even from 
foetal liver cells (Wucherpfennig et al., 1993) although these are predominantly Vδ2+ 
(Carding et al., 1990).  Whatever the origin of these cells, the high degree of repertoire 
focussing and clonality is strongly suggestive of an important role for the TCR in shaping 
this population. 
These results highlight that hepatic γδ T cells are not only phenotypically but also 
functionally distinct from equivalent subsets in peripheral blood. While overall still 
responsive to TCR stimulation/costimulation, unlike blood Vδ2neg T cells they displayed 
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increased responsiveness to IL-12/IL-18 in line with CD8+ T cells isolated from the same 
tissue.  A previous study of peripheral human Vδ1+ T cells has demonstrated sensitization 
of these cells to IL-18 following TCR ligation (Guerville et al., 2015), and these findings 
were also demonstrated in mice with concomitant TCR hyporesponsivity (Wencker et al., 
2014).  This paradigm of TCR-driven “switching” from adaptive to innate-like responses 
cannot be ruled out here, although evidence of response to TCR stimulation here clearly 
rules out a full switch to innate-like response.  Activation through TCR mediated 
stimulation was considerably more variable for intrahepatic Vδ1+ cells compared with 
PBMC-derived, although whether this was a transcriptionally controlled re-programming 
of the cells or merely exhaustion from the isolation protocol, which is more stressful for 
the liver-derived cells than the blood-derived, is unclear.   Additionally, this paradigm 
doesn’t fit if the large blood-associated clonal expansions are considered TCR-mediated, 
as seems likely, as they remain IL-12 and IL-18 insensate, even within the liver, so TCR-
mediated expansion and indeed liver microenvironment cannot be the sole driving 
influences on cytokine sensitisation.  Other factors, possibly microenvironmental in 
nature or possibly developmentally imprinted, must be at play in this scenario, and 
hopefully techniques such as single cell transcriptomic analysis may lead to an answer in 
future studies.   
In addition to increased sensitivity to exogenous activatory cytokines, the CD45RAlo/neg 
subset also appeared to display enhanced production of pro-inflammatory cytokines and 
decreased potential cytotoxicity compared with CD45RA+ cells.  This observation has 
been made in both liver-resident intrahepatic NK cells (Marquardt et al., 2015, Harmon et 
al., 2016) and CD8+ αβ T cells (Pallett et al., 2017, Stelma et al., 2017), and certainly gives 
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credence to these cells being genuinely liver resident.  Further examination of cellular 
function with a direct link to clonotype via indexed single cell sorting would help establish 
whether it is truly the liver-associated clonotypes that account for the differences 
observed between the CD45RA+ and CD45RAlo/neg Vδ1+ cells.  One may even be able to 
extend such a study to include αβ T cells, where the influence of clonality has not been 
linked with liver-residency in human studies to date.   
Overall, these observations suggest CD45RA+ and CD45RAlo/neg subsets may have 
significantly different roles, the former more vascular focussed and cytotoxic, the latter 
an immunoregulatory tissue-associated subset more focussed on cytokine production 
and potential induction of a wider T cell response to stress challenges.  Since liver-
resident Kupffer cells represent a potent source of IL-12 and IL-18, one can speculate on 
the biological significance of liver-associated Vδ1+ cells being activated by these 
cytokines.  Activation of KC via TLR would induce IL-12 (Takahashi et al., 1996) and, via 
the caspase-1 inflammasome, IL-18 expression (Shrivastava et al., 2013), which could 
then activate pro-inflammatory cytokine release by liver-associated Vδ1+ gamma delta T 
cells, thereby forming part of the liver associated “firewall” against microbial gut-
associated antigen.  Whether or not this is the case, it is unclear if the distinct features of 
the CD45RAlo/neg populations of Vδ1+ T cells stem directly from expansion in response to 
tissue-specific TCR-mediated antigenic cues or whether they reflect the preferential 
homing and/ or retention of certain non-tissue restricted clonotypes, perhaps according 
to response to hepatic microenvironmental factors. 
This study establishes that in humans, clonally expanded γδ T cell effector subsets can be 
selectively deployed to at least some solid tissues, thereby providing ongoing immune 
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surveillance against previously encountered infectious or non-infectious challenges. 
Moreover, the finding that such subsets can be phenotypically, functionally and most 
importantly clonotypically distinct from those in peripheral blood provides a basis for 
future investigation of tissue-resident γδ T cell populations. 
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A novel subset of Vδ2+ gamma delta T cells 
are enriched in liver 
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6.1 Introduction 
 
Previous chapters have highlighted the enrichment of clonally expanded effector gamma 
delta T cells in human liver, focussing mainly on the historically tissue associated 
Vδ1+ subset.  However, evidence from matched donor liver and peripheral blood samples 
suggests that, as a percentage of the total infiltrating T cell population, the liver is also 
slightly enriched for the Vδ2+ subset of gamma delta T cells, normally thought of as blood 
associated.  Additionally, experiments detailed in Chapter 3 also demonstrated the 
enhanced adhesion and transmigration of Vδ2+ cells across primary human liver 
endothelial cells compared with both αβ T cells and Vδ2neg gamma delta T cells, 
suggesting these cells may be capable of enhanced recruitment to the liver in both 
inflammatory and non-inflammatory conditions.  In this chapter, a closer examination of 
this relatively well studied population of cells is performed, but in the previously 
undocumented context of human liver.     
Perhaps the prototypic unconventional T cell, Vδ2+ T cells typically co-express Vγ9 TCR 
chains and represent the major γδ subset in adult peripheral blood.  This common chain 
pairing is made when Vγ9 rearranges with the JγP joining segment, and splices to C1 to 
form the Vγ9JγPC1 chain (Tribel et al., 1988).  Despite there being no clear restriction in 
pairing, the rearranged Vγ9JγP chain pairs mainly with Vδ2 chains (Borst et al., 1989).   
Whether the formation of the strongly Vδ2+Vγ9+JγP dominant repertoire is the result of a 
molecular bias in TCR recombination, or driven by antigenic selection during 
development and maturation of these cells is not yet clear, although research in this area 
is still underway.  Interestingly, the pre-thymic (<8 weeks) human liver gamma delta T cell 
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population is uniformly composed of functional Vδ2+Vγ9+ cells (McVay and Carding, 
1996).  A more recent study of the gamma delta TCR repertoire at different stages of 
foetal development in humans described a sharp increase in the population of Vδ2+Vγ9+ T 
cells with limited junctional diversity in blood at around 23 weeks of gestation (Dimova et 
al., 2015).  While forming the dominant population at this time point, the frequency of 
these cells steadily declined until birth and was at very low frequency in cord blood and 
neonatal venous blood.   
This high enrichment of Vδ2+Vγ9+ T cells at an early stage of development, both in the 
foetal liver and blood, as well as the restricted CDR3γ9 usage early in gestation, is 
consistent with an innate-like ontogeny for Vδ2+Vγ9+ T cells, at least pre-natally.  
However, post-natally, a dramatic expansion of Vδ2+Vγ9+ T cells has been observed in the 
blood, which does occur extrathymically (Casorati et al., 1989).  In addition, this 
expansion appears to occur clonotypically (Kalyan and Kabelitz, 2013, Carding and Egan, 
2002, Pauza and Cairo, 2015), which naturally is suggestive of an adaptive immunobiology 
for these cells (Shen et al., 2002).   
As described in Chapter 1, Vδ2+Vγ9+ T cells respond to prenyl-pyrophosphate metabolites 
(phosphoantigens, or P-Ag) produced either by the microbial non-mevalonate pathway 
((E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate, or HMB-PP) or the host mevalonate 
pathway (isopentenyl pyrophosphate, or IPP) .  In this way, they are capable of 
recognising both exogenous antigen as well as endogenous antigen associated with 
stressed-self.  The expansion of Vδ2+Vγ9+ T cells observed in adult peripheral blood has 
been attributed to post-natal exposure to P-Ag producing pathogens (De Libero et al., 
1991, Davodeau et al., 1993), reflective of an adaptive-like mechanism, although the 
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basis of these expansions appears to occur polyclonally (M. Davey, unpublished).   
Consistent with this, primate models highlight improved Vδ2+ responses to 
Mycobacterium tuberculosis upon secondary challenge (Chen et al., 2005).  Indeed, the 
importance of the role of Vδ2+ gamma delta T cells has been demonstrated in many anti-
microbial immune responses, including against Mycobacterium tuberculosis (Chen et al., 
2013) and plasmodium falciparum, where they target red blood cell-invasive extracellular 
plasmodium merozoites in a TCR specific manner (Costa et al., 2011), although the basis 
for recognition is unclear .     
Vδ2+Vγ9+ T cells have been demonstrated to increase numerically both systemically and 
at the site of many microbial infections (Davey et al., 2011), and can reach frequencies of 
over half of all peripheral T cells in a remarkably short time period during infection 
(Morita et al., 2007), revealing a fundamental role of this unconventional T cell 
population in acute disease.  Despite these dynamics however, the limited diversity of the 
Vδ2 TCR and pattern recognition receptor-like MHC-independent recognition of P-Ag is 
more suggestive of an innate-like biology. 
As for all gamma delta T cells, recognition of P-Ag appears to occur independently of both 
classical and non-classical MHC molecules (Morita et al., 1995, Lang et al., 1995).  More 
recent studies have highlighted the role of a member of the B7 family of costimulatory 
molecules, butyrophilin 3A (BTN3A1/ CD277) in sensing of IPP/ HMB-PP by Vδ2+ gamma 
delta T cells (Harly et al., 2012).  While both intracellular and extracellular domains of 
BTN3A have been demonstrated to interact with P-Ag, suggestive of an innate pattern 
recognition receptor, it is unclear exactly how this binding leads to Vδ2+ TCR-mediated 
cell activation.  Further to this, monocytes are required for the activation of Vδ2+ cells by 
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the P-Ag pamidronate (Miyagawa et al., 2001), and it is thought that internalisation of P-
Ag by endocytic monocytes is involved in subsequent activation of Vδ2+ cells (Eberl et al., 
2009). 
Irrespective of the exact activation mechanism, Vδ2+Vγ9+ T cells are capable of exerting a 
wide range of effector functions upon activation.  These include cytolysis of infected and 
stressed cells, driving inflammatory and wound healing processes, inducing dendritic cell 
maturation and interestingly, they appear to have a significant role as antigen 
presentation cells, providing B cell help and priming αβ T cells (Tyler et al., 2015). 
Accordingly, the aim of this chapter was to investigate the frequency, phenotype and 
function of a classically blood-associated subset of gamma delta T cells in the context of 
human liver and compare this with the periphery.  To do this, a combination of TCR 
repertoire profiling, flow cytometry and immunological assays was combined, which 
unexpectedly also revealed the presence of a novel tissue-tropic subset of 
Vδ2+Vγ9neg cells that may play a role in liver immunosurveillance. 
6.2 Results 
6.2.1 TCR repertoire sequencing of Vδ2+ gamma delta T cells 
6.2.1.1 Choice of Ab-based Vδ2+ T cell purification strategy 
 
Previously in this study, next generation sequencing of TCR repertoires from 10 explanted 
human livers was conducted to investigate the degree of clonality and publicity of the 
repertoire of the intrahepatic Vδ2neg gamma delta T cell population (Chapter 4).  These 
cells were sorted using a MoFlo Astrios cell sorter according to fluorophore -conjugated 
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antibody directed labelling of CD3, pan-γδ TCR and Vδ2 TCR (Figure 4.3).  Initial analysis 
of antibody performance conducted on peripheral blood established that one commonly 
used commercial antibody for the Vδ2 TCR (clone B6) does not stain all Vδ2+ gamma delta 
T cells (Figure 6.1a & b), with the Miltenyi 123R3 Vδ2+ antibody staining a higher 
frequency by comparison of the same donor sample.  The 123R3 clone was therefore 
used in both negative sort selection of Vδ2neg gamma delta T cells (Chapter 4) but also 
positive selection of Vδ2+ gamma delta T cells here. 
A puzzling outcome of the Vδ2neg sorting strategy used in Chapter 4 was the presence of 
Vδ2+ CDR3 sequences in the supposedly Vδ2neg population, despite use of the 123R3 
antibody.  In human blood, Vδ2 conventionally pairs with Vγ9 to form the 
phosphoantigen reactive Vδ2Vγ9 TCR.  This pairing also includes the JγP joining region.  
However, when the iRepertoire next generation TCR sequencing dataset was analysed, 
despite the presence of Vδ2+ CDR3δ sequences there were very few Vγ9JγP CDR3γ 
sequences - within shared CDR3γ clones across all samples only 20 Vγ9JγP clones were 
identified versus ~6000 shared CDR3γ clonotypes in total.  This finding was suggestive of 
the existence of a Vδ2+Vγ9JγPneg gamma delta T cell subset present at significant levels in 
the liver-derived Vδ2neg samples analysed in this study.  Such a subset has never 
previously been highlighted in human solid tissue or blood, and so accordingly further 
investigation of such a putative subset was carried out as part of this study. 
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Figure 6.1:  Vδ2+ TCR antibody clone 123R3 is necessary for correct Vδ2neg γδ cell sorting 
a) Representative flow cytometry plots of Vδ2+ staining for B6 and 123R3 clones in healthy 
donor peripheral blood sample.  Right:  comparison of Vδ2+ proportion in CD3+ T cells 
with antibody clones B6 and 123R3, n=4, **p<0.01, Student’s T test. Taken from Davey et 
al, 2017. 
b) Example of Vδ2+ contamination in Vδ2neg sorted cell population determined by deep 
sequencing following sorting using B6 antibody clone, visualised using iRepertoire iRtools. 
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6.2.1.2 Analysis of Vδ2+ CDR3 sequences  
 
While no liver-derived Vδ2+ samples were sorted for TCR repertoire deep sequencing, 
next generation TCR sequencing was performed on healthy donor PBMC-derived Vδ2+ 
cells as part of a study conducted by this group (n=7), using a Vδ2+ sorting strategy with 
the 123R3 Vδ2 antibody.  Consistent with previous findings (McVay et al., 1991) and their 
categorisation as semi-invariant innate-like T cells, Vδ2+ TCRγ repertoires were 
predominantly composed of Vγ9 chains and the joining region JγP (Figure 6.2).  However, 
the presence of non-Vγ9 (i.e. Vγ2-8) sequences in the TCR repertoires was detected 
(mean 4.46%  0.78%) even in these PBMC derived samples. 
Like the intrahepatic Vδ2neg population, there was evidence of repertoire focussing and 
clonotypic expansion in the PBMC Vδ2+ subset, illustrated by tree plots in Figure 6.3.  
When compared with liver-derived Vδ1+ and Vδ3+ cells (Figure 4.18), the 10 most 
prevalent PBMC-derived Vδ2+ cells displayed shallower cumulative frequency curves, 
suggesting an intermediate level of repertoire focussing present in these populations 
(Figure 6.4a) in comparison with Vδ1+ T cells from “focussed” donors or cord blood.  
Analysis of the D75 metrics (the percentage of clonotypes required to occupy 75% of TCR 
repertoire) from PBMC-derived Vδ2+ cells suggested they were generally not composed 
of as many expanded clonotypes as the intrahepatic Vδ2neg populations, particular in the 
δ-chain repertoire, with a mean δ-chain D75 of 9.8% compared with 2.6% for the 
intrahepatic Vδ2neg δ-chain repertoire.  In comparison, the γ-chain D75 was lower at 5.8% 
compared with 3.4% for intrahepatic Vδ2neg, suggestive of greater focussing of this chain 
in the Vδ2+ TCR (Figure 6.4b).  Analysis of the CDR3 length for PBMC-derived  
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Figure 6.2:  Healthy PBMC donor Vδ2+ chain usage is dominated by Vγ9 pairing 
V-region and J-region chain usage for Vδ2+ gamma delta T cells from healthy PBMC donor 
cohort and determined using deep sequencing. 
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Figure 6.3:  PBMC-derived Vδ2+ cells display evidence of clonal expansion 
Tree maps derived from FACS sorted peripheral blood Vδ2+ cells show CDR3 clonotype usage in 
relation to repertoire size (each CDR3 colour is chosen randomly and does not match between 
plots).  This data is representative of the raw iRepertoire data and has not undergone MiXCR 
error correction. 
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Figure 6.4:  PBMC-derived Vδ2+ display intermediate clonal focussing 
a)  Comparison of frequency of top 10 most prevalent clonotypes across all blood samples 
for Vδ2+ (blue) as well as Vδ1+ cells identified in “focussed” healthy adult blood donors 
(black) and cord blood (green) (from Davey et al, 2017). 
b) D75 diversity estimation for TCRδ and TCRγ sequences from Vδ2+ gamma delta T cell 
subset for healthy adult blood (n=7)  
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Vδ2+ cells confirmed previous observations of limited γ-chain diversity (Rock et al, 1994), 
with a strong bias towards 14 amino acids (53.4% ± 4.2%) with a broader range of CDR3 
lengths in the δ-chain (Figure 6.5). 
Reflective of this difference in observed diversity between TCRγ and TCRδ in Vδ2+ T cells 
is the degree of sharing found in γ- and δ-chain CDR3 region sequences.  Across all 
donors, an average of 79.1% ± 2.8% of CDR3γ9 sequences were shared by at least 2 
donors, demonstrating the high degree of publicity among CDR3γ in Vδ2+ gamma delta T 
cells.  However, as has been reported previously (Cairo et al., 2010), the CDR3δ2 were 
considerably less public, with a mean of 8.7% ± 1.1% of sequences observed in more than 
one donor (Figure 6.6a).  To investigate the nature of the shared clonotypes, the 10 most 
prevalent shared CDR3γ9 sequences were determined by frequency, filtered from each 
donor’s CDR3γ9 protein lists (n=7).  These sequences were then ordered by frequency for 
sequences that were shared between >2 donors to create a hierarchy of 10 common 
sequences.  The proportion of the repertoire occupied by these sequences is depicted for 
each donor in Figure 6.6b. 
Two CDR3γ sequences were observed in all 7 donors; CALWEVQELGKKIKVF (mean 13.1%) 
and CALWEVRELGKKIKVF (mean 4.3%).   CALWEVQELGKKIKVF has been observed in 
previous studies in foetal liver and foetal blood (McVay et al., 1998, Dimova et al., 2015), 
as well as adults (Sherwood et al., 2011).  Single cell TCR sequencing analysis of individual 
Vδ2+ T cells revealed this sequence paired with multiple different CDRδ chains within the 
same donors, forming a “pseudoclonotype” where the same CDR3γ9 is generated and 
independently paired with differing CDR3δ2 chains (Table 6.1).  Importantly, this 
sequence can be generated using basic recombination of Vγ9 and JγP gene segments 
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Figure 6.5:  PBMC-derived Vδ2+ CDR3 lengths display limited γ-chain diversity 
Comparison of mean + s.e.m. CDR3δ (upper) and CDR3γ (lower) pseudo-spectratypes of Vδ2+ T 
cells from healthy adult blood donors (n=7) 
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Figure 6.6:  Vγ9+ CDR3 sequences in Vδ2+ cells are public 
a) Comparison of extent of sequence sharing (i.e. sequences identified in more than one 
sample) amongst Vδ2Vγ9+ gamma delta T cells from healthy PBMC donors (n=7) 
b) Contribution of the 10 most prevalent public Vγ9 sequences to the total Vγ9 repertoire in 
healthy PBMC donors (n=7) 
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Donor 
 
CDR3γ9 
 
CDR3γ nucleotide (nt) sequence 
N nt 
addition 
 
CDR3δ2 
3 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT germline CACDSLLGDTPNFDKLIF 
 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT germline CACDTGGAQSWDTRQMFF 
28 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTTCAAGAGTTGGGCAAAAAAATCAAGGTATTT 1 CACDSLGTYTDKLIF 
 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT germline CACDIILGGQYTDKLIF 
35 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAGGAGTTGGGCAAAAAAATCAAGGTATTT 3 CACESLGPTGGNPSSDKLIF 
 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTTCAAGAGTTGGGCAAAAAAATCAAGGTATTT 1 CACDTITHRTGGPQVTDKLIF 
 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT germline CACDGLGGEYTDKLIF 
42 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT germline CACDKVGYGSPWDTRQMFF 
 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT germline CACDTIPTGGHDPYTDKLIF 
3 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT germline CACDSLLGDTPNFDKLIF 
 CALWEVQELGKKIKVF TGTGCCTTGTGGGAGGTGCAAGAGTTGGGCAAAAAAATCAAGGTATTT germline CACDTGGAQSWDTRQMFF 
 
 
Table 6.1:  Prominent shared CDR3γ9 sequences are germline and pair with multiple CDR3δ2 
sequences 
Single cell PCR analysis of multiple healthy PBMC donors identified common CDR3γ9 sequences 
shared across one or more donors.  Sequence CALWEVQELGKKIKVF was identified in all donors, 
and paired with multiple different CDR3δ2 sequences. N-nucleotide additions are highlighted in 
red. 
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with no N nucleotide addition, thereby indicative of a “germline” sequence.  The relative 
simplicity of this rearrangement combined with likelihood of convergent recombination 
(Venturi et al., 2008), whereby identical CDR3 regions are created through alternate N 
nucleotide addition and exonuclease activity of initially different sequences, may explain 
the apparent lack of diversity in the γ-chain repertoire relative to delta as well as the high 
degree of sharing observed in this analysis.  This is very much in contrast with the 
considerably more diverse repertoire of the intrahepatic and diseased blood Vδ2neg 
gamma delta T cell repertoire determined in Chapter 4, which exhibited significantly less 
sharing of γ-chain sequences by comparison (Figure 4.24). 
6.2.2  Phenotype of PBMC-derived and intrahepatic Vδ2+ T cells 
Having established that the healthy Vδ2+ T cell repertoire largely consists of shared, 
expanded clonotypes expressing easily recombined CDR3γ9 sequences, phenotypic 
analysis of differentiation markers CD27, CD45RA, CCR7 and CD62L was conducted using 
donor matched PBMC-derived and intrahepatic Vδ2+ T cells, in a similar manner to the 
analysis performed on intrahepatic Vδ1+ T cells in Chapter 5.  PBMC-derived Vδ2+ CD27 
expression was 58.1% ± 7.1% (Figure 6.7a), significantly higher than CD27 expression in 
liver-derived Vδ2+ cells (30.1% ± 6.0%, p=0.002, n=10), reflective of a similar loss of 
CD27+ cells observed for the Vδ2neg gamma delta T cells in transition from periphery to 
liver.  In sharp contrast with both PBMC-derived and intrahepatic Vδ1+ T cells, only 4.6% ± 
0.5% PBMC-derived Vδ2+ cells were CD27negCD45RA+, or TEMRA-like.   
Analysis of the lymphoid homing markers CCR7 and CD62L showed that expression of 
these were higher in blood derived Vδ2+ cells compared with matched liver derived 
Vδ2+ cells (CCR7:  72.8% ± 6.1% vs. 14.5% ± 3.7%, p=0.25; CD62L:  73.2% ± 7.4% vs. 26.9%  
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Figure 6.7:  Intrahepatic Vδ2+ T cells are less phenotypically naïve than those in the periphery 
a) Representative dot plot showing distribution of CD27 and CD45RA expression in 
Vδ2+ cells from donor matched blood and liver (left) and overall CD27 expression (n=8, 
**p<0.01) 
b) CD62L and CCR7 expression in blood and donor matched liver samples (n=3) for Vδ2+ 
gamma delta T cells 
 
 
  
C
D
2
7
 
CD45RA 
Blood Liver 
a 
b 
 
237 
± 12.5%, p=0.25) (n=3) (Figure 6.7b).  Combined with the lower CD27 expression, this is 
highly suggestive of the loss of a central memory lymphoid homing phenotype in liver 
associated Vδ2+ populations.  This observation is pertinent in light of findings from this 
group that loss of CD27 and CCR7 and adoption of a TEMRA-like phenotype is observed in 
certain donor’s blood-derived Vδ2+ T cells, concomitant with clonal expansion (Davey et 
al¸ unpublished). 
6.2.3   Detection of a novel Vδ2+Vγ9neg subset 
As indicated by the NGS Vδ2+ samples, flow cytometry based analysis of the repertoire of 
both healthy blood and matched blood from liver donors also confirmed the presence of 
a small subset of Vδ2+Vγ9neg cells in peripheral blood.  Although small, this frequency was 
similar in magnitude to α-GalCer reactive NKT cells in the same healthy blood donor 
cohort (Figure 6.8a).  This subset represented 4.2% ± 3.1% of the Vδ2+ and 0.19% ± 0.07% 
of the total CD3+ T cell compartment in healthy donors (n=18) and 17.6% ± 10.2% of Vδ2+ 
cells in matched blood donors (n=9) (Figure 6.8b).  The proportion in blood from liver 
transplant donors was significantly higher than in the healthy blood donor cohort 
(p=0.02).  It is important to note that this population was only observed when the 123R3 
clone was used in the staining panel, and not the B6 clone, which suggests the B6 clone 
may be specific for a Vδ2+Vγ9+ TCR epitope not present in the Vδ2+Vγ9neg TCR. 
The deep sequencing data of liver gamma delta T cells had suggested that a Vδ2+Vγ9neg 
population may exist in the liver, and accordingly flow cytometry based analysis using the 
123R3 Vδ2 TCR antibody and a Vγ9 specific antibody was used to attempt to quantify 
such a population in a number of explanted human livers (n=16).  Firstly, the frequency of 
Vδ2+ cells was found to be significantly lower in liver than the healthy donor blood cohort  
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Figure 6.8:  Vδ2+Vγ9neg cells are a small but significant subset of human peripheral blood CD3+ T 
cells 
a) Frequency of Vδ2+Vγ9neg and iNKT cells in healthy donor blood as a proportion of total 
CD3+ T cells, determined by flow cytometry (n=18 Vδ2+, 5 iNKT) 
b) Frequency of Vδ2+Vγ9neg in healthy and liver disease patients as a proportion of all 
Vδ2+ gamma delta T cells (n=18 – 9) 
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used for the Vδ2 repertoire analysis, comprising 2.3% ± 0.9% of liver infiltrating CD3+ T 
cells compared with 6.8% ± 2.0% in the periphery (data not shown).  However, in the 
matched blood and liver cohort there was no significant difference between the 
Vδ2+ proportion of total CD3+ cells observed between liver and blood derived cells (Figure 
5.2), suggesting that the difference between healthy blood and liver may be due to 
differences in the nature of the donors and highlighting the importance of obtaining 
matched samples whenever investigating differences between tissue and the periphery. 
Further to this, a significantly higher proportion of Vδ2+Vγ9neg T cells was observed as a 
proportion of Vδ2+ T cells in the intrahepatic samples compared with the healthy 
peripheral blood donors (25.9% ± 11.7% liver vs. 4.2% ± 3.1% healthy blood, p=0.0002) 
and indeed a higher, although not statistically significant, proportion than matched donor 
blood (17.7% ± 10.2% p=0.25) (Figure 6.9).  This enrichment is likely indicative of a tissue-
associated nature for this previously uncharacterised population.  Consistent with this 
hypothesis, expression of CD27 and CD45RA in PBMC-derived Vδ2+Vγ9neg T cells 
suggested a generally naïve/ central memory phenotype, with 81.2% ± 3.4% being CD27hi.  
This contrasted with intrahepatic Vδ2+Vγ9neg T cells which were predominantly CD27lo 
(85.7% ± 3.6% vs. 18.8% in blood, p=0.0003) (Figure 6.10a).  The overwhelming majority 
of these cells in the liver were also CD45RA+ (98.5% ± 6.1%), suggestive of a TEMRA-like 
differentiation status.  Interestingly, the expression of CD27 in PBMC derived Vδ2+Vγ9neg 
cells was significantly higher than that of Vδ2+Vγ9+ when measured by mean fluorescence 
intensity, and comparable to that exhibited by CD27hi Vδ1+ T cells (n=3, p=0.008)  (Figure 
6.10b). 
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Figure 6.9:  Vδ2+Vγ9neg cells are enriched in human liver 
a) Representative histogram (left) and dot plots (right) of Vδ2 and Vγ9 expression among 
CD3+ cells isolated from donor matched liver and blood 
b) Frequency Vδ2+Vγ9neg cells as a proportion of Vδ2+ cells in the same cohorts as a) (left) 
and a cohort of donor matched blood and liver samples (n=9) (right) 
 
 
Matched Donors 
Vγ9 
Liver 
Blood 
Vδ2+ CD3+ 
 
241 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10: Intrahepatic Vδ2+Vγ9neg cells are TEMRA-like 
a) Representative dot plots of CD27 and CD45RA expression among Vδ2+Vγ9neg T cells 
derived from PBMC of healthy donors and liver explants (left).  Comparison of CD27lo/neg 
populations as a proportion of total Vδ2+Vγ9neg T cells between healthy donor (n=18) and 
explanted liver cohorts (n=16) ****p<0.0001 
b) MFI of CD27 expression among various gamma delta T cell subsets (n=3, **p<0.01) 
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6.2.4   Phenotype and clonotypic overlap of intrahepatic Vδ2+Vγ9neg cells 
Next, expression of other surface markers associated with differentiation was also 
assessed by flow cytometry for PBMC-derived Vδ2+Vγ9neg and intrahepatic Vδ2+Vγ9neg T 
cells (n=3).  Overall, PBMC-derived Vδ2+Vγ9neg T cells expressed higher levels of CCR7 
compared with Vδ2+Vγ9+ cells (58.8% vs 8.3%, p=0.0006), similar levels of IL-7R (85.2% vs. 
82.1%, p=0.99) but significantly lower levels of CX3CR1 (2.0% vs 43.2%, p=0.0001) (Figure 
6.11a).  In addition to the marked downregulation of CD27 reported earlier, liver derived 
Vδ2+Vγ9neg T cells expressed the characteristic clonal-γδ effector marker CX3CR1 and had 
downregulated IL-7R (n=1) (Figure 6.11b).  These data suggest this subset is 
phenotypically similar to the Vδ1+ TEMRA-like subset identified in both liver and blood in 
Chapter 5.  Finally, expression of CD69, highlighted in the previous chapter as being 
associated with tissue-specific Vδ1+ clonotypes,  was significantly upregulated in 
intrahepatic Vδ2+Vγ9neg T cells compared to matched blood populations (82.5% ± 5.7% vs. 
15.4% ± 10.7%, p=0.03, n=6) (Figure 6.11c).  These data contrast intrahepatic Vδ2+Vγ9neg 
T cells with both Vδ2+Vγ9+ and Vδ2+Vγ9neg populations derived from peripheral blood, 
and identifies them as phenotypically analogous to the clonal Vδ1+ populations isolated 
from liver samples in the previous chapter and indeed with Vδ1+ cells from the same 
donor. 
To investigate the relationship between these observed phenotypes and TCR clonality, 
indexed single cell sorting was again used in conjunction with sc-PCR to sequence full TCR 
CDR3 regions (Chapter 5).  To begin, Vδ2+Vγ9neg were sorted from blood of three healthy 
donors, and in keeping with their CD27hi CCR7+ phenotype all the cells sorted across all 
donors possessed unique CDR3s with no clonotypes shared between any of the analysed  
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Figure 6.11:  Vδ2+Vγ9neg T cells adopt a TEMRA-like phenotype in liver 
a) Comparison of expression of surface markers associated with cell differentiation between 
PBMC-derived Vδ2+Vγ9neg and Vδ2+Vγ9+ cells (n=3, ***p<0.001, ****p<0.0001, Mann-
Whitney U test) 
b) Comparison of expression of surface markers associated with cell differentiation between 
liver-derived Vδ1+ and Vδ2+Vγ9neg T cells (n=1) 
c) Comparison of CD69 expression between blood and liver derived Vδ2+Vγ9neg T cells from 
matched donors (n=6, **p<0.01, Mann-Whitney U test) 
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cells (Figure 6.12a).  This is suggestive of a predominantly naïve population of cells.  In 
contrast, Vδ2+Vγ9neg isolated from livers appeared to be strongly clonal in nature, with 
two large clones comprising 21/24 cells sequenced (Figure 6.12b).  Again, this is 
consistent with the strong clonal focussing observed in intrahepatic TEMRA-like Vδ1
+ T cells 
observed in the previous chapter, and is strongly suggestive of a similar adaptive biology 
in the formation of these apparently tissue-associated cells.   
Since clonotypically identical CD27loCD45RA+ Vδ1+ subsets of gamma delta T cells had 
been demonstrated to be present in both the liver and blood of matched donors in this 
study, PBMC and liver-derived Vδ2+Vγ9neg cells were sorted from an additional donor and 
sequenced by sc-PCR.  In the liver the analysed population of 12 cells consisted entirely of 
one Vδ2+Vγ5+ clonotype, which was mirrored in the blood for the δ-chain sequence, with 
the caveat that only 8 of the 12 cells analysed also expressed the same Vγ5 sequence, 
while the remaining sequences appeared to be an out of frame Vγ5JγP2 (Figure 6.12c).  
Although the reason for this is unclear, it is evident that the large degree of clonal overlap 
observed between the blood and liver Vδ1+ CD45RA+ cells is also possible for Vδ2+Vγ9neg 
populations. 
6.2.5 Function of the intrahepatic Vδ2+Vγ9neg subset 
It is well established that Vδ2+Vγ9+JγP+ cells are P-Ag reactive, and can be activated by 
incubation with exogenous HMB-PP (Eberl et al., 2003).  To determine whether this was 
also the case for the Vδ2+Vγ9neg populations identified in this study, PBMC- (n=5) and 
liver-derived (n=3) T cells were incubated in vitro with 10nM HMB-PP and, for blood 
derived cells, proliferation assessed using CFSE or, for liver derived cells, CD25 
upregulation was assessed by flow cytometry.  In the case of blood derived cells, a  
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Figure 6.12:  Vδ2+Vγ9neg are clonally diverse in blood and focussed in liver 
a) Single cell PCR TCR sequencing analysis of Vδ2+ subsets derived from healthy PBMC 
donors.  Each slice in the pie chart represents an individual cell and each colour 
corresponds to a unique CDR3 sequence 
b) TCR sequencing of liver derived Vδ2+Vγ9neg cells 
c) TCR sequencing of blood and donor matched Vδ2+Vγ9neg cells 
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strong proliferative response was observed in the Vδ2+Vγ9+ cells as expected (82.3% ± 
12.7% diluted CFSE), but the Vδ2+Vγ9neg were significantly less responsive (8.2% ± 0.3% 
diluted CFSE, p=0.0002), in line with CD8+ αβ T cells and Vδ1+ cells isolated from the same 
donors (Figure 6.13a).  For liver-derived cells, although the response of Vδ2+Vγ9+ cells 
was lower than that observed in blood, there was nevertheless again a significant 
decrease in response as measured by surface CD25 upregulation between Vδ2+Vγ9+ 
(45.7% ± 4.2%) and Vδ2+Vγ9neg (10.4% ± 1.1%, p=0.025), as well as CD8+ αβ T cells and 
Vδ1+ cells (Figure 6.13b).  These data suggest that Vδ2+Vγ9neg are minimally responsive to 
classically Vδ2+ activating antigen. 
In the previous chapter it was established that both intrahepatic Vδ2+ and Vδ1+CD45RAneg 
gamma delta T cells were activated in vitro by exogenous IL-12 and IL-18.  This led to the 
suggestion that these cells may act as part of the protective liver “firewall” that 
eliminates harmful gut-associated pathogen, responding to TLR-activated myeloid cell 
production of these cytokines.  To investigate this further, heat inactivated E.coli bacteria 
were co-cultured with liver derived mononuclear cells for 48 hours, with and without 
neutralising antibodies specific for the IL-12 and IL-18 receptors (Figure 6.14).  Activation 
of liver associated lymphocyte populations was then assessed, using flow cytometry to 
assess the presence of intracellular interferon-γ, a potent inducer of a TH1 inflammatory 
response.  Following co-culture, little IFN-γ production was observed for intrahepatic 
CD8+ αβ or Vδ1+ T cells, and there was no significant difference between the CD45RA+ 
and CD45RAneg Vδ1+ T cells.  Consistent with previous findings (Hintz et al., 2001) and the 
strong response to IL-12/IL-18 stimulation observed in this study, Vδ2+Vγ9+ cells were 
induced to produce IFN-γ following co-culture with E. coli.  Inclusion of αIL-12R  
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Figure 6.13:  Vδ2+Vγ9neg T cells are not HMB-PP reactive 
a) Comparison of loss of CFSE staining in PBMC-derived T cell subsets after 48 hours 
incubation with HMB-PP  (n=4, ****p<0.0001, 2-way ANOVA, Tukey’s comparison) 
b) Representative histogram (left) and comparison of activation by HMB-PP (right) of various 
liver-derived T cell populations (n=3, ****p<0.0001, 1-way ANOVA, Dunn’s comparison) 
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Figure 6.14:  Intrahepatic Vδ2+Vγ9neg do not respond to co-culture with E. coli 
Comparison of interferon-γ production by various liver-derived T cell subsets following 72 hour 
co-culture with heat killed E. coli, either with or without αIL-12 and αIL-18 blocking antibodies.   
 
249 
and αIL-18R blocking antibodies did significantly reduce the frequency of IFN-γ producing 
Vδ2+Vγ9+ cells, suggesting of a role for these cytokines in the E. coli specific response of 
these cells.  Without further experiments, it is unclear whether the liver-derived myeloid 
cells present in the culture were the source of the cytokines.  Interestingly, the 
intrahepatic Vδ2+Vγ9neg population did not produce IFN-γ, again suggestive of similar 
biology to the Vδ1+ and CD8+ αβ T cells. 
In conclusion, the data presented in this section highlights the presence of a previously 
unreported subset of Vδ2+Vγ9neg gamma delta T cells in human blood and liver.  
Additionally these data suggest that unlike the Vδ2+Vγ9+ TCR gamma delta T cell 
population, which is composed of highly public pseudoclonotypes in the periphery, liver 
enriched Vδ2+Vγ9neg cells share a similar biology with blood and liver Vδ1+ CD45RA+ cells, 
with highly expanded clonotypes and potential for endothelial homing and cytotoxicity. 
6.3 Discussion 
 
In this chapter, the unexpected detection of Vδ2+ gamma delta T cells in FACS sorted 
populations that were expected to be Vδ2 negative led to the discovery of a novel subset 
of gamma delta T cells that are enriched in the liver and that display the hallmarks of 
undergoing an adaptive-like immune response, in common with intrahepatic 
Vδ1+ gamma delta T cells described previously in this thesis.  These cells were Vδ2+Vγ9neg, 
although it cannot be ruled out that there may be Vδ2+Vγ9+non-JγP gamma delta T cells 
that may also share this biology. 
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Extensive previous research into Vδ2+ T cells has described a population that is P-Ag 
reactive and displays limited TCR diversity, leading to these cells being described as semi-
invariant unconventional T cells.  The discovery of the essential role of immunoglobulin-
like BTN3A1 in P-Ag-mediated activation of Vδ2+ T cells seems to confirm a similar biology 
as that exhibited by MAIT and NKT cells, even if the precise mechanism of this activation 
mechanism remains unclear.  In this study, TCR sequencing analysis of PBMC-derived 
Vδ2+ T cells demonstrated that, although some evidence of clonal focussing was 
observed, comparison of specific CDR3 region sequences revealed a remarkably high 
degree of clonal overlap between donors, with several public germline or convergently 
recombined sequences identified.  This was particular prevalent in CDR3γ sequences, 
where sc-PCR determined the presence of pseudoclonotypes, with multiple common 
CDR3γ chains pairing with different δ-chains.  This is in marked contrast to the 
intrahepatic Vδ2neg population sequenced in a similar manner in Chapter 4, where γ-chain 
publicity was orders of magnitude lower, and further strengthens the hypothesis that 
Vδ2neg gamma delta T cells do not conform to the same innate-like biology exhibited by 
Vδ2+ cells.  To this day, many studies investigating gamma delta T cells do not make the 
distinction between Vδ2 and Vδ2neg cells, classifying all gamma delta T cells under the 
same umbrella (e.g. Ravens et al, 2017), which, under the evidence presented here, may 
be considered a flawed approach.   
Interestingly, there is little distinction between adult- and cord blood-derived Vδ2+Vγ9+ 
repertoires in terms of clonal focussing, CDR3 lengths and phenotypic differentiation 
status, which is consistent with a post-natal polyclonal expansion specifically tailored to 
be P-Ag reactive from birth (Davey et al, in press).  The authors propose that this is at 
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least in part due to butyrophilin 3 family member A1 (BTN3A1)-mediated shaping of the 
Vδ2+ repertoire in utero through sensing of endogenous IPP.  This innate-like biology 
contrasts not only with the Vδ2neg subsets but also with MAIT cells, which emerge from 
the conventional αβ T cell repertoire only in response to microbial exposure, and 
suggests the immunological paradigm that applies to Vδ2+Vγ9+ T cells is most likely 
unique.   
Phenotypic comparison of Vδ2+ cells from liver and blood indicated a modest decrease in 
expression of CD27 and lymphoid homing associated molecules CD62L and CCR7 in the 
liver compared with the periphery.   While statistically significant in the case of CD27, the 
loss of the CD27+ subset of Vδ2+ cells within the liver was not as stark as that observed for 
the intrahepatic Vδ2neg gamma delta T cell population, presented in the previous chapter.  
This suggests that although these cells do undergo some phenotypic differentiation and 
will accumulate in the liver, likely due to similar mechanisms proposed here for Vδ2neg 
cells, this process is not as defined in the Vδ2+ subset, with many intrahepatic Vδ2+ cells 
retaining a blood-like expression pattern of CD27+, CD69neg. 
Deep sequencing and flow cytometry analysis of Vδ2+ T cells derived from the peripheral 
blood of healthy donors revealed a small proportion of circulating cells that were not 
Vγ9+ (Vδ2+Vγ9neg), expressing alternative γ-chains paired with Vδ2 and not using the JγP 
joining region common to P-Ag reactive Vδ2+Vγ9+ cells.  In the periphery, these cells were 
highly polyclonal and phenotypically naïve, expression CD27, CCR7 and CD62L.  Critically, 
these cells were enriched as a proportion of all Vδ2+ gamma delta T cells in liver tissue 
compared with healthy blood donors.  Further analysis of additional matched blood and 
liver donors is important to verify whether this is truly the case, as the proportion was 
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not significantly enriched when donor matched blood and liver was analysed, although 
the same trend was also observed in these samples.  Nevertheless, occupying a mean of 
over 25% of the intrahepatic Vδ2+ populations, Vδ2+Vγ9neg T cells do form a significant 
and previously unappreciated proportion of liver infiltrating gamma delta T cells in many 
donors. 
Phenotyping of this novel population of cells further discriminated them from the 
Vδ2+Vγ9+ subset and led to intriguingly suggestive possibilities regarding their origin when 
compared with Vδ1+ cells.  In contrast with the polyclonal expansions observed in 
peripheral Vδ2+Vγ9+ T cells,  intrahepatic Vδ2+Vγ9neg populations were strongly 
dominated by expanded CD27loCD45RA+ TEMRA-like clonotypes, and the similarity between 
these and intrahepatic CD27loCD45RA+ Vδ1+ T cells is striking.  Both exhibit high cytotoxic 
potential, expression of the fractalkine receptor CX3CR1, and both populations are 
composed of few clones that also appear to be shared between the liver and blood.  The 
phenotypic similarity between intrahepatic Vδ2neg gamma delta T cells and virus-specific 
CD8+ αβ T cells having been established in the previous chapter, it is now possible to 
extend that comparison to include intrahepatic Vδ2+Vγ9neg T cells.  The adaptive-like 
induction of a CD27loCD45RA+ phenotype under clonal expansion from a CD27hi 
polyclonal population in the periphery is also suggested here with Vδ2+Vγ9neg T cells.  This 
is again indicative of potential transcriptional changes following antigenic stimulation that 
induce a “vasculature association” phenotype and confers these highly cytotoxic cells the 
capacity to patrol liver and other tissue vasculature and to mount rapid responses with 
essentially innate-like kinetics (Vieira Braga et al., 2015, McNamara et al., 2017).  As with 
CD45RA+ Vδ2neg cells, since identical clonotypes appear to be present in liver and blood, it 
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is unclear whether these cells are genuinely liver-associated or merely accumulate there 
due to the upregulation of homing receptors and integrins that accompanies maturation 
of T cells following TCR engagement, and the nature of the activating ligand remains 
unknown.  What is clear, however, is the enhanced expression of the tissue-association 
marker CD69 in the intrahepatic Vδ2+Vγ9neg subset compared with both Vδ2+Vγ9neg cells 
from the periphery and Vδ2+Vγ9+ cells from the same liver.  Although not as strikingly 
upregulated as in the liver-derived Vδ2neg CD45RAlo population, this is highly suggestive of 
a local tissue-associated retention of these cells.  .  Recent work from Cockburn’s group 
has highlighted potential mechanisms by which CD8+ T cells patrol murine hepatic 
sinusoids (McNamara et al., 2017) – further work in this line could reveal a role for 
phenotypically similar gamma delta T cells. 
In addition to being non-responsive to the classical Vδ2-activating ligands, intrahepatic 
Vδ2+Vγ9neg T cells did not produce IFN-γ following co-culture with E. coli, in contrast to 
Vδ2+Vγ9+ cells, which did.  While this experiment did further ally the Vδ2+Vγ9neg liver 
population with Vδ2neg and CD8+ αβ T cells, it also demonstrated the potential 
importance of “conventional” Vδ2+Vγ9+ T cells in the immune response to commensal or 
pathogenic microbial load in the liver.  Further experiments are required to determine 
the precise cellular mechanism involved, but the activation of these cells was at least in 
part dependent on IL-12 and IL-18, both readily secreted by TLR-activated myeloid cells.  
Although direct activation of the Vδ2+Vγ9+ cells, either by TCR or TLR, cannot be ruled 
out, the fact that the E. coli were heat killed prior to co-culture suggests that the TCR is 
unlikely to be involved as it is sensitive to bacterial metabolites, although the presence of 
these metabolites cannot be ruled out.  Although the Vδ2neg gamma delta subsets are 
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enriched in liver compared with the periphery, the Vδ2+ population is clearly present, has 
a higher transmigrational capacity than other T cell subsets and likely has a greater 
potential antimicrobial response than other T cell subsets, suggestive of a greater role in 
liver immunosurveillance than previously considered, even if extensive phenotypic 
alterations do not seem to be associated with these cells in liver.  It is not inconceivable 
that local activation may indeed induce phenotypic changes in the liver-associated 
Vδ2+ subset, but that these cells undergo apoptosis after responding and are not retained 
locally, consistent with the high frequency of central memory Vδ2+ cells observed in the 
periphery. 
The data presented in this chapter have established both a tissue-tropism for CD27lo Vδ2+ 
gamma delta T cells and the presence in the liver and periphery of a Vδ2+Vγ9neg T cell 
population.  While the Vδ2+Vg9+ cells are likely to be polyclonally expanded in response 
to P-Ag exposure, the Vδ2+Vγ9neg cells exhibit the hallmarks of adaptive oligoclonal 
expansion in response to unknown antigen, and appear to seed the liver with strongly 
clonally dominated populations that are shared between liver and blood, consistent with 
a role in vasculature-associated effector function.  This is significant as being the first 
detailed description of such a population in man, and establishes a phenotypic and 
functional link between these cells and both Vδ2neg and CD8+ αβ T cells in the liver. 
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General Discussion 
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7.1 Introduction  
 
This study was conducted with the ultimate aim of furthering our understanding of an 
enigmatic subset of unconventional T cells, namely Vδ2neg gamma delta T cells, in the 
context to which they have often been attributed but rarely investigated – human solid 
tissue.  To this end, in collaboration with clinicians at the Queen Elizabeth II Hospital, 
Birmingham, explanted human liver tissue was analysed by various means, including 
immunohistochemistry, flow cytometry and TCR sequencing, with the aim of not only 
learning more about the general nature of Vδ2neg T cells in solid tissue, but also whether 
these cells may have an impact on liver disease progression. 
7.2 Vδ2neg gamma delta T cells do not appear linked with chronic liver 
inflammation 
 
Having access to a large depository of historical liver tissue sections and, uniquely, freshly 
explanted human liver tissue from liver diseases of many aetiologies, a primary aim of 
this study was to establish whether gamma delta T cells, and specifically Vδ2neg T cells, 
may have a role in the development or progression of chronic inflammatory liver 
diseases.  Previous studies of human liver tissue had suggested that gamma delta T cells 
were enriched in diseased liver compared with the periphery, and perturbations in 
gamma delta T cell frequencies had also been observed in the periphery of patients with 
various chronic liver diseases, including PBC and HCV.  Typically categorised as pro-
inflammatory, highly cytotoxic innate-like T cells, a reasonable hypothesis, and indeed 
one made in several previous studies, would be that activated tissue associated gamma 
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delta T cells could contribute to liver disease progression, either through activation of a 
pro-inflammatory immune response or through direct tissue damage. 
Accordingly, throughout this study effort has been made to compare normal liver, 
obtained from discarded donor tissue, with diseased liver.  In Chapter 3, 
immunohistochemical analysis of tissue sections from a variety of chronically diseased 
explanted livers identified that, at least in terms of proportion of infiltrating T cells, 
normal livers had a significantly greater level of gamma delta T cells than diseased livers.  
These findings were subsequently confirmed using flow cytometry analysis of fresh tissue 
populations, and seem to suggest that while the baseline of healthy, homeostatically 
regulated tissue contains a relatively high frequency of Vδ2neg gamma delta T cells, under 
inflammatory conditions the frequency of these cells is reduced, in turn suggesting that it 
is the conventional αβ T cell population that is most affected by chronic inflammation.  
Additionally, there was no clear difference in gamma delta T cell numbers in any specific 
liver disease, suggestive of systemic infiltration and/or expansion of αβ T cells in the liver 
under inflamed conditions, rather than any disease related gamma delta T cell-specific 
effect.  Although it is conceivable that activation induced cell death may result in a loss of 
intrahepatic gamma delta T cells under inflammatory conditions, the 
immunohistochemistry analysis suggested that overall infiltration of the liver by gamma 
delta T cells remained relatively unchanged in inflammation, and that αβ T cells did 
indeed hugely increase in number.  Although these data don’t exclude the possibility that 
γδ T cells impact on the initiation of inflammation, arguably the simplest explanation for 
these data is  that gamma delta T cells and chronic liver disease actually have little impact 
on one another.  Indeed, perhaps previous studies reporting a relative increase in gamma 
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delta T cell numbers in liver disease did so simply because compared with the periphery, 
gamma delta T cell numbers are indeed increased in the liver even during disease. 
This possibility was supported by TCR sequencing data presented in Chapter 4 and 
phenotyping data in Chapter 5.  No differences were determined between normal and 
diseased liver in terms of Vδ2neg TCR repertoire on a chain usage, clonal prevalence, CDR3 
length or indeed CDR3 sequence basis in the NGS approach used in Chapter 4.  It is not 
inconceivable that increasing the number of samples analysed may potentially identify 
disease associated clonotypes but there was no evidence of any clonal overlap in this 
dataset between any sample.  This does not rule out the possibility of disease related 
antigen-driven private Vδ2neg expansions, but suggests that if such expansions exist they 
are likely to have multiple private CDR3 sequences.   Furthermore, immunophenotyping 
of Vδ2neg T cells from normal and diseased livers revealed, even in healthy liver samples, 
a heavy skew towards TEMRA-like clonally expanded populations of Vδ2
neg cells, which 
would likely mask any potential shift in repertoire induced by liver disease, were one to 
occur.  If disease related Vδ2neg clonal expansions do occur, it may be hard to distinguish 
the disease-influenced repertoire from the likely pre-existing skewed repertoire. 
The data presented in this study extend previous findings from other studies that 
highlight a shift in frequency of circulating Vδ2neg T cells in patients with certain chronic 
liver diseases to also include autoimmune hepatitis.  Here, Vδ2neg cells dominate the 
peripheral gamma delta T cell population and are at least in part more activated and 
more differentiated than equivalent populations in healthy donors.   As noted in Chapter 
4, it is possible that all these observations may be attributable not solely to antigenic TCR 
stimulation but perhaps also the nature of the therapy or non-TCR specific activatory 
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signals such as pro-inflammatory cytokines.  Whether these enriched Vδ2neg T cells are 
directly involved in the progression of pathology in these individuals or whether they are 
“bystanders” in a systemically inflated immune response is unclear, although other work 
has identified other innate-like lymphocytes that are enriched and activated in 
autoimmune liver disorders (Schoknecht et al., 2017, Chang et al., 2015), suggesting the 
latter hypothesis may be more likely. 
Overall then, the data presented in this thesis suggest that, in end stage disease at least, 
gamma delta T cells do not appear to be significantly changed in comparison with cell 
isolated from healthy liver.  While the possibility of a role in the development of disease 
cannot be ruled out, it appears that it is likely αβ T cells that are mainly associated with 
intrahepatic infiltration in chronic liver disease rather than gamma delta T cells.  This 
finding is accordant with findings for other innate-like T cells in human liver, including 
intrahepatic MAITs, which appear to be enriched in liver compared with the periphery 
but do not increase in frequency in chronic liver disease (Jeffery et al., 2016), and iNKTs, 
which do not appear to increase in frequency in virally infected livers compared with 
healthy livers (Yanagisawa et al., 2013). 
7.3 Gamma delta T cells and tissue  
7.3.1 The liver harbours a population of TRM-like gamma delta T cells 
 
The identification of large populations of predominantly MHC Class I restricted CD8+ T 
cells in the gut (intra-epithelial lymphocytes, or IEL), with high expression of the CD8αα 
homodimer not readily observed in the periphery (Jarry et al., 1990) led to the 
postulation that these were tissue associated cells, distinct from systemic T cells (Hayday 
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et al., 2001).  This finding was particularly resonant for gamma delta T cell biologists, 
since a large proportion of the IEL were determined to be γδ TCR+ (Goodman and 
Lefrancois, 1988), which in conjunction with the identification of an epidermally 
restricted population of Vγ5+ gamma delta T cells in murine skin (DETC), suggested 
gamma delta T cells may have an important role in tissue-specific immunity.  Importantly, 
in humans, the predominant δ-chain used in IEL populations was Vδ1 (Deusch et al., 
1991).  More recent studies have expanded on these observations for gamma delta T 
cells, and additionally investigated conventional T cells in tissues.  Here, a newly 
characterised subset of cells that do not return to the circulation has been identified, that 
are retained in the tissue at the site of antigenic stimulation and continue to provide 
lasting protection against local re-exposure – the tissue resident memory T cells (TRM) 
(Gebhardt et al., 2013). 
However, studies of TRM in humans, which began with CD8
+ αβ T cells (Thome and Farber, 
2015), and latterly included CD4+ αβ T cells (Turner and Farber, 2014) and NK cells (Lugli 
et al., 2016), have not to date addressed whether one of the archetypal tissue associated 
lymphocyte subsets, gamma delta T cells, conform to the paradigms defined for other 
lymphocytes in this body of work.  Phenotyping by flow cytometry, and indeed functional 
experiments conducted to determine responsivity to stimulation and cytokine production 
(Chapter 5), established a strong parallel between Vδ2neg gamma delta T cells and 
CD8+ αβ T cells in human liver, with one major difference – the majority of liver infiltrating 
Vδ2neg cells are TEMRA-like, expressing low CD27, IL-7R, CD28, CD62L and CCR7 and high 
CD45RA.  In contrast, intrahepatic CD8+ T cells are predominantly TEM-like, with low CD27, 
IL-7R, CD28, CD62L and CCR7 expression but also low CD45RA expression.  In a separate 
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study, from the group of Maini at UCL, CD8+ CD45RAneg TEM-like CD69
+ cells were 
identified as being liver-resident in humans (Pallett et al., 2017), and the author’s 
ascribed a certain phenotype which mirrored that identified in the smaller TEM-like 
population in Vδ2neg gamma delta T cells in this study.  This included high expression of 
CD69, CXCR6, CXCR3, as well as low expression of transcription factors Tbet, Hobit and 
Eomes and lower cytotoxic potential than the CD45RA+ subset.  As in the Maini-led study, 
here, Vδ2neg CD45RAlo/neg TEM-like cells were present within the liver but not detected in 
the periphery.   
However, in this study, further evidence for genuine tissue-association, and indeed 
putative classification as a TRM-subset, was presented in the form of TCR sequencing.  As 
Vδ2neg T cells are in general highly clonally focussed, whether liver or blood derived, 
single cell PCR provided a low-depth examination of TCR sequence overlap between 
blood and liver Vδ2neg from matched donors.  Strikingly, a large percentage of TEM-like 
Vδ2neg TCR sequences were found only in the liver samples, while TEMRA-like Vδ2
neg TCR 
sequences were often identified in both liver and blood.  Although the number of cells 
examined in this study was relatively low, this represents, to the author’s knowledge, the 
first CDR3-based approach to identification of tissue associated gamma delta T cells, and 
highlights the potential of such an approach in future studies.  If sufficient numbers of 
cells could be sorted from human explanted tissue, deep sequencing of TEM-like and 
TEMRA-like cells from liver and blood may add weight to this hypothesis.  Additionally, if 
homologous cells could be identified in mice, it may be possible to prove whether or not 
TEM-like gamma delta T cells are indeed tissue-resident using standard labelling and 
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parabiosis experiments as have been conducted with αβ T cell studies (Schenkel et al., 
2014, Steinert et al., 2015).   
TRM are distinguished from other tissue resident cells as they are genuine memory cells 
rather than innate or innate-like cells responding to TCR-independent signals such as 
cytokine stimulation (Masopust et al., 2010).  Nevertheless, the TCR sequencing data 
presented in Chapter 4 and 5 suggests that intrahepatic Vδ2neg cells, including the TEM-like 
subset, have likely undergone private, most likely antigenically-driven clonal expansion 
and therefore are more similar to CD8+ or CD4+ αβ TRM than innate tissue associated 
lymphocytes such as NK cells.  The apparent increase in sensitivity to cytokines such as IL-
12 and IL-18, as well as reduced cytotoxicity compared with TEMRA-like cells may be due to 
microenvironmental factors in the liver, possibly including IL-15 (Pallett et al., 2017), a 
cytokine that Vδ2neg cells are highly sensitive towards.  As discussed in Chapter 3, the 
potential for using a combination of ISH-based techniques such as BASEscope alongside 
IHC to identify localisation of specific TCR sequences of TRM-like gamma delta T cells in 
not just liver but all tissues could also be a powerful tool in future studies exploring tissue 
associated gamma delta T cells. 
7.3.2 The majority of intrahepatic gamma delta T cell appear to be 
vasculature associated 
 
While the discovery of this TRM-like subset of Vδ2
neg T cells in liver is of great interest, the 
majority of intrahepatic Vδ2neg cells are phenotypically and clonally very similar to those 
found in the periphery.  While there will be some element of overlap between the blood 
and liver compartments due to the contiguous vascular nature of liver tissue, it should be 
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emphasised that there are enough differences between the two compartments to 
suggest that the intrahepatic Vδ2neg cells are not simply “contaminating” blood.  Higher 
expression of CD69, loss of the CD27hi/ CD62L+/ IL-7R+ population, not to mention the 
increase in frequency of these cells in the liver compared with the periphery, both as a 
proportion of total T cell infiltrate as well as a change from Vδ2+ to Vδ2neg dominance 
within the gamma delta population, all strongly suggest that there is a distinct population 
of liver-associated Vδ2neg cells in both normal and diseased livers compared to blood. 
However, the high degree of clonal and phenotypic overlap between blood and liver in 
many matched donors is striking.  In addition to the clonal overlap, these cells were 
predominantly TEMRA-like CD27
loCD45RAhi, expressed lower levels of CD69, CXCR3 and 
CXCR6 but higher CX3CR1, CD16, Tbet and Hobit as well as being generally non-responsive 
to cytokine stimulation, in comparison with the TEM/TRM-like population.  As with the TEM-
like/ TRM-like population, the TEMRA-like Vδ2
neg cells were phenotypically and functionally 
similar to autologous CD8+ αβ T cells.  CD8+ αβ T cells specific for chronic viral infections 
such as cytomegalovirus (CMV) have been demonstrated to be TEMRA-like, with low 
expression of CD27, CD28, and re-acquisition of the CD45RA isoform (van Aalderen et al., 
2014).  These cells appear to be long-lived and antigenically induced with reduced 
potential TCR repertoire compared with other CD8+ αβ T cells (Wallace et al., 2011, 
Hamann et al., 1999). CX3CR1 expression has been demonstrated to cluster with loss of 
CD62L and gain of CD45RA expression in virus-specific T cells in proteomic studies of 
human CD8+ T cell differentiation (Bottcher et al., 2015, van Aalderen et al., 2017), and 
was demonstrated to be associated with the subset of both CD8+ and Vδ2neg cells in this 
study.  While TEMRA-like CD8+ T cells form a relatively minor proportion of intrahepatic 
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CD8+ T cells, they are enriched compared with the periphery. Overall enrichment of the 
TEMRA-like  subset of Vδ2
neg T cells was not demonstrated in the liver compared with 
blood, it could be speculated that this is due to the fact that the periphery is already 
heavily enriched for this phenotype of Vδ2neg cells, even in healthy donors (Davey et al., 
2017).  Indeed, in addition to Vδ2neg T cells, data presented in Chapter 6 revealed a 
previously unreported population of gamma delta T cells, Vδ2+Vγ9neg, which are 
apparently enriched in liver but share a similar phenotype with the TEMRA-like Vδ2
neg 
intrahepatic and blood-derived cells.  These cells also had specific clonotypes identified in 
both liver and blood-derived populations, suggesting a clear analogy to the Vδ2neg 
population and raising the possibility that they are potentially similarly vasculature-
associated in nature.  Although Vδ2neg T cell numbers have been demonstrated to 
increase in CMV-infected donors (Pitard et al., 2008) and are capable of targeting CMV-
infected endothelium (Halary et al., 2005), the antigenic trigger for such expansions is still 
unclear.  Despite this, the parallel between these apparently antigenically induced TEMRA-
like populations of Vδ2neg or Vδ2+Vγ9neg T cells in both liver and blood and CMV-specific 
CD8+ αβ T cells is striking.  Recent work from the Prinz group has identified clonal 
response to acute CMV infection following haematopoietic stem cell transplantation in 
gamma delta  T cells (Ravens et al., 2017) and unpublished data from this group also 
supports induction of a clonal response in Vδ2+Vγ9neg cells in CMV infection following 
kidney transplantation.  Furthermore, intrahepatic TEMRA-like Vδ2
neg cells express high 
levels of CD16, previously demonstrated to be upregulated in hCMV-induced gamma 
delta T cells (Couzi et al., 2012).  One hypothesis that could be worthy of future study is 
that these TEMRA-like Vδ2
neg or Vδ2+Vγ9neg cells are vasculature associated, essentially 
composed of antigenically induced memory populations of cells that remain in circulation 
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rather than re-entering tissue, perhaps due to a systemic proliferation in response to viral 
or virally associated antigen, but that remain in close association with vascular 
endothelium, likely through upregulation of integrins such as LFA-1 (McNamara et al., 
2017).  Since the liver is heavily enriched with vascular endothelium, it is possible that 
Vδ2neg T cells that have clonally expanded in blood due to virally-associated antigen are 
then retained within the liver, perhaps through ICAM - LFA-1 interactions, thereby 
generating a large population of liver associated cells that overlap clonotypically with the 
periphery.  Whether these liver associated Vδ2neg or Vδ2+Vγ9neg TEMRA-like cells have any 
specific function in the liver beyond immunosurveillance of the vasculature, although it 
must be emphasised that these populations do exist in CMV-negative donors, so 
involvement in anti-viral responses  may not be restricted to those directed towards 
CMV.  It would be interesting to investigate how this high apparent level of clonal seeding 
from the periphery into the liver for Vδ2neg or Vδ2+Vγ9neg TEMRA-like cells applies to other 
lymphocyte subsets, particularly if there is any observable correlation with liver disease.  
This model and the contrasting TRM-like population of liver-specific clonotypes is 
summarized in Figure 7.1. 
How this model may apply to other tissues is unclear, but in the author’s opinion this is 
certainly worth further investigation.  In tissues where distinct transmigration across 
basal membrane, whether epithelial or endothelial, is required for lymphocytic access it 
could be hypothesised that a greater difference between peripheral and tissue-associated 
Vδ2neg T cells may be observed than is the case in liver.  It would be interesting to 
compare the extent of the TRM-like population of Vδ2
neg in tissues such as  
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Figure 7.1: Intrahepatic Vδ1+ T cells segregate into cytokine producing and cytotoxic 
subsets 
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the gut or lung, where enrichment of Vδ2neg cells has been identified, and also determine 
the extent of the clonal overlap with the peripheral populations, if indeed there is any. 
 
7.4 Vδ2neg gamma delta T cells conform to an adaptive paradigm 
 
Data presented in Chapters 4, 5 and 6 identify strong, private, complex clonal expansions 
in parallel with phenotypic variation from naïve-like CD27hi, CD62L+, IL-7R+, CCR7+ Vδ2neg 
T cells present in the periphery to effector-like CD27lo CD62Lneg, IL-7Rneg, CCR7neg Vδ2neg T 
cells  T cells in the liver.  This is strongly suggestive of TCR-associated antigenically driven 
expansion, in contrast to the essentially semi-invariant like polyclonal expansions of 
Vδ2+Vγ9+ cells presented in Chapter 6.  These data highlight the previously overlooked 
possibility that Vδ2neg T cells are likely predominantly associated with the adaptive 
immune response, rather than the classical innate-like response that appears to apply to 
the Vδ2+Vγ9+ T cell compartment, which features a semi-invariant TCR repertoire 
(Chapter 6).  Further analysis of Vδ2neg cells in lymphoid tissue may help prove whether 
Vδ2neg T cells undergo a similar program of lymph node homing, priming and subsequent 
expansion exhibited by conventional T cells. 
Of course, gamma delta T cells are not MHC-restricted, which raises questions as to how 
they are regulated during development, especially since the majority of bona fide TCR 
ligands so far identified are self-ligands.  It can be hypothesised that a combination of TCR 
binding to self-stress ligands alongside co-stimulation with such surface adhesion 
molecules as ICAM-1 or CD2 may act in concert in order to activate Vδ2neg T cells via TCR 
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(Willcox et al., 2012) – the “multi-molecular stress signal”.  What is clear from this dataset 
is that the repertoire is highly private, with long varied CDR3s, suggestive of a potentially 
huge variety of TCR ligands, perhaps indicative of why so few ligands have been identified 
thus far and of the potential for recognition of exogenous ligands, as suggested by studies 
on γδ TCR-mediated binding to algal protein phycoerythrin (Zeng et al., 2012).   
7.5 The future of tissue-associated gamma delta T cell research 
7.5.1 Vδ2neg gamma delta T cells and cancer immunotherapy 
 
Although a considerable amount of translationally-oriented research has been carried out 
on the Vδ2+ subset of gamma delta T cells in humans, primarily because phosphoantigen-
based expansion protocols are readily available, the Vδ2neg subset are also potential 
vectors of adoptive transfer and chimeric antigen receptor (CAR)-based cellular therapies.  
Demonstrated to be capable of killing haematologically and epithelially derived 
malignancies both in vitro (Wu et al., 2015) and using murine models (Devaud et al., 
2013), human Vδ2neg T cells share with Vδ2+ T cells the advantage of being non-MHC 
restricted.  This means they can by-pass one problem encountered with αβ T cell 
therapies, namely tumour mediated downregulation of MHC or antigen processing 
defects.  Additionally, they express many NK receptors that enable non-TCR mediated 
recognition of stressed tumour cells conferring in some cases superior cytolytic potential 
than other T cell subsets (Choudhary et al., 1995).   
Finally, and as demonstrated in this study in the transmigration experiment detailed in 
Chapter 3, Vδ2neg are capable of migrating into and being retained in solid tissues such as 
liver at a better rate than αβ T cells, meaning they are potentially more likely of reaching 
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their intended tumour target, and have been demonstrated to be capable of infiltrating 
tumours in several solid cancers (Kitayama et al., 1993, Ferrarini et al., 1996, Cordova et 
al., 2012). Moreover, a meta-analysis of 18,000 human tumours identified a gamma delta 
T cell signature as most highly linked with favourable outcome (Gentles et al., 2015), 
although the basis of this signature is questionable since the TCR itself was not included 
in the array data analysed and gamma delta T cells do share a strong TH1 transcriptional 
profile with many cytotoxic lymphocytes.  
Recent work has identified GMP-compliant expansion methods for Vδ1+ gamma delta T 
cells for adoptive transfer (Almeida et al., 2016) and there is also on-going work looking 
to use gamma delta T cells as CARs, exploiting the natural cytolytic and homing properties 
of these cells with a recombinant tumour associated antigen specific TCR receptor 
(Mirzaei et al., 2016).  Although questions regarding co-stimulation still need to be 
addressed, there is great potential in such immunotherapy.   
7.5.2 Vδ2neg ligand identification 
 
As described in Chapter 1, one of the greatest challenges in gamma delta T cell biology is 
the identification of TCR ligands for the Vδ2neg subset of cells.  Sequence level TCR 
repertoire studies such as those carried out in this thesis may prove a useful platform for 
ligand identification by tissue associated gamma delta T cells.  Recent studies have 
suggested that Vδ1 TCRs are capable of recognising antigen via a predominantly non-
CDR3 associated interaction (Uldrich et al., 2013), throwing into question the extent of 
the gamma delta CDR3 in antigen binding.  However, most ligand identification studies 
for Vδ2neg, including Uldrich et al, are based on a priori selection of target, for example 
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from CD1d-reactive cells, which represent a very low proportion of the actual gamma 
delta T cell population present in most individuals.  By placing more emphasis on the 
immunophenotype and TCR repertoire data generated in studies such as this one, ligand 
identification studies will focus on physiologically relevant clonotypes that are expanded 
in vivo.  This approach could then be used to define TCR ligands with respect to specific 
stress stimuli such as infectious challenges, including CMV infection.     
Having identified whole CDR3 regions from single cell PCR, it is possible to transfect both 
primary human T cells or cell lines such as Jurkat cells with full length specific expanded 
TCRs identified in samples obtained in studies such as this one.  One could then adopt a 
screening strategy using tissue-relevant transformed cell lines to identify reactive TCR-
transductants, and then in combination with blocking antibodies (Halary et al., 2005) and 
RNAseq of the targets attempt to identify cell surface moieties critical to activation.  
Further insight may be gained from ACD’s BASEscope technology, allowing localisation of 
T cells with specific TCR sequences within tissue.  Knowing where in the tissue specific 
clonotypes are localised may allow better definition of likely antigenic targets. 
7.5.3 Single cell transcriptomics of tissue associated gamma delta T cells 
 
As an extension of the index sorted single cell PCR conducted in Chapter 5, 
transcriptomics studies, including single cell transcriptomics would be of great interest.  
Advances in fluidics and RNA sequencing technology now allow analysis of the 
transcriptome of individual cells by RNASeq (Haque et al., 2017), allowing an 
unprecedented insight into the heterogeneity of individual cells.  Algorithms such as 
TraCeR now also allow interrogation of such transcriptomic data for TCR sequences, 
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allowing correlation of clonality with transcriptome and tracking of clonal fate in 
response to infection (Stubbington et al., 2016).   This algorithm has since been modified 
to identify gamma delta T cell TCR sequences (Stubbington & Willcox, unpublished).  With 
access to such powerful analytical tools, one can envisage comprehensive tracking of 
gamma delta clonotypes within blood and solid tissues and in combination with protein 
level index sorting and RNASeq build a detailed portrait of the processes governing 
activation, differentiation and migration of these cells. 
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